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COMPUTATIONAL MODELING AND SIMULATION STUDY OF DERMAL 
WOUND HEALING PROLIFERATIVE PHASE 
 
By Le Yang 
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Virginia Commonwealth University, 2011 
 
Major Director: Tarryn M. Witten, Ph.D 
Associate Professor, Center for the Study of Biological Complexity 
 
Dermal wound healing proliferative phase is a complicated physiological process in 
which many growth factors, cell types and matrix components participate. The 
process must be well coordinated to restore the structural and functional integrity 
of tissue injured. Many disorders interrupting healing process result in abnormal 
healing such as chronic wounds or excessive scarring. Mathematical modeling has 
been used to investigate many aspects of wound healing.  
Angiogenesis is pertinent for dermal wound healing since the cellular activities 
involved in tissue repair requires oxygen and nutrients to be delivered to the wound 
site. By using a hybrid agent-based model, we investigated the interactive dynamics 
of vasculature growth and collagen network growth. Our model further examine the 
effects of tissue oxygen tension (hypoxia, normoxia,  hyperoxia) on healing process.  
XIV 
 
Wound contraction is generally beneficial for the overall healing since it reduces the 
wound size thus reduces the chance to be infected. However, contraction going 
overboard may result in excessive scarring. Our model seeks to investigate the 
source of driving force during early and late stage of wound contraction. For the 
first time, skin is modeled as a fiber-reinforced anisotropic soft tissue.  The effects of 
a dynamically orienting collagen matrix on the contraction process are thus shown. 
The simulation results of the model agree with the hypothesis that scar formation is 
the byproduct of collagen fiber synthesis and alignment in the presence of the 
tensile stress field generated by a wound contraction process. 
Multi-scale modeling is illuminating because it can help explain the phenomena at 
tissue level by the subcellular level events. We built a multi-scale model of general 
wound healing proliferative phase by embedding a TGFbeta pathway to each 
fibroblasts. The subcellular level model is an ODE system and the cellular level 
model is a hybrid agent-based model of fibroblast migration, proliferationg and 
collagen production. Our model clearly shows how varying mechanics of the 
subcellular level system results in varying tissue level pattern (collagen orientation 
and cell population distribution). The model can be further extended to incorporate 
subcellular events relating to angiogenesis and wound contraction. 
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1 Introduction 
1.1 Wounds cause economic burden and deteriorate the quality of 
patient’s life 
1.1.1 Life Quality is deteriorated by wounding 
Patient’s life Quality is adversely affected by wounding, especially chronic wounds.  
Wounds are rarely life threatening, but may have a major impact on patient’s life quality, 
including physical, psychological and social problems. [1]  
Wound pain is a serious problem for elderly patients suffering from chronic leg ulcers, 
and it may lead to reduced wound healing rates.[2] Chronic wound pain is caused by 
regular procedures (dressing changes) or intermittent manipulation (debridement) of the 
wound, or by the wound itself. Other causes of pain are wound infection and 
inflammation.  
The burn victims are subjected to intense trauma: they experience severe pain, have a 
prolonged hospital stay, has been suddenly and catastrophically separated from his family 
and work, as well as suffering some degree of scarring and deformity.  
 Clinical condition of venous ulcer patients--- such as the long duration of tissue repair, 
the high frequency of recurrences, and the high treatment costs--- cause many problems.  
They have significantly greater lack of mobility, more worries and concerns about health, 
lower lever of self-esteem, depression, psychosocial suffering, sleep disorders, feelings of 
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frustration, difficulties in body hygiene, social isolation, and difficulties at work, among 
others. [3]   
Leg ulcers impaired mobility was swelling of the leg. For younger, working patients, leg 
ulceration was correlated with time lost from work, job loss, and adverse effects on 
finances. Fifty-eight percent of patients found caring for the ulcer burdensome. There 
was a strong correlation between time spent on ulcer care and feelings of anger and 
resentment. Sixty-eight percent of patients reported that the ulcer had a negative 
emotional impact on their lives, including feelings of fear, social isolation, anger, 
depression, and negative self-image.  [4] 
Wound care is crucial to life quality of dying people. The majority of people die from 
chronic degenerative diseases. Dying patients may have surgical wounds, complicating 
wound (e.g. pressure ulcers), and malignant wounds. The skin of dying patients can be 
fragile and sensitive and is subsequently at risk of being compromised from wound 
exudates, body fluids, pressure, and friction. Owing to advanced chronic conditions or 
malignancies, wound care can complicate care, increase the cost of care, and threaten the 
quality of life for patients. Providing wound care, although it is often curative, is also 
palliative to the patients at the end of life. [5] 
Given that wounding and wound-caused complication with other diseases have greatly 
deteriorated patients’ life quality, we are expecting more efficient treatment and 
manipulation to promote wound healing, to help patients return to baseline standards 
earlier, or to relive pain and immobility of the dying. 
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1.1.2 Cost Analysis of wound 
Wound causes a great economic burden to the national health system because of its high 
frequency of occurrence and complication with other diseases. In the following, I will 
give a comprehensive overview of the economic burden caused by wound. 
Injuries (exclude fracture) account for a considerable share in the global burden of 
disease, which is estimated at 12% for the established market economies and even higher 
shares for other global regions. In addition to their impact on public health, injuries are a 
major source of health care costs, similar to the costs of cancer and stroke. Total medical 
costs of injury were 1.15 billion or 3.7% of total health care costs[6].       
Without medical need for hospitalization, minor injuries account for a substantial share of 
health care costs. In the Netherlands, superficial injury (mainly bruises, abrasions and 
contusions) accounts for 13.4% of these total injury health care costs, while open wounds 
accounts for 7%. They are ranked as the 2nd and 3rd among injuries with the highest 
health care costs. Patients with minor injury account for 50% of ED patients[6] . 
 Acute open wounds that require additional health care resource utilization via referral to 
home health care impose a significant economic burden on society and the healthcare 
system in the US. Only 40.6 % of patients with open wounds referred to home health care 
had private insurance and for burn patients only 34.9% of home health care referrals had 
private insurance. Taxpayer subsidized government insurance paid for 48.9% of acute 
open wounds. The increased complexity of care that must be provided to these patients 
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and the poor payer mix of this population put a severe economic strain on both the 
institutions and physicians.[7] 
Chronic wounds affect over 6.5 million Americans per year or 1% of the US population. 
The vast majority of these wounds are pressure ulcers, venous stasis ulcers, and diabetic 
foot ulcers. These conditions have been well characterized epidemiologically and cause 
considerable morbidity, mortality, and financial burden. Overall, chronic wounds account 
for 2% of all health care spending, with wound care products alone totaling more than $7 
billion annually. [7] 
Gunshot wounds cost Americans $2.3 billion each year to treat and taxpayers are footing 
about half the bill. Using information from 10 large data banks, the researchers calculated 
the cost of each gunshot wound treated in a hospital at $14, 600 for emergency care and 
$35,400 for lifetime medical care. Wounds resulting from deliberate assaults with 
firearms accounted for three-fourths of the total cost of treatment. Spinal cord injuries 
resulted from only 2 percent of gunshots but accounted for half the cost of treatment.  
Age-related delayed healing, associated with excessive inflammation and matrix 
degradation, creates a tremendous financial burden to health services worldwide, with 
costs for largely ineffective treatment exceeding $9 billion per annum in the U.S. 
Hypertrophic scar formation is caused by accidental injuries and surgical procedures. 
Although the incidence of hypertrophic scarring following these types of injuries is not 
known, it is a common outcome that creates a problem of enormous magnitude. 
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Treatment of these cases is estimated to cost at least $4 billion per annum in the US 
alone. [8] 
1.2 The physiological mechanisms of wound healing 
 
According to the degree and depth of injury, wounds can be classified into epidermal and 
dermal wound.  An epidermal wound is a superficial one where the vasculature and 
dermal matrix underlying epidermis are not affected. Epidermal wound simply heals by 
kerotinocytes migrating from the wound edges, leading to the recovering of the wound 
surface[9]. A dermal wound is also called a full-depth wound, in which vasculature and 
dermal matrix are destroyed. In order for a dermal wound to heal, numerous biological 
events need to be orchestrated to rebuild the vasculature and matrix. In the rest of this 
section, I will briefly introduce the physiological mechanisms of general dermal wound 
healing. This is followed by detailed description of events during proliferation phase in 
section 1.2.1 and discussion of abnormal healing in section 1.2.2-1.2.3. 
The physiological process of dermal wound healing is artificially divided into four 
phases: coagulation; inflammation; proliferation; remodeling. [10] 
Coagulation occurs instantly after an injury. Exposure of blood to collagen and tissue 
factors triggers platelets activation and fibrinogen conversion. Fibrinogen is converted to 
fibrin which polymerizes to form a blood clot. Platelets accumulate in the clogging area 
and release pro-inflammatory chemicals to attract neutrophils and macrophages. The 
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fibrin clot prevents excessive bleeding, and is the main structural support for the wound, 
and a matrix for invading cells, until collagen is deposited. [11] 
Inflammation starts during the late phase of coagulation. During this phase, neutrophils 
and macrophages are recruited by platelet-released factors and arrive at the wound site. 
They will get rid of bacteria and debris by phagocytosis.  On the other hand, they will 
further release growth factors and chemokines to stimulate the granulation process. Upon 
completing their task, the neutrophils and macrophages will be eliminated from the 
wound by apoptosis.[12] 
After bacteria and debris are cleaned out, fibroblasts start to infiltrate the wound and 
dissolve the fibrin clot replacing it with a collagen matrix. Angiogenesis occurs to repair 
the destroyed vascular system. The closure of the wound is accomplished by the process 
of epithelialization and wound contraction. This phase is called proliferation, which starts 
on the third day after wounding and lasts for about 2 weeks thereafter. 
During remodeling phase, the preliminary collagen matrix is remodeled to give a mature, 
organized matrix, again by dermal fibroblasts, which can take several months to a year. 
Type III collagen, which is prevalent during proliferation, is gradually degraded and the 
stronger type I collagen is laid down in its place. Originally disorganized collagen fibers 
are rearranged, cross-linked, and aligned along tension lines. 
Participating growth factors and cell types during different phases and their functions are 
summarized in Table1.1. 
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Phases Cell types and their functions Cytokines and their functions 
Coagulation Platelets---provide initial signals to begin 
the repair process 
PDGF---main origin platelets; macrophage chemotaxis 
TGFβ---main origin platelets; macrophage chemotaxis 
Inflammation Neutrophils---important cells to prevent 
wound infection, ingestion and 
destruction of bacteria and foreign 
materials 
Macrophages---the most essential 
inflammatory cell for wound healing 
a.PDGF---main origin macrophages; fibroblast chemotaxis and 
proliferation;   
b.FGF---main origin macrophages; fibroblast chemotaxis and 
proliferation; 
c.IL-1, TNF---additional chemical signals to stimulate fibroblasts to 
proliferate 
Proliferation Macrophages, neutrophils--- 
Fibroblast---the only type of cells that 
synthesizes the extracellular matrix, so 
play a critical role in wound healing. 
Myofibroblast--- 
a. PDGF---main origin macrophages, endothelial cells;  stimulate 
fibroblasts to produce MMP, fibronectin and hyaluronan; angiogenesis 
b. TGFβ---main origin macrophages, endothelial cells, fibroblasts;  
stimulates fibroblasts to produce collagen; TIMP synthesis; MMP 
production inhibition 
c.EGF---main origin macrophages; fibroblast proliferation, granulation 
tissue formation 
d.FGF---main origin endothelial cells, fibroblasts; fibroblast 
proliferation; angiogenesis; wound contraction; matrix deposition 
d.VEGF---main origin mesenchymal cells; endothelial cell proliferation 
e.KGF---main origin fibroblast; kerotinocyte migration, proliferation 
and differentiation 
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Remodeling Fibroblast a.PDGF---main origin endothelial cells; wound remodeling 
Table1.1 Participating growth factors and cell types during different phases of wound healing and their functions. 
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1.2.1 Cellular and molecular events during proliferation phase 
1.2.1.1 Fibroplasia and granulation tissue formation. 
Granulation tissue is formed in connective tissue layer during wound healing, chronic 
inflammation, and certain pathological conditions. It is light red or dark pink in color, 
being perfused with new capillary loops or buds, soft to the touch, moist and bumpy in 
appearance. In wound healing, granulation tissue formation is a prerequisite for normal 
tissue regeneration. It begins to appear in the wound already during the inflammatory 
phase, gradually replaces the fibrin clot during proliferation phase, and continues 
growing until the wound bed is covered.  It functions as rudimentary tissue, providing 
viable matrix for kerotinocytes to migrate across during re-epithelialization.  [13] 
Granulation tissue is a dense population of blood vessels, macrophages, and fibroblasts 
embedded within a loose provisional matrix of fibronectin, hyaluronon and collagen. The 
provisional matrix is different in composition from normal tissue matrix, and its 
components originate from fibroblasts. It contains more fibronectin and hyaluronan, 
which create a very hydrated matrix and facilitate cell migration.  Later on this 
provisional matrix is replaced by normal tissue matrix, which contains more 
collagen.[13] 
Fibroblasts are a type of cells that synthesizes the extracellular matrix, the structural 
framework for animal tissues. Fibroblasts are morphologically heterogeneous depending 
on their location and activity. Unlike the epithelial cells, fibroblasts do not form flat 
monolayers. Instead, they are sparsely distributed in dermis.  Fibroblasts can migrate 
slowly over substratum as individual cells, again in contrast to epithelial cells, which 
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migrate as a continuous sheet. The main function of fibroblasts is to maintain the 
structural integrity of connective tissue by continuously secreting precursors of all 
components of the extracellular matrix. 
Granulation-tissue fibroblasts are specific types of fibroblasts which appear transiently in 
regenerating wound tissue and seem to persist in chronically inflamed tissue. They have 
many properties different from normal tissue fibroblasts, including altered cell 
morphology, proliferation rate, interaction with fibronectin, and response to growth 
factors [14]. Morphologically, granulation-tissue fibroblasts are mainly large, indicating 
active metabolism. Granulation-tissue fibroblasts show a more pronounced decrease in 
proliferative capacity. They show enhanced type I and III pro-collagen production[15]. 
Granulation fibroblasts play critical roles in wound healing. In the first two or three days 
after wounding, fibroblasts mainly proliferate and migrate, while later, they are the main 
cells that lay down the collagen matrix in the wound site.  
Fibroblast proliferation and its regulatory mechanism.Fibroblasts proliferate before 
they migrate into wound site. There is a spectrum of growth factors that can stimulate 
fibroblast to proliferate, including EGF, FGF, PDGF, IGF, TNFα and TGFβ. Hypoxia 
and ECM components such as fibronectin also encourage fibroblast proliferation. 
Fibroblasts migration and its molecular mechanism. Fibroblasts are scattered 
throughout the dermis before the wound occurs. After wounding, in response to the 
chemical signals given by neutrophils and macrophages at the wound site, fibroblasts 
residing in the nearby tissue become motile and migrate to the wound following the 
11 
 
chemotactic signals.  PDGF and TGFβ both serve as chemokines for fibroblast 
chemotaxis. 
 The general mechanism of chemotaxis depends on the cell’s ability to sense the spatial 
gradient of the cytokines and to become polarized, which requires signaling events.  For 
fibroblasts, the main signaling events involved in chemotaxis is PI3K-Akt pathway, and 
Ras GTPase and Rho GTPase[16]. PI3K stimulates PIP3 accumulation at the plasma 
membrane, and allows for recruitment and phosphorylation of proteins containing 
plackstrin homology domains, such as Akt, also allows for the reorganization of 
cytoskeleton[17].   Polarization of cell is the result of differential receptor activation at 
either end of the cell, thus polarized membrane distribution of PI3K molecules[18]. 
Spatial asymmetry in signaling drives the polarized actin modifications. The growing 
distal ends of actin filaments develop connections with the internal surface of the plasma 
membrane via different sets of peptides and results in the formation of pseudopods.   
In addition to chemotaxis, ECM provides another directional clue for fibroblast 
migration. On the one hand, fibroblasts will co-orient with local collagen direction. On the 
other hand, cells migrate up a gradient of cellular adhesion sites or substrate-bound 
chemoattractants (haptotaxis). These gradients are naturally present in ECM during wound 
healing. ECM mediates fibroblast migration through integrin-related signaling pathway. 
Integrin ligands, such as fibronectin, are not passive adhesive molecules but are active 
participants in the cell adhesive process that leads to signal transduction[19].  Integrin-
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mediated cell adhesion causes increased tyrosine phosphorylation of focal adhesion 
kinase(FAK), leading to cytoskeletal organization and focal adhesion formation[20].        
Collagen production and regulatory mechanism.  Collagen is the most abundant protein 
in human body. It provides strength and structure for all tissues. It forms organic mass for 
bone, skin, tendon, blood vessels, cornea, etc. and serves as framework for liver, spleen 
and kidney. The main source of collagen is fibroblast. It can be degraded by collagenases 
and other factors, among which is matrix metalloproteinase (MMP). The function of 
MMP is inhibited by tissue inhibitor of metalloproteinase (TIMP)[21]. The balance 
between MMP and TIMP regulates the collagen deposition dynamics [22]. TGFβ regulate 
collagen production and metabolism. It stimulates the synthesis of collagen and fibronectin, as 
well as many other ECM components by fibroblasts. It also inhibits MMP production, while 
stimulate TIMP production[23]. There are principally two types of collagen: type I and type 
III. Type III collagen is abundant in granulation tissue, while type I mainly resides in 
normal tissue. In the remodeling phase of wound healing, type III collagen is gradually 
replaced by the stronger type I collagen. The ratio of type I to type III collagen 
determines the diameter of collagen fibers, thus affecting the physical properties of 
collagen network.  
The functions of TGFbeta, PDGF signaling and ECM signaling are interactive. 
TGFbeta signaling and PDGF signaling are regulated by each other. In certain conditions, 
they will repress each other so that fibroblasts will not achieve a phenotype that can both 
migrate and secret collagen to the maximal extent. 
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ECM affects the function of growth factors directly or indirectly.  ECM can directly bind 
and release certain growth factors, which sequester and protect them from degradation, 
and enhance or inhibit their activity. One example is that binding of TGFbeta to decorin, 
betaglycan and biglycan inhibits its activity. Binding of cells to ECM via integrins 
enables cells to respond to growth factors, and can induce growth factor expression.  For 
example, the extent of PDGF induced fibroblast proliferation is dependent on the 
mechanical properties of ECM[24]. Additionally, subcomponents of ECM molecules can 
bind to cell surface receptors for cytokine or growth factors, stimulating cellular 
activities.[23] 
1.2.1.2 Epithelialization  
The healing of a wound requires epithelial cells to migrate across the newly established 
granulation tissue to form a barrier between the wound and the environment. Basal 
keratinocytes from the wound edges and dermal appendages such as hair follicles, sweat 
glands and sebacious glands are the main cells responsible for the epithelialization. 
Keratinocytes migrate without first proliferating. Migration can begin as early as a few 
hours after wounding. However, epithelial cells require viable tissue to migrate across, so 
if the wound is deep it must first be filled with granulation tissue. Cells on the wound 
margins proliferate on the second and third day post-wounding in order to provide more 
cells for migration. Migration of keratinocytes over the wound site is stimulated by lack 
of contact inhibition and by chemicals such as nitric oxide. Growth factors cause cells to 
proliferate at the wound edges. 
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1.2.1.3 Angiogenesis 
When a wound occurs, the vasculature at the wound site is destroyed. Since the activity 
of fibroblasts and epithelial cells require oxygen and nutrients, establishment of a new 
vasculature is imperative for restoring the impaired tissue. The vasculature is formed 
from existing vessels at the surrounding tissue through sprouting angiogenesis. VEGF 
stimulates endothelial cells to degrade basal lamina and escape parent vessel, thus form 
new capillary tips. These tips migrate up chemokine gradient, repeatedly branch and form 
loops by anastomosis. Blood flow in the wound site is gradually restored in the new 
vascular network. Remodeling of the newly formed vascular network gives a mature 
vasculature. A detailed mechanism of wound healing sprouting angiogenesis is given in 
Section 2.1.1. 
1.2.1.4 Wound contraction 
Contraction is key phase of wound healing. By reducing wound size, wound contraction 
is usually beneficial to the overall repair process. At first, contraction occurs without 
myofibroblast involvement. The coordinated migration of a densely packed rim of freshly 
proliferated fibroblasts pulls the wound edge inward. Myofibroblast acts its role mainly 
after fibroblasts stop migrating. Myofibroblasts are differentiated from fibroblasts 
stimulated by growth factors.  They attach to each other and to the wound edges by 
desmosomes and link across cell membrane to ECM molecules like fibronectin and 
collagen. Myofibroblasts have many such adhesions, which allow them to pull the ECM 
when they contract, reducing the wound size. A detailed discussion of wound contraction 
mechanism is given in Section 3.1.1. 
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1.2.2 Physiology of chronic wound 
 
Wounds are chronic or acute depending on the healing trajectories followed. Whereas 
acute wounds follow the wound healing process described before, disruption of any stage 
in this complex cascade may lead to chronicity. In most chronic wounds, however, the 
healing process is thought to be stuck in the inflammatory or proliferative phases. As 
growth factors, cytokines, protease, and cellular and extracellular elements all play 
important roles in different stages of the healing process, alteration in one or more of 
these components could account for the impaired healing. 
There are significant differences between acute and chronic wound microenvironment.  
The amounts and types of proteases and their inhibitors differ, so acute wound fluid 
(AWF) is stimulatory to cells in culture whereas chronic wound fluid (CWF) appears 
inimical to cell proliferation. Bleeding from acute wounds results in the release of growth 
factors that help to orchestrate the wound-healing process - healing occurs spontaneously, 
rapidly, and in predictable phases. CWF are characterized by elevated levels of pro-
inflammatory cytokines (TNF-α, IL-1β), proteases (MMPs) and neutrophils elastase, and 
reduced levels of tissue inhibitors of metalloproteinases (TIMPs) [25].  The cytokines 
cause excessive inflammation and the proteases are extremely detrimental for normal 
functioning of connective tissue proteins and growth factors.  CWF also have reduced 
levels of growth factors, such as PDGF, bFGF, EGF and TGF-β. [26] 
In the phases of normal wound healing the production and activity of proteases are tightly 
regulated but this regulation appears to be disrupted in chronic wounds[27]. The elevated 
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pro-inflammatory cytokines and proteases in chronic wound fluid are due to increased 
amount of neutrophils and their hyper-stimulation.  This is further exacerbated by 
susceptibility of open wound to infection.[26]  
The components of ECM are altered in chronic wounds compared to acute wounds. 
Elevated levels of chemokines and proinflammatory cytokines lead to an abnormal 
secretion and activation of different proteinases, which may result in a suboptimal ECM 
composition that diminishes the action of growth factors via reduced integrin binding.  
Type I and III collagen, laminin, and tenascin in diabetic foot ulcers are not remarkably 
different from those seen in acute wounds.  Fibronectin was absent in the base of non-
healing venous leg ulcers. Fibronectin deficiency may impair cellular migration and 
proliferation. This is related to increased degradation rather than to decreased synthesis. 
Degradation products of fibronectin, vitronectin and tenascin-C are found in CWF. 
Fibronectin fragments are capable of inducing MMPs. [28] 
Epithelialization in chronic wounds is often impaired, which appears to be due to faulty 
ECM and impaired signaling required for keratinocyte motivation.  Angiogenesis is 
disturbed in chronic wounds as CWF is detrimental to tubule formation by endothelial 
cells. [28] 
Fibroblast activity is altered in chronic wounds. Diabetic fibroblasts showed a significant 
lower proliferation rate and altered morphology. It is concluded that the diabetic process 
and the ulcer environment itself cause the fibroblasts to age. [29]Diabetic fibroblasts also 
have a decreased proliferation response to growth factors, caused by a deficiency in 
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growth factor receptor expression, or by dysfunctional intracellular signal pathways[30].  
Diabetic fibroblasts exhibited a 75% reduction in migration compared to normal 
fibroblasts, and was not significantly stimulated by hypoxia. Diabetic fibroblasts 
produced twice the amount of pro-MMP as normal fibroblasts. Diabetic fibroblast 
exhibited a seven-fold impairment in VEGF production compared to wild-type 
fibroblasts.[31] 
In chronic wounds, the interactions between growth factors and ECM are disrupted, most 
often due to systemic abnormalities such as diabetes or venous insufficiency. The 
fundamental biochemical abnormalities of the chronic wound ECM, as well as increased 
levels of proteases like MMPs and neutrophils elastase, preclude the progression of 
ECM-growth factor interactions that are needed to heal wounds. ECM and growth factor 
abnormalities in diabetic, venous and other chronic wounds may result from underlying 
pathophysiological processes.  Ulcers are distinguished from acute wounds by the loss of 
tissue from the epidermis and dermis, including both cells and ECM.  Venous ulcers are 
caused by circulatory deficits such as microangiopathy and reduced skin perfusion. The 
skin of individuals with venous insufficiency can be fibrotic and edematous, and minor 
trauma or infection can result in dermal fibrosis and ulcer formation. The loss of ECM 
that characterizes these ulcers may occur due to an imbalance between matrix degrading 
enzymes and their inhibitors, mechanical disruption of the tissue such as physical 
debridement, and bacterial overgrowth. [23] 
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1.2.3 Physiology of excessive scar 
There are several basic results of the healing process: regeneration (perfect replacement), 
average repair (reestablished equilibrium), exaggerated healing (fibrosis and 
contractures), and deficient healing (chronic ulcers). Scars are caused by fibrosis, which 
comprise of excess amounts of collagen in the wound as the body attempts a repair. The 
net result is that the original skin defect is replaced by a nonfunctional mass of tissue.  
Many scars eventually fade. But they tend not to go away completely. 
Sometimes the body goes overboard in the healing process, leading to the development of 
thick or raised scars. There are several types of these “problematic” scars. Hypertropic 
scars are raised, pinkish-red areas located inside the borders of the original injury.  In 
some cases, hypertropic scars shrink and fade on their own. Keloids are raised, deep-red 
areas that tend to cover much more area than that of the original injury. Even when 
surgically removed, keloids tend to recur. 
Normal skin contains collagen bundles running parallel to the epithelial surface. In 
hypertrophic scars, the primarily type III collagen bundles are flatter, with the fibers 
arranged in a wavy pattern.  In keloids, collagen bundles are virtually nonexistent, and 
the collagen type I and III fibers lie in haphazardly connected loose sheets randomly 
oriented to the epithelial surface. [32] 
 The pathophysiology of hypertrophic scar formation involves a constitutively active 
proliferation phase of wound healing, which features high vascularity and robust 
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inflammation. The activities of fibroblasts seem to be continually turned on.  In keloids, 
the collagen synthesis is approximately 20 times as great as that in normal unscarred skin 
and three times as great as in hypertrophic scars. The ratio of type I to type III collagen is 
also high, which may be due to the inefficient down-regulation of type I collagen 
synthesis.  Keloid fibronectin biosynthesis rate is 4 times as high as normal scars.[32] 
High vascularity and persistent inflammation can account for each other through positive 
feedback loops. The net result is that the original skin defect is replaced by a 
nonfunctional mass of tissue, which does not regenerate into normal tissue [8].   
Various growth factors influence scar and keloid formation.  The majority of cells 
involved in wound healing express TGFbeta in an inactive form that strongly promotes 
the chemotaxis of fibroblasts to the site of injury. Moreover, TGFbeta plays a critical role 
in fibroblast proliferation and collagen production. When wound repair is completed, the 
activity of TGFbeta is normally turned off. In keloidal tissue, TGFbeta is overproduced 
and poorly regulated through normal autocrine signaling mechanism. At the same time, 
keloid fibroblasts have greater numbers of growth factor receptors and respond more 
intensely to growth factors such as TGFbeta and PDGF. [32] 
Less synthesis of MMPs may also explain the lack of scar regression seen in keloids[33].  
Furthermore, disturbed apoptosis mechanisms are discussed in the development of 
hypertrophic scars and keloids[34].  
Mechanical environment of ECM is essential in hypertrophic scar development. 
Fibroblasts and keratinocytes respond to the density and orientation of collagen and other 
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matrix components. As a result, cells from the wound martin proliferate, while those at 
the wound site produce and remodel the surrounding matrix.  It is this delicate balance 
that is responsible for a rapid and healthy response. Differentces in exogenous forces may 
act to change cellular activation in the wound healing milieu and, when over-activated, 
lead to hypertrophic scar formation. Skin subjected to high levels of stress (secondary to 
trauma or joint movement) usually demonstrates robust hypertrophic scar formation. [8] 
Early fetal wound healing is characterized by the complete absence of scar formation, 
with both low fibroblast activity and a decreased inflammatory response to injury.   When 
compared to fetal wound healing, adult wound healing is a response to injury that 
sacrifices the regeneration of original tissue for a rapid matrix plug, or scar, that protects 
the organism from infection and trauma.  
 The cellular and molecular differences between embryonic and adult wounds help 
explain the different healing results.  In the embryo the immune system is developing, so 
embryonic wounds have lower numbers of less differentiated inflammatory cells, 
inducing a much shorter period of inflammation. Embryonic skin contains high levels of 
morphogenetic factors involved in skin growth, remodeling and morphogenesis. As a 
consequence of these two principal variables (altered inflammatory response and skin 
morphogenesis), growth factor profile in a healing embryonic wound is very different 
from that in an adult wound. Low levels of TGFbeta1 and TGFbeta2, low levels of PDGF 
and high levels of TGFbeta3.[35] 
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 Embryonic wounds contain increased levels of hyaluronic acid(HA), which can 
significantly inhibited fetal fibroblast proliferation, while stimulating collagen and non-
collagen protein synthesis. A reduction in fetal wound HA results in an adult-like healing 
response with increased fibroplasias and neo-vascularization. [36] Despite marked 
increases in fetal wound collagen synthesis, fetal wounds exhibited no evidence of 
excessive collagen deposition, indicating rapid collagen turnover and degradation[37]. 
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2. A hybrid agent based model of sprouting angiogenesis during 
wound healing 
2.1 Introduction 
Sprouting angiogenesis is the process of new capillaries forming from existing vessels. It 
is a normal and vital process in growth and development. It can also be observed under 
pathological conditions, such as wound healing and tumor growth. During wound healing 
proliferative phase, the process of angiogenesis occurs concurrently with fibroblasts 
proliferation, collagen production and epithelial cells migration. Actively proliferating 
and migrating fibroblasts and epithelial cells consume oxygen and nutrients at a fast rate, 
which makes angiogenesis imperative for other events during proliferative phase of 
wound healing. 
2.1.1 Sprouting angiogenesis during wound healing  
When a wound occurs, the vasculature at the wound site is destroyed. A series of events 
must occur to establish a new vascular network in the wound site. The process begins 
with bleeding and coagulation, during which platelets and proteins come into the wound 
to form a clot to prevent further bleeding. Inflammatory cells, like macrophages and 
platelets accumulate at the wound site to degrade necrotic tissue and bacteria. At the 
same time, they produce angiogenic growth factors in response to hypoxia.  The 
coagulation proteins, inflammatory cells, and metabolic byproducts provide a flood of 
growth and angiogenic factors into the wound environment, which is conditioned to a 
moderate hypoxia, an accumulation of lactate, a slight lowering of pH, and an elevation 
of pCO2. The growth factors recruit fibroblasts, while the angiogenic factors recruit 
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endothelial cells, which accumulate in the wound region. The accumulation and 
activation of cells increases the requirement for a blood supply, usually well beyond the 
capacity of the normal vessels that once fed the site. Fibroblasts produce collagen to 
replace the temporary fibrin matrix, as well as to promote the growth of capillary tubes. 
Endothelial cells line the capillary tubes that allow for blood flow into the required 
wound site. Once the metabolic needs of healing are met and the wound closes, the new 
vessels regress, leaving a vascularized fibrous scar containing a collagenous matrix that 
persists somewhat in proportion to the degree to which inflammation has occurred and 
the time that has been required for healing. In short, wound angiogenesis represents a 
response to coagulation, inflammation, and temporary metabolic need. 
The detailed process of angiogenesis is given as following: 
VEGF is the most important one among several growth factors involved in the process of 
angiogenesis. VEGF diffuse throughout the wound space and form a spatial gradient 
before it arrives at the existing vasculature at the wound boundary. Once VEGF has 
reached a vessel, it binds with receptors located on endothelial cells (EC), which line the 
vascular vessel wall. This binding stimulates endothelial cells to release proteases to 
degrade the basal lamina, and then to escape parent vessel walls and enter extracellular 
matrix (ECM). Further signaling events, initially triggered by VEGF, increase EC 
proliferation and coordinate the selection of migrating ECs located at the tip of 
outgrowing sprouts. 
24 
 
Migrating sprout tip cells probe their environment by extending filopodia and migrate 
along VEGF gradient toward regions of higher concentration, a directed motion referred 
to as chemotaxis. ECs are also attracted to the wound area by fibronectin found on the 
fibrin scab. ECs located behind the migrating tip cells proliferate, thus extending the 
sprouting blood vessel. The heterogeneity and the anisotropy of the extracellular matrix 
can also affect the movement /extension of capillary sprouts. The resistance of the 
extracellular matrix for the sprout extension might be strong in some directions and weak 
in others. This is realistic since collagen network of ECM can possess structured 
orientation.  
After the initial sprouts have extended for some small distance to the ECM, repeated 
branching of the tips can be observed. Sprout tips approaching each other may fuse and 
form loops, a process called “anastomosis”. Another mechanism of anastomosis is that 
sprout tips can fuse with already established sprouts. The formation of lumen within the 
strands of endothelial cells establishes a network that allows blood circulation.  
ECM is multi-functional on vasculature morphogenesis[44-46]. ECM serves essential 
functions in supporting key signaling events involved in regulating EC migration, 
invasion, proliferation and survival. Moreover, the provisional ECM serves as a pliable 
scaffold wherein mechanical guidance forces are established among distal ECs, thereby 
providing organizational cues in the absence of cell-cell contact. Finally, through specific 
integrin-dependent signal transduction pathways, ECM controls the EC cytoskeleton to 
orchestrate the complex process of vascular morphogenesis by which proliferating ECs 
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organize into multicellular tubes with functional lumens. Thus, the composition of ECM 
and therefore the regulation of ECM metabolism and remodeling serve pivotally in the 
control of lumen and tube formation and finally, neovessel stability and maturation.  
2.1.2 Tumor-induced angiogenesis vs. Wound angiogenesis 
Many of the above mentioned models are built with an application in tumor therapy. The 
fundamental mechanisms for cell migration, branching and anastomosis of tumor 
angiogenesis are the same for wound healing angiogenesis. However, the differences 
between tumor angiogenesis and wound healing angiogenesis are significant: while tumor 
vasculature keeps growing as the tumor grows larger, wound angiogenesis process in a 
controlled manner. Wound healing angiogenesis will stop once the pathological condition 
is alleviated. Angiogenesis is imperative for the proliferative phase due to the high 
oxygen and nutrients consumption by actively proliferating and migrating, and collagen 
secreting fibroblasts, as well as the migrating epithelial cells. However, after a robust 
granulation tissue fills the wound space, the oxygen and nutrients demand returns to the 
normal tissue level, and the angiogenesis stops, the established capillary networks is 
modified to a mature vasculature. As a result, it’s essential for a wound healing 
angiogenesis model to include feedback mechanism from established vasculature to 
angiogenic growth factors. 
2.1.3 Angiogenesis, hypoxia, and chronic wound  
Chronic wound is a multi-factorial pathological condition while hypoxia is a common 
factor. Chronic wounds may be formed originally similarly as acute ones, such as surgery 
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or accidental trauma, or they may form as the results of systemic infection, vascular, 
immune or nerve insufficiency. Most of chronic wounds fall into three categories: venous 
ulcers, diabetic ulcers and pressure ulcers. In the case of venous ulcer, venous 
hypertension caused by improper function of valves existing in the veins prevents blood 
from flowing backwards, and thus cause ischemia. In the case of pressure ulcers, 
continuous pressure limits blood supply and causes ischemia, and the inflammation 
occurs during reperfusion.  This process may occur repeatedly and eventually damages 
tissue enough to cause a wound.  In the case of diabetic ulcers, immune compromise and 
damage to small blood vessels prevent adequate oxygenation of tissue, which can cause 
chronic wounds. 
Insufficient angiogenesis thus insufficient oxygen and nutrient supply result in deficiency 
in collagen layout and other cellular activity required for the establishment of a robust 
tissue repair. While hypoxia acutely triggers the expression of angiogenic factors and 
responses, severe and long-term hypoxia cannot sustain the formation of new functional 
vasculature resulting in wound chronicity.  
2.1.4 Computational models of sprouting angiogenesis  
Continuous models. Partial differential equation modeling was first applied to tumor-
induced angiogenesis by Balding and McElwin [47] and then developed by Chaplain and 
Sleeman[48], who studied concentration profiles of tumor angiogenic factors (TAFs). 
More recent work has shown that the structure and morphology of the capillaries and the 
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network also depend crucially on the interactions between the endothelial cells and local 
gradients of extracellular matrix components[49, 50].  
The process of bud formation observable in the early stage of angiogenesis was first 
addressed mathematically by Orme and Chaplain[49]. The position of aggregating 
endothelial cells is marked to form bud later. Mechanical aspects of angiogenesis have 
been investigated by Manoussaki et al.[51] and Holmes and Sleeman[52], in which the 
ECM is represented as a viscoelastic material interacting with the ECs, and the cell 
generated traction on the ECM in turn influences the resulting pattern of vasculature. Sen 
Chandan[53] modeled the effects of oxygen therapy on wound healing. 
Discrete models. Although continuous models are successful in describing average 
behavior of cell populations, they are unable to capture the realistic structure of the 
formed vasculature network, which is important in efficient nutrient, oxygen and drug 
delivery. Discrete models have been presented, describing the behavior of individual 
endothelial tip cells and their interaction with other cells and extracellular matrix.  A 
lattice-based model is proposed by Anderson and Chaplain[50] by discretizing of a two-
dimensional continuum model. Tip cells located at discrete lattice carry out a biased 
random-walk, and are assigned probabilities to branch depending on the sprout age, 
chemokine concentration and EC density. This model framework is utilized by 
McDougall[54, 55] to simulate the flow through 2D and 3D vascular networks. These 
lattice-based models use the theory of cellular automata, which are computationally fast 
and efficient. However, lattice based cellular automata employs nearest-neighbor 
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interactions, while in biological reality, cells and collagen fibers in extracellular matrix 
assumes an elongated shape which enables distant interaction. One of the first lattice-free 
models was introduced by Stokes and Lauffenburger[56]. They define sprouts by the 
trace of individual tip cells and consider branching to occur according to predefined 
probabilistic rules. Tip cell migration is governed by a stochastic differential equation 
accounting for chemotaxis and random motion. Another lattice-free model by Sun[57] 
introduce a concept of conductivity tensor of ECM. By doing this, they are able to model 
the influence of the heterogeneity and anisotropy of ECM on migration and branching 
behavior of tip cells. Recently, a 3D model of sprouting angiogenesis is proposed by 
Koumoutsakos[58]. It considers the effect of soluble as well as matrix-bound growth 
factors on the dynamics and the morphology of the generated vascular networks. Das[59] 
developed another 3D model of angiogenesis which incorporate probabilities of an 
individual cell to transition in to one of four stages—quiescence, proliferation, migration 
and apoptosis, and identify the transition probabilities that result in specific vasculature 
pattern.  
Hybrid models. Some of the discrete models above simply assume a static chemokine 
profile. However in reality, the chemokine profile is constantly changing subject to 
reaction-diffusion dynamics, as well as modified secretion and consumption by various 
cell types. All recent models [57-59] employ a hybrid strategy which combines the high-
quality of visual illustration of a discrete model with the ability of a continuous model to 
trace the dynamics 
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2.1.4 A hybrid agent-based model of sprouting angiogenesis during wound 
healing 
The goal of this work is to build a novel deterministic hybrid model for wound healing 
angiogenesis that considers the effect of collagen orientation and metabolism on the 
morphology of generated vascular networks, and to further consider the effects of tissue 
oxygen tension on angiogenesis and healing process. The model combines a continuum 
approximation of VEGF, fibronectin and collagen density with a discrete, agent-based 
particle representation of vascular tip cells.    
 Tip cells carry out grid-independent migration. We keep using chemotaxis as the first 
directional cue for vascular tips as in existing models. The heterogeneity and anisotropy 
of ECM put another directional limitation on extending sprouts. This has been addressed 
by Sun[57] and Koumoutsakos [58] by introducing an indicator of ECM called 
“conductivity tensor”, which is randomly distributed and static during the angiogenesis 
process. However, we know that the collagen fibers of ECM possess structured instead of 
completely random orientation, and are constantly modified during wound healing 
proliferative phase.  Novelties in this work lie in the consideration of the effect of a 
dynamically changing collagen orientation field on the morphology of generated vascular 
network. Modeling of orientation of collagen is based on previous models by J.A. 
Sherratt[60]. 
In existing models of angiogenesis, the positions of vascular tips are predefined (at the 
boundary of modeling space). Bud formation was addressed in a one-dimensional 
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continuous model as the first step of tumor-induced angiogenesis[49].  However, new tip 
formation has never been incorporated into a model of the whole process of vascular 
network formation to visualize its effect on the vessel geometry. Another novelty of this 
work is that it explicitly models the formation of new sprout tip from existing vessels. 
Endothelial cells can be directly stimulated by low oxygen concentration and form new 
bud.  
Further, our model enables the exploration of effects of tissue oxygen tension on 
angiogenesis and healing process. We model in detail the interacting dynamics of 
oxygen, inflammation and VEGF. VEGF is secreted by inflammatory cells accumulated 
at the wound site in response to hypoxia. No VEGF is produced when there are no 
inflammatory cells. It is assumed that inflammation increases when there is not sufficient 
collagen matrix, and dies out at a constant rate. Inflammatory cells keep producing VEGF 
until the oxygen and nutrient supply are restored by the formed vascular network.   
Our model allows simulation of angiogenesis along with other crucial events of 
proliferation phase of wound healing. These include fibroblast migration and 
proliferation, collagen metabolism and orientation. This enables us to examine a lot of 
interesting interactions. The simulation will be carried out on two different settings.  
First, we assume a uniform distribution of collagen density (no production and 
consumption of ECM). Then we’ll consider collagen and fibronectin metabolism by 
fibroblasts.   
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2.2 Modeling Methods 
2.2.1 Initiation of new vascular tips 
In the first part of the simulation, vascular tip cells are located at the wound boundary and 
each assumes a direction inward. In the second part of the simulation, new tips form from 
existing vessels determined by local VEGF gradient and oxygen concentration. VEGF 
not only serves as a chemokine for vascular tip migration, but also stimulate vascular tip 
formation from existing vessels. Endothelial cells can also be directly stimulated by low 
oxygen concentration and start to form protrusions.[61] 
A new vascular tip will form when local VEGF concentration is above some threshold, 
and the local VEGF gradient is approximately perpendicular to the existing vessels. It’s 
easy to see there will be a section of existing vessel that satisfies this condition for new 
tip formation. The exact position along the existing vessel for vascular tip formation is 
randomly chosen.  
When local oxygen concentration is below some threshold, the vascular tube has a 
probability to form new tip spontaneously.  
௧ܲ௜௣ = ߚ(1 − [ܱଶ]) 
This potential of spontaneous tip formation will decrease as the oxygen level rises and 
approaches the normal level. 
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2.2.2 Directional guidance for vascular tips 
VEGF is secreted by platelets and macrophages due to hypoxia to attract vascular tips 
from wound boundary. When an area is filled with vasculature, the oxygen level will 
recover and the platelets and macrophages will stop secreting VEGF. VEGF 
concentration field is modeled as a continuum and follows reaction-diffusion dynamics. 
We describe the tendency for vascular tips to follow chemotaxis guidance with a 
parameter ρ1. [62] 
Collagen fibers align with migrating fibroblasts and forms bundles. The rules for 
alignment are the same as described in J.A. Sherratt and will be explained later. Vascular 
tips tend to move along with the collagen. We describe this tendency with a second 
parameterρ2. [44] 
The vascular tips also have a tendency to move in its original direction. This is described 
as (1- ρ1- ρ2).  So the equation for vascular tip direction is: 
ߠ௘(ݐ) = (1 − ߩଵ − ߩଶ) ∗ ߠ௘(ݐ − 1) + ߩଵ ∗ ߠ௩ + ߩଶ ∗ ߠ௖     (1)                                                                                                                          
where ߠ௘  is the direction of endothelial tip cell, ߠ௩ is the direction of VEGF gradient, and 
ߠ௖is the direction of collagen. 
The equation for vascular tip migration is: 
ݔ௘(ݐ) = ݔ௘(ݐ − 1) + ݏ௘(ܿ, ݂) ∗ ܿ݋ݏߠ௘ 
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ݕ௘(ݐ) = ݕ௘(ݐ − 1) + ݏ௘(ܿ, ݂) ∗ ݏ݅݊ߠ௘                                                        (2) 
where ݏ is the speed of vascular tips. Here s is assumed to be a function of fibronectin 
and collagen density[1]. The effect of oxygen level on the speed of vascular tips is 
represented by function ܩ௘. 
ݏ௘ =
⎩
⎪
⎨
⎪
⎧ݏ ∗ ܩ௘ ቆ
[ܱଶ]
[ܱଶ]௡௢௥௠௔௟
ቇ ∗
1 + 2 ∗ [݂݊]
3
                             (݂݅ [ܿ] < 0.7)
ݏ ∗ ܩ௘ ቆ
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ቇ ∗
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3
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 
ܩ௘(ݓ) = ൜
ݓ              ݂݋ݎ  0 ≤ ݓ ≤ 1
1              ݂݋ݎ        ݓ ≥ 1
  
An alternative mechanism for ECM to modify the direction of endothelial cells is treating 
ECM as an anisotropic tensor[57]: 
ࡷ = ൤
K୶୶ K୶୷
K୷୶ K୷୷
൨
= kୡ୭୬ୢ ൤
cosଶθୡ cosθୡsinθୡ
cosθୡsinθୡ sinଶθୡ
൨  
+
kୡ୭୬ୢ
kୟ
൤
sinଶθୡ −cosθୡsinθୡ
−cosθୡsinθୡ cosଶθୡ
൨ 
The tensor K is the conductivity of the ECM for the movement and extension of capillary 
endothelial cells. The anisotropy of the ECM means that the resistance of the ECM for 
the sprout extension might be strong in some direction and weak in others.  
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ߠ௘(ݐ) = ࡷ ∙ ((1 − ߩଵ) ∗ ߠ௘(ݐ − 1) + ߩଵ ∗ ߠ௩) 
In the first and second part of simulation, collagen density is assumed to be evenly 
distributed among wound space, so that it’s equivalent to a model without haptotaxis. In 
the third part of simulation, a primary ECM comprised mainly of fibronectin is gradually 
replaced with a mature ECM comprised mainly of collagen. Chemotaxis, haptotaxis, and 
collagen orientation are the three directional cues for migrating endothelial cells. 
2.2.3 Branching mechanisms 
In our model, branching happens if and only if the following two conditions are 
simultaneously satisfied:  
(i)The current sprout has an age greater than a certain threshold τ. That is, new sprouts 
must mature for a length of time at least equal to τ before they are able to branch. 
(ii) The matrix structure and the VEGF gradient provide diverging directional guidance. 
Local value of  (ߠ௩ − ߠ௖) exceeds a threshold level.  
2.2.4 Contact inhibition  
Contact inhibition for cell proliferation happens when two cells comes to proximity. In 
angiogenesis, two tips approaching each other will finally join together. So contact 
inhibition only demonstrates its effect in preventing highly frequent branching event. For 
growing vascular tips, established vasculature “in front of” of the growing tip within 
certain distance will stop the tip from branching. Vasculature “behind” the growing tip 
will not affect growth and branching. 
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2.2.5 Anastomosis mechanisms 
When a vascular tip meets with an existing sprout, it merges with the sprout and stops 
migration. When two sprout tips meet each other, they will fuse and both stop migration.  
There are two types of anatomosis: “head to head” or “shoulder to shoulder”. The first 
means two sprouts approximate each other in opposing directions and merge to form a 
loop. The second means two sprouts approximate each other in parallel and merge to 
form one sprout.  
2.2.6 Diffusible layer 
VEGF profile. VEGF concentration is subject to reaction diffusion dynamics, with a 
reaction term describing production by inflammatory cells and consumption by ECs. 
݀[ܸܧܩܨ]
݀ݐ
= ܦ௏ாீி ∗ ∆[ܸܧܩܨ] + ܩ௏ாீி ቆ
[ܱଶ]
[ܱଶ]௡௢௥௠௔௟
ቇ [ܫ]
− (݀௘௏ாீி[݁] + ݀௏ாீி)[ܸܧܩܨ] 
ܩ௏ாீி(ݓ) = ቐ
3ݓ       ݂݋ݎ    0 ≤ ݓ < 0.25
1 − ݓ     ݂݋ݎ   0.25 ≤ ݓ < 1
0       ݂݋ݎ     ݓ ≥ 1 
 
Oxygen profile (only in Scenario 3). As vascular sprouts migrate and new vasculature 
network is established by anastomosis, nutrients supply is gradually restored and the 
hypoxia is alleviated. This will stop the tissue from releasing more angiogenic growth 
factor. As a result, the VEGF spatial gradient field will be modified. Vasculature density 
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is calculated as the local percentage of vasculature occupation. Oxygen level is assumed 
to be proportional to local vasculature density. 
݀[ܱଶ]
݀ݐ
= ܦைమ ∗ ∆[ܱଶ] +  ݌௘ைమ ∗ [݁] − ݀௙ைమ [݂][ܱଶ] 
Inflammatory cells (only in Scenario 3). Inflammatory cells (i.e., macrophages and 
neutrophils) assist wound healing by migrating to the injury site where they release 
angiogenic growth factors that promote the ingrowth of new blood vessels to the wound 
space. Inflammatory cells will keep migrating in if the collagen matrix is not layout. This 
is modeled as a source term which is reversely correlated with the density of collagen 
matrix. It is assumed that macrophages decay at a linear rate. 
݀[ܫ]
݀ݐ
= ൜
ܦூ ∗ ∆[ܫ] + ݌ூ ∗ (0.5 − [ܿ]) ∗ [ܫ] − ݀ூ ∗ [ܫ]   ݂݋ݎ [ܿ] < 0.5
ܦூ ∗ ∆[ܫ] − ݀ூ ∗ [ܫ]                                              ݂݋ݎ[ܿ] > 0.5
 
2.2.8 Initial and boundary conditions 
Wound space is modeled as a 1000μm×1000μm square. For the primary model, collagen 
fibers are randomly oriented, and their density is even among the wound space. 
Fibroblasts are randomly distributed. For the reaction-diffusion PDE for growth factors, 
we use Newmann boundary condition. New sprout tips are located along the wound 
boundary, and each assumes a direction almost perpendicular to wound boundary.  
 
Parameter Description Reference Value Unit 
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Model 
ܮ௫  Width of the 2D modeling space. --- 1000 ߤ݉ 
ܮ௬  Length of the 2D modeling space. --- 1000 ߤ݉ 
ܮ௭  Depth of the wound assumed.  100 ߤ݉ 
݀ݔ, ݀ݕ Spatial step for calculating EGF 
concentration. 
--- 1 ߤ݉ 
--- Collagen direction grid. --- 100 × 100 --- 
ܶ Time duration of the whole simulated 
process. 
--- 50 ℎݎ 
݀ݐ Length of each time step for calculating 
the chemokine diffusion. 
--- 0.01 ℎݎ 
ݐ݈݁݊݃ݐℎ Length of each time step for updating 
location of fibroblasts and collagen 
orientation, etc. 
--- 0.15 ℎݎ 
Vascular endothelial cells 
ܧܰ݅݊݅ݐ Initial total number of vascular tips in our 
modeling space. 
--- 12 # 
ߩଵ The influence coefficient of VEGF 
gradient on the direction of endothelial 
cells. 
--- 0.3 --- 
ߩଶ The influence coefficient of collagen 
orientation on the direction of endothelial 
cells. 
--- 0.3 --- 
1 − ߩଵ − ߩଶ Endothelial cells polarization. --- --- --- 
ݏ Maximal speed of vascular endothelial 
cells migration. 
 15 ߤ݉ ∙ ℎݎିଵ 
݇௖௢௡ௗ  Anisotropic tensor parameter as a 
measure of heterogeneity of collagen 
density profile. 
Sun et 
al.(2004)[14] 
1 --- 
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݇௔  Anisotropic tensor parameter as a 
measure of anisotropy of collagen 
orientation profile. 
Sun et 
al.(2004)[14] 
2 --- 
β     
Fibroblast 
ܨܰ݅݊݅ݐ Total number of fibroblasts in our 
modeling space. 
 
Jonathan et 
al.(1999)[20] 
Adams, 
J.J.(1997) 
Olsen et 
al.(1995)[21] 
1000 # 
 
ߩଵ௙ The influence coefficient of EGF gradient 
on the direction of fibroblasts.  
(Total influence isߩଵ ∗ min ൬1,
௚௥௔ௗಶಸಷ
்௛೒ೝೌ೏
൰) 
 --- 0.3 --- 
ߩଶ௙  The influence coefficient of collagen 
orientation on the direction of fibroblasts. 
(Total influence is ߩଶ ∗ [ܿ݋݈݈ܽ݃݁݊]) 
--- 0.3 --- 
1 − ߩଵ௙ − ߩଶ௙  Fibroblast polarization. --- --- --- 
ݏ Maximal speed of fibroblast migration.  Jonathan et 
al.(1999)[20] 
15 ߤ݉ ∙ ℎݎିଵ 
ܶℎ௚௥௔ௗ The upper threshold of the influence of 
chemotaxis on the direction of 
fibroblasts.  
estimated 0.001 ܯ ∙ ߤ݉ିଵ 
Collagen 
ܮ Support of fibroblast weight function. Jonathan et 
al.(1999)[20] 
10 ߤ݉ 
ߢ Rate at which fibroblasts alter the 
collagen orientation.  
Jonathan et 
al.(1999) [20] 
20(5,10,20) --- 
݌௖ Rate of collagen production. Jonathan et 
al.(1999) [20] 
0.44-0.64 ℎݎିଵ 
݀௖ Rate of collagen degradation. Jonathan et 0.44 ℎݎିଵ 
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al.(1999) [20] 
݀௙௡ Rate of fibronectin degradation. Jonathan et 
al.(1999) [20] 
0.6 ℎݎିଵ 
ܶℎ௧ௗ Threshold of local tissue displacement 
above which collagen will respond and 
align with the tension line. 
Collagen: 
structure and 
mechanics[22] 
20% --- 
Diffusible components 
[ܧܩܨ]଴ Initial EGF concentration at the wound 
site. 
 Olsen et 
al.(1995)[21] 
10-8 ݃ ∙ ܿ݉ିଷ 
ܦாீி  Diffusion coefficient of EGF. Olsen et 
al.(1995)[21] 
5*10-2 ܿ݉ଶ/݀ܽݕ 
݀ாீி  The rate coefficient that fibroblasts 
consume EGF. 
(The actual rate is ݀ாீி ∙ [ܧܩܨ] ∙ [݂] ) 
estimated 0.3 --- 
[ܸܧܩܨ]଴ Initial VEGF concentration at the wound 
site. 
 Chandan et 
al.(2007) [10] 
10-8 ݃ ∙ ܿ݉ିଷ 
ܦ௏ாீி  Diffusion coefficient of VEGF.  Chandan et 
al.(2007) [10] 
1*10-6 ܿ݉ଶ ∙ ݏିଵ 
݀௘௏ாீி The rate coefficient that endothelial cells 
consume VEGF. 
(The actual rate is ݀௏ாீி ∙ [ܸܧܩܨ] ∙ [݁] ) 
 Chandan et 
al.(2007) [10] 
4 ܿ݉ଷ ∙ ݃ିଵ
∙ ݏିଵ 
[ܱଶ]଴ Initial O2 concentration at the wound site.  Chandan et 
al.(2007) [10] 
5.4*10-6 ݃ ∙ ܿ݉ିଷ 
[ܱଶ]௡௢௥௠௔௟  O2 concentration at normaxia. Chandan et 
al.(2007) [10] 
5.4*10-6 ݃ ∙ ܿ݉ିଷ 
ܦைమ  Diffusion coefficient of O2.  Chandan et 
al.(2007) [10] 
5*10-7 ܿ݉ଶ ∙ ݏିଵ 
݌௘ைమ  The rate coefficient that vasculature 
deliver O2. 
Chandan et 
al.(2007) [10] 
0.00615 ܿ݉ଷ ∙ ݃ିଵ
∙ ݏିଵ 
݀௙ைమ  
 
The rate coefficient that fibroblasts 
consume O2. 
 Chandan et 
al.(2007) [10] 
0.0123 ܿ݉ଷ ∙ ݃ିଵ
∙ ݏିଵ 
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[ܫ]଴ Initial level of inflammatory cells at the 
wound site. 
  Chandan et 
al.(2007) [10] 
 1*10-3 ݃ ∙ ܿ݉ିଷ 
ܶℎ௖ Density level of collagen matrix when 
inflammatory cells stop migrating in. 
This work 0.5 NA 
݌ூ The rate of accumulation (in response to 
insufficient layout of collagen matrix) of 
inflammatory cell. 
This work 0.1 NA 
ܦூ  Diffusion coefficient of inflammatory 
cells. 
  Chandan et 
al.(2007) [10] 
  5*10-8 ܿ݉ଶ ∙ ݏିଵ 
݀ூ  The rate that inflammation die out.   Chandan et 
al.(2007) [10] 
 2*10-6 ݏିଵ 
 
2.3 Results 
We report results on the blood vessel morphology as influenced by (1) the various 
contributions of chemotaxis and alignment with collagen to vascular tip directional 
guidance, (2) parameters for collagen alignment,(3) mechanisms by which collagen 
orientation affects EC migration, (4) VEGF dynamics, (5) new bud formation 
mechanisms. Also we report the retrospective effects between newly formed vascular 
network and metabolism of ECM components. 
Simulation 1 Tips located at wound boundary, no collagen metabolism 
In the first series of simulation, we assume that the vascular tips are evenly distributed 
along the wound boundary, and no new tips are formed from established vessels during 
the following angiogenesis, i.e. the only source of new tips are from vascular tip 
branching. We assume that fibronectin has been replaced by collagen, and collagen is 
evenly distributed across the wound space and randomly oriented initially.  
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Effect of varying contribution of chemotaxis and alignment with collagen to vascular 
tip directional guidance 
We use the following parameter sets: (1) ρ1 = 0.3, ρ2 = 0.3; (2) ρ1 = 0.3, ρ2 = 0.5; (3) ρ1 
= 0.5, ρ2 = 0.3, where ρ1 represents the contribution of alignment with collagen, and ρ2 
represents the contribution of chemotaxis to directional guidance of vascular tip. 
Parameters for collagen alignment model are fixed as: ρf=0.8.We found that the density 
and morphology of vasculature network are significantly different between different 
parameter setting. A greater alignment with collagen results in a denser vasculature, 
while a greater chemotactic tendency causes the tips to “rush” to the wound center 
without branching and filling non-vascular space between them.  
Effects of varying collagen orientation structure 
A more organized collagen orientation profile is formed as the parameter ρf increases 
from 0 to 1. However, the morphology of vasculature network changes very subtly as the 
collagen network becomes more organized. (Fig2.4) 
 
An alternative mechanism of how collagen orientation affects tip cell migration  
Here, we model an alternative mechanism in which collagen alignment affects the 
vascular tip migration, and compare the established vasculature network with the one 
formed with the original mechanism. In the alternative mechanism, local collagen 
orientation modifies the direction of vascular tip migration by working as an anisotropic 
tensor. That describes the resistance of the extracellular matrix for the sprout extension 
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might be strong in some directions and weak in others. Fig2.5 shows that more cell 
clusters form under this mechanism, but the vasculature density is not altered generally. 
Effect of VEGF dynamics 
Here we model the scenario in which VEGF is dynamically consumed by vasculature. 
When VEGF is consumed by generated vasculature, the VEGF gradient profile is no 
longer concentric, instead, there will be local gradient formed between the densely 
packed vasculature and the space between them. Therefore more branching events occur 
and result in increased density of vasculature. (Fig2.6) 
Simulation 2 Tips formed from existing vessels, no collagen metabolism 
From the first series of simulation, as the vascular tips approach the center of the wound, 
a lot of space is left between them, which cannot be filled with vasculature till the end of 
angiogenesis. This is not realistic because vasculature should assume an approximately 
even density profile among the wound space.  These vacancies should be filled by 
vasculature formed from more new tips. In the second series of simulation, we assume 
that sections of isolated vessel have the potential to form new tips.  
Effects of different tip formation mechanisms on vasculature morphology 
Fig2.7 shows that when new tip formation is incorporated, the resulting vasculature is 
denser (compared to Fig2.1). Compared to the VEGF consumption scenario, this dense 
vasculature is better cross-linked and thus more efficient in oxygen and nutrient delivery.  
Then in Fig2.8 we increase the new tip formation probability. Initially, there will be more 
43 
 
tips formed, but vasculature density is almost not altered because of the contact 
inhibition. Fig2.9 and Fig2.10 gives the vasculature generated under altered conditions. 
Each gives a denser vasculature compared to without new tip formation.  
Simulation 3 Interaction between angiogenesis and collagen metabolism—effects of 
tissue oxygen tension and implications on chronic wound dynamics 
In the third series of simulation, we consider the interaction between collagen metabolism 
and angiogenesis. As the activity of fibroblasts requires oxygen supply, the establishment 
of a mature ECM composed of well-organized collagen is dependent on formation of a 
new efficient vascular network. On the other hand, fibronectin and collagen both affect 
the migratory characteristics of vascular tips, thus the morphology of the new vascular 
network. It would be interesting to see how these interactions affect the process of 
healing.  
To model collagen metabolism during wound healing, we take into consideration 
fibroblast chemotaxis and collagen layout. Fibroblasts from the healthy tissue 
surrounding the wound infiltrate the wound by migrating up chemokine gradient. The 
temporary wound matrix composed mainly of fibronectin is gradually replaced by 
collagen, which is secreted by fibroblasts. The migration speeds of fibroblasts and 
vascular tip endothelial cells and the rate of collagen production are affected by the 
composition of ECM, as well as by oxygen level. Vascular tip cells migrate more rapidly 
on fibronectin-rich matrix, while highly packed collagen matrix will inhibit the migration 
and branching of vascular tips.  
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In order to incorporate the effects of oxygen, we add two continuum profile—oxygen and 
inflammation. Oxygen is produced by vasculature, and consumed by active fibroblasts 
(fibroblasts that are producing collagen). We assume that the wound doesn’t have access 
to oxygen in environment. Therefore only the initial oxygen level is set up in the 
program, and the oxygen level throughout the simulation is subject to alteration by 
internal production and consumption, instead of by environment.  The inflammation 
profile is an abstract representation of inflammatory cells density and activity. It is 
produced where collagen matrix is not sufficient to suppress inflammation, and it has a 
constant rate of dying out. 
In this series of simulation, VEGF is not constant profile, nor is it directly consumed by 
established vasculature. The feedback from vasculature to VEGF is bridged by oxygen 
and inflammation level. VEGF is produced by inflammatory cells in response to oxygen 
level. When there is not sufficient vasculature to transport oxygen, oxygen is low, and the 
rate of VEGF production by inflammatory cells is high. When there is enough 
vasculature to transport oxygen, oxygen is high, and the rate of VEGF production by 
inflammatory cells is low. Therefore, as a general rule, angiogenesis will be induced in 
the region lack of vasculature.  
Extreme hypoxia may lead to delayed wound healing 
Fig 2.11 shows angiogenesis and healing process under different level of tissue oxygen 
tension. When oxygen is extremely low (0.10 * normal oxygen level), angiogenesis is 
halted and healing is delayed. There is a general acceleration of angiogenesis and healing 
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when initial oxygen level increases from extreme low to normal level. When oxygen 
further increases beyond normaxia, collagen layout continues to moderately accelerate, 
while angiogenesis slows down.  
There is a new phenomenon compared to results in the previous sections that vasculature 
doesn’t solely migrate inward; instead, some parts of it branch and migrate outward 
following the VEGF gradient. This is due to the more complicated VEGF dynamics and 
results in a more balanced vasculature. Severe hypoxia will generate a high density of 
vasculature, since the halted vasculature has more chance to branch and migrate outward. 
The tendency of growing outward is decreasing with the increasing oxygen level, because 
the vascular tips will rush without branching much when oxygen level sustain a high 
speed of migration. 
Interactive dynamics of vasculature growth and collagen matrix growth 
When initial oxygen is low, fibroblast flux and thus collagen layout is limited to the area 
already reperfused. As the initial oxygen level increases, the effect of limitation becomes 
increasingly weak, and fibroblasts can migrate to the center of wound and layout collagen 
before vasculature is established.  
Implications on chronic wounds 
Hypoxia is a common factor of chronic wounds. However, the real scenario of chronic 
wounds is complicated by ischemia-reperfusion damage and other pathology which are 
not described in the model setting. Therefore this is not an adequate model for chronic 
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wounds. However, it does reflect several aspects of chronic wounds: First, the model 
suggests that an extremely hypoxia cannot sustain vascular growth. Second, increasing 
oxygen level promotes wound healing and results in a simple vasculature network. One 
phenomena that is not consistent with chronic wounds is that: angiogenesis and healing 
can be completed even under extreme hypoxia in simulation. This can be explained 
considering chronic wounds poorly per fused usually experience persisting inflammation 
which will damage the vasculature. Therefore this counterintuitive phenomenon in 
simulation can be corrected after incorporating the effects of inflammation on new 
established vasculature.  
Oxygen gradient is another factor in determining an acute or chronic wound. In normal 
wound with minimal tissue destruction angiogenesis occurs without problems at the 
wound edge where a steep oxygen gradient exists. The stimulus for angiogenesis is 
hypoxia at the wound edge that causes various growth factors to be released from 
inflammatory cells. Steep oxygen gradient results in steep VEGF gradient. However, in 
chronic or non-healing wounds, the difference is that the oxygen gradient is very shallow. 
The significance of oxygen gradient in our model is subject to further examination. 
 Angiogenesis Collagen 
metabolism 
Oxygen level VEGF level Inflammation 
level 
Severe 
hypoxia 
Movie A1 Movie A2 Movie A3 Movie A4 Movie A5 
Hypoxia Movie B1 Movie B2 Movie B3 Movie B4 Movie B5 
Hypoxia Movie C1 Movie C2 Movie C3 Movie C4 Movie C5 
Normaxia Movie D1 Movie D2 Movie D3 Movie D4 Movie D5 
Hyperoxia Movie E1 Movie E2 Movie E3 Movie E4 Movie E5 
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2.4 Discussion 
We present a novel model of sprouting angiogenesis during wound healing that 
incorporates for the first time, effects of a dynamic collagen density and orientation 
profile on the vasculature morphology and considers new sprout tips formation from 
existing vessels. It also incorporates the effects of tissue oxygen tension on angiogenesis 
and healing process. 
The resulted morphology of vasculature bears a great similarity to that observed in 
experiments. The model allows us to assess the vasculature morphology as influenced by 
directional guidance of tip cells, the ECM structure and the new tip formation 
mechanisms. The simulations demonstrate that the morphology and density of the 
generated vasculature is directly affected by various contribution of directional guidance. 
More branching events occur when VEGF consumption is considered. The incorporation 
of new tip formation favors a more evenly cross-linked, thus more efficient vasculature. 
The simulation results of oxygen effect model agree with the experimental literature on 
wound healing. Therefore it can be used as a platform to explore the effects of different 
treatments on the healing effect. 
There are several shortcomings in the current version of model: First, oxygen is produced 
by vascular tube, no matter if it’s already looped. However, in reality, blood is only 
restored after anastomosis. Second, in the current model assumption, VEGF 
concentration does affect the speed of fibroblast migration, which results in the 
phenomena that vasculature keep growing denser even oxygen level has been recovered. 
48 
 
Third, hypoxia is only one factor for chronic wounds, while ischemia-reperfusion damage 
is a related one which put on more complexity to the problem.    
The model can be used as a simple model of the wound healing proliferative phase, as it 
considers most important events including collagen production and alignment. The model 
can be further extended to incorporate epithelialization and wound contraction, which 
makes it a more comprehensive model of proliferative phase. 
 
(a)         
(b)       
Fig2.1 VEGF is not modified by vasculature consumption. Collagen alignment: ρf=0.8. 
 ρ1 = 0.3, ρ2 = 0.3.  
       
Fig2.2 ρ1 = 0.3, ρ2 = 0.5. 
       
Fig2.3 ρ1 = 0.5, ρ2 = 0.3. 
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(a)                                      (b)                                             (c)                                             (d) 
Fig2.4 ρ1 = 0.3, ρ2 = 0.3. Collagen alignment: (a) ρ2f=0.2; (b) ρ2f =0.5; (c) ρ2f=0.8; (d) ρ2f=0.9. 
 
(a)                                (b) 
Fig2.5 ρ1 = 0.3, ρ2 = 0.3, ρ2f=0.8. (a) Weighted average of collagen direction is used as migration guidance. (b) 
Collagen as anisotropic tensor. 
(a)         
(b)        
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Fig2.6 VEGF is modified by vasculature consumption, consumption rate = 0.1. ρ1 = 0.3, ρ2 = 0.3, ρ2f=0.8. 
       
Fig2.7 New tip is formed. Green sections of vessel have the potential to form new tips. ρ1 = 0.3, ρ2 = 0.3, 
ρ2f=0.8.VEGF is not consumed. Tip formation probability is low.   
     
Fig2.8 New tip is formed. Green sections of vessel have the potential to form new tips.  ρ1 = 0.3, ρ2 = 0.3, 
ρ2f=0.8.VEGF is not consumed. Tip formation probability is high. 
  
Fig2.9 New tip is formed. ρ1 = 0.3, ρ2 = 0.5, ρ2f=0.8.VEGF is not consumed. Probability of new tip formation as in 
Fig2.7. 
  
Fig2.10 New tip is formed. ρ1 = 0.5, ρ2 = 0.3, ρ2f=0.8.VEGF is not consumed. Probability of new tip formation as in 
Fig2.7. 
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(a) 
       
       
(b) 
       
       
(c) 
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(d) 
       
       
(e) 
Fig2.11 (a) severe hypoxia: initial oxygen concentration = 0.10* normal oxygen level. (b) hypoxia: initial oxygen 
concentration = 0.25* normal oxygen level. (c) hypoxia: initial oxygen concentration = 0.50* normal oxygen level. 
(d)normaxia. (e)hyperoxia: initial oxygen concentration = 1.5* normal oxygen level. Time interval: 15hrs per frame. 
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3 A biomechanical model of wound contraction and scar formation  
3.1 Introduction 
3.1.1 Wound contraction 
Contraction is a key phase of wound healing. By reducing the size of the defect, wound 
contraction is usually beneficial to the overall repair process. However, insufficient 
contraction may cause delayed or impaired healing, whilst excessive contraction often 
induces poor quality repair with substantial scarring. Contraction commences 
approximately a week after wounding and can last for several weeks and continues even 
after the wound is completely re-epithelialized. A large wound can become 40 to 80% 
smaller after contraction.  
There are a lot of controversies on the cellular mechanisms of contraction of open full-
thickness excision wounds in adult human skin. One prevailing hypothesis is that the 
central granulation tissue is a contractile machine that can reduce itself and pull the edges 
of the wound together[66]. However, experiments in porcine skin (an analog to human 
skin) demonstrated that repeated excision of granulation tissue to the wound boundary 
does not alter the contraction dynamics[67]. This questions, but not entirely excludes the 
contribution of granulation tissue to wound contraction. Actually, the contraction of cell-
populated collagen lattice, albeit not involved in the early stage of wound closure, may be 
the principal driving force of wound contraction in the ensuing stage. And the 
spontaneous closure of full-thickness wounds excised of granulation tissue with an 
unaltered dynamics may be specific to porcine skin.  
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The same experimental examination prove against the possibility that the edges are 
pushed in by a process occurring in the peripheral tissue; in fact, there is a steady tension 
tending to distract the wound[67].A purse-string mechanism of closure was also excluded 
by showing that the surgical interruption of wound edge continuity does not alter closure 
kinetics or wound shape[68].  
Compared to the specious function of granulation tissue self-contraction, there is a more 
solid belief in fibroblast induced contraction. Migration of fibroblasts into and through 
the extracellular matrix during the initial phase of wound healing, prior to the expression 
of alpha-SMA, appears to be a fundamental component of wound contraction. In the 
context of fibroblast migration driven wound contraction, the location and the force 
generation mechanisms is of central concern. Excision of wound margin down to the 
deep facsia, instead of excision of granulation tissue caused immediate distraction of the 
wound area to a size greater than that of the original wound[67]. This indicates that the 
force-generating cells were localized at the wound margins rather than in the center of the 
granulation tissue. Polarized coordinated migration of a rim of densely packed freshly 
proliferated fibroblasts pull inward the dermal edges and close the wound[67], while the 
more random migration of fibroblasts inside the wound site facilitates a more normal 
arrangement of collagen[69]. There are two types of forces generated by fibroblasts: 
isometric tension by static cells[70] and traction generated by migrating cells[71]. The 
isomeric tension seems to produce the steady tension tending to distract the wound, while 
the traction by migrating cells is responsible for wound contraction and collagen 
alignment.  
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Another type of cells that play an important role in wound contraction is myofibroblast. 
Rat wounds that were kept open for 10 days before released contract to about 50% of 
their initial size; this cannot be explained by enhanced proliferation and migration of 
fibroblasts at the wound edge, but can be explainable by myofibroblasts driven 
contraction of extracellular matrix. The in vitro models such as contraction of isolated 
granulation tissue or of the cell-populated collagen lattice[72, 73] may be more relevant 
for understanding the cell biology of in vivo wound closure[68] when considered in 
conjunction with myofibroblasts. Fibroblasts differentiate into myofibroblasts in response 
to the changes in composition, organization and mechanical properties of extracellular 
matrix (ECM) and the increasing stress in environment. Myofibroblast acts its role 
mainly after fibroblasts stop migrating. They attach to each other and to the wound edges 
by desmosomes and link across cell membrane to ECM molecules like fibronectin and 
collagen. Myofibroblasts have many such adhesions, which allow them to pull the ECM 
when they contract, reducing the wound size. In this part of contraction, closure occurs 
more quickly than in the first, myofibroblast-independent part.  
Wound contraction and scar formation. There are many factors involved in scar 
formation including the prolonged inflammatory phase, the presence of myofibroblasts, 
etc. In the fetus, the transition from scarless tissue repair to healing with scar formation 
coincides with the expression of alpha-SM actin by myofibroblasts. The privileged 
healing of oral injuries involves a diminished inflammatory phase featuring lower levels 
of macrophage, neutrophil, and T-cell infiltration.  
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Wound contraction plays a significant role in scarring. The nature of scar is actually the 
uneven look of the healed tissue resulting from disfigured tissue deformation and over 
aligned collagen. Scar formation may strongly depend on the presence of contraction 
during healing. One hypothesis is that scar formation is the product of collagen fiber 
synthesis in the presence of the tensile stress field generated by a wound contraction 
process. A wound perpendicular to tension lines of body will induce hypertrophic scars 
maybe due to the overalignment of collagen fibers to resist the distraction by tension. The 
size and shape of the wound both have important effect on the resulting scarring through 
contraction process. The larger the wound, the larger of tissue displacement is needed to 
close the wound, the more prominent the resulting scar. With a complicated shape, the 
wound contraction pattern will be complicated instead of symmetric, thus cause more 
severe scar.   
Since scar is secondary to wound contraction, efforts to block scar formation can 
therefore benefit from strategies for blocking contraction. Prominent fiber orientation in 
the plane of the hallmarks of scar, should accordingly disappear following cancellation of 
the tensile mechanical field. Blocking of contraction by an appropriate scaffold should 
cancel such a mechanical field and should block synthesis of oriented fibers. In fact, 
when scaffolds that block contraction, even to a relatively minor extent, have been used, 
collagen fibers in the closed wound showed very poor orientation.[74] 
Abnormal wound contraction and scar contracture. The supposition that the formation 
of scar contractures is solely the result of a continuation of wound contraction is an 
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oversimplification. After the migration of fibroblasts ceases, myofibroblasts appear and 
play a key role in the production of hypertrophic scars, given that their prolonged 
presence and over-representation are the hallmarks of this pathology. One of the pivotal 
differences between wounds that proceed to normal scar compared with those that 
develop hypertrophic scars and scar contractures may be a lack of myofibroblast 
apoptotic cell death. The combined contribution of fibroblasts and myofibroblasts to 
abnormal extracellular matrix protein production results in an excessive and rigid scar.  
The isometric application of contractile forces by myofibroblasts probably contributes to 
the formation of the whorls, nodules, and scar contractures characteristic of hypertrophic 
scars.[75]  
Human skin as fiber-reinforced anisotropic soft tissue. Connective tissues (tendons, 
ligaments, blood vessels, skin) may be distinguished from hard tissues such as bones for 
their high flexibility and softness. Soft connective tissues of our body are complex fiber-
reinforced composite structures. Their mechanical behavior is strongly influenced by the 
concentration and structural arrangement of constituents such as collagen and elastin. 
Soft tissues behave anisotropically because of their fibers which tend to have preferred 
directions. The tensile response of soft tissue is nonlinear stiffening and tensile strength 
depends on the strain rate. The biomechanics of fiber-reinforced anisotropic soft tissue 
has been investigated amply before by Hozapfel [76]. The constitutive framework 
proposed by Hozapfel is suitable to describe a wide variety of physical phenomena of soft 
tissues. The models are suitable for predicting the anisotropic elastic response of soft 
tissue in the large strain domain. We employ Hozapfel’s framework in our model and 
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will give an introduction in Methods part. Odgen[77]gives a very detailed illustration of 
model deduction for cases of isotropic material, transversely isotropic material and 
anisotropic material with two preferred directions. We mainly follow Odgen’s principles 
to develop our model. 
3.1.2 Computational models of wound contraction  
The problem of modeling wound contraction, which is of great importance and 
complexity, is raised by Oster&Murray[78], who provide a continuum framework for 
mechanochemical models of tissue morphogenesis. The first series of computational 
models of wound contraction are proposed by Tranquillo &Murray[79]. The continuous 
model they employed consists of a system of PDEs based on conservation laws for 
fibroblasts, ECM and linear momentum. J.A. Sherrat[80] extends the work of Tranquillo 
& Murray[78] by explicitly incorporating the variable dynamics of a generic chemical 
and incorporating an element representing myofibroblasts. Their model effectively 
predicts steady states representing normal skin, a contracted wound and fibro-contractive 
diseases.    
S. Ramtani(2002) [81]  shows the effect of ECM remodeling upon the contraction 
phenomenon in connection with the other parameters such as ECM density, cell number 
and cell-matrix interaction stress. It is clearly shown that the remodeling can disturb 
considerably the cellular activities. This work also considers the dependency of elastic 
modulus on the collagen density. S.Ramtani(2004) [82]introduce the stress partition—
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inclusion of cell/ECM interaction force as an initial stress, and cell/cell interaction force 
as an additional stress. 
Vermolen(2007)[83] and E.Javierre(2008)[84] considers wound morphology as an 
important factor in wound healing. They deal with general wound shapes in two-
dimensions. Their results show that healing is always initiated at regions with high 
curvatures. They also combine angiogenesis with wound contraction. However, they 
don’t consider the effect of mechanical factors.    
E. Javierre(2009)[85] extended the model of Olsen et al.(1995) by incorporating a cell 
differentiation mechanical signaling, a cell mechanical sensing and transmission of 
traction forces to the ECM and a dynamical change of the ECM mechanical properties 
with collagen deposition.  The effect of wound morphology is analyzed using 
mechanochemical model.    
3.1.3 A novel hybrid model of wound contraction and collagen alignment 
during wound healing  
Of all the models of wound contraction, the earlier models have described ECM as a 
homogeneous isotropic elastic material, several works trying to capture how mechanical 
properties (or strength) of the wound tissue are modified by the local collagen density, 
but none has considered the anisotropy of ECM and its influence on the wound 
contraction results. The simplification of considering ECM as isotropic material, albeit 
unrealistic in biology, doesn’t affect the results of the 1D model. However, it’s our goal 
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here to reveal the importance of collagen orientation to the material properties, thus to the 
2D wound contraction pattern. Therefore we introduce the model of fiber-reinforced soft 
tissue. In our model, the elastic characteristics of ECM are modified by embedded 
collagen fibers. With the layout and alignment of collagen, wound granulation tissue 
grows from isotropic material to fiber-reinforced anisotropic soft tissue. Both the 
mechanical strength and the structure patterns grow.  
On the other hand, in the context of modeling biomechanics of fiber-reinforced 
anisotropic soft tissue, existing papers only considers homogeneous fiber direction over 
the entire modeling area. Our paper considers inhomogeneous fiber direction, which is a 
more realistic resemblance to the wound granulation tissue.   
Several works have tried to incorporate mechanical sensing and signaling, thus describe 
the feedback of mechanics to the biological events. However, they were unable to 
characterize the structure and mechanical properties change of ECM matrix in response 
to mechanical environment. The incorporation of collagen alignment as a component of 
the model enables us to model the collagen response to mechanical tension field. At the 
location of large tissue deformation, collagen fibers will realign with the tension lines. 
Collagen alignment with the tension may be somehow confounded with collagen 
alignment with fibroblasts. But it’s necessary to incorporate it as a separate step because 
there is tension existing in human skin other than that produced by fibroblasts. In our 
model, we consider the isomeric tension and traction produced by fibroblasts as the 
contraction mechanism. We give a more realistic description of fibroblast produced 
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traction. Myofibroblast driven collagen matrix contraction is to be incorporated in future 
work. 
By combining an elastic model for 2D stress and deformation response of wound 
granulation tissue with a hybrid agent-based model of collagen alignment, our model 
gives a more detailed and more realistic 2D view of the contracted wound, including the 
detailed pattern of tissue displacement and collagen alignment.  The rest part of this paper 
is organized as follows: First, we introduce the basic principle of modeling fiber-
reinforced anisotropic soft tissue and discuss about the mechanical properties of skin and 
wound tissue. Subsequently, the dynamics of other elements are described, emphasizing 
the response of collagen fibers to the mechanical environment. Then in the result part, we 
will show the advance of our model strategy, identify the important parameters 
determining wound contraction patterns, and investigate various scarring mechanism. In 
the Discussion part, we’ll talk about reasons for disagreement between modeling and 
experimental results, state several crucial biological implications, the existing and 
potential therapies for scar prevention, and propose future improvements to the model. 
Several test simulations will be given in the Appendix (which is usually not biologically 
realistic) demonstrating the suitability of modeling ECM as a fiber-reinforced anisotropic 
soft tissue.   
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3.2 Modeling Methods 
3.2.1 Model overview 
We give a detailed biomechanical description of the wound tissue based on the theory of 
fiber-reinforced soft tissue. We describe fibroblasts as discrete particles and chemokine 
profile as a continuum. Wound tissue is represented by four profiles combined: collagen 
orientation profile, tissue displacement profile, collagen density and fibronectin density 
profile. Fibroblasts migrate from the wound boundary inward following chemotactic 
guidance and contact guidance (collagen orientation). Tissue displacements are caused by 
fibroblasts-produced tension, and are calculated based on the elastic characteristics of the 
wound tissue, which are modified by the collagen density and orientation. Collagen fibers 
are produced and aligned by fibroblasts, and they also align with the tension line when 
tissue is stretched. As a simple setting, we carry out the simulation on a piece of 1mm * 
1mm square tissue. The shape and size of wound may be varied in some parts of the 
paper and will be stressed otherwise. Primarily, we model a circular wound of radius 
400μm in the center. 2D collagen orientation profile is visualized by streamline plot. 2D 
wound contraction pattern is visualized by vector plot view of the tissue displacement.  
3.2.2 Force balance equation for fiber-reinforced soft tissue 
We are working on modeling the deformation of elastic material under body force. 
Basically, this requires us to solve the force balance equation, in which the stress 
produced by the extending material can cancel out the stress exerted otherwise.  
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∇ ∙ σ = Fୣ୶୲ୣ୰୬ୟ୪ 
For simple isotropic elastic material, σ usually take the form of  
E
1 + v
(ε +
v
1 − 2v
θ) 
where strain tensor ε =
ଵ
ଶ
(∇u +  ∇u୘ )and dilation θ = ∇ ∙ u 
However, for an anisotropic material, fibers embedded determine that it is more 
extensible in some direction and more rigid in another direction. Usually, the material 
will be more extensible in a direction with little fibers; and will be rigid in a direction 
with more fibers.  
In order to characterize the anisotropy, we introduce strain energy function W, which 
basically means the energy stored when the material is stretched. W has various forms 
depending on the mechanical properties of the material. For a homogeneous material W 
depends only on the deformation gradient W=W (F). For inhomogeneous material, its 
properties depend on location within the material and W=W(X, F). With the form of W 
known, we can calculate the stress in the material by taking the derivative of W with 
respect to the strain: 
σ୉େ୑ = Jିଵ۴
∂W
∂۴
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For isotropic material, W depends on the stretch tensor U (see Appendix B for definition) 
only through its eigenvalues, i.e. the principal stretchesλଵ, λଶ, λଷ.  It’s a symmetric 
function of the principal stretches, so that it can be regarded as function of the principal 
invariantsIଵ, Iଶand Iଷ: 
Iଵ = λଵ
ଶ +  λଶ
ଶ +  λଷ
ଶ  
Iଶ = λଵ
ଶλଶ
ଶ + λଵ
ଶλଷ
ଶ +  λଶ
ଶλଷ
ଶ  
Iଷ = λଵλଶλଷ 
For materials with a preferred direction, W additionally depends on M⨂M(M is the 
structure tensor, See Appendix B for detailed definition), thus depends on five invariants, 
namely Iଵ, Iଶ, Iଷ and Iସ = M ∙ (CM), Iହ = M ∙ (CଶM). 
Equilibrium equation now evolves to the following form: 
Div ൬
∂W
∂۴
൰ = Fୣ୶୲ୣ୰୬ୟ୪ 
൬
∂
∂x
∂
∂y
൰
⎝
⎜
⎛
∂W
∂F૚૚
∂W
∂F૚૛
∂W
∂F૛૚
∂W
∂F૛૛⎠
⎟
⎞
= ൬
∂
∂x
∂W
∂F૚૚
 +
∂
∂y
∂W
∂F૛૚
,
∂
∂x
∂W
∂F૛૚
 +
∂
∂y
∂W
∂F૛૛
൰ = Fୣ୶୲ୣ୰୬ୟ୪ 
With some deduction (see Appendix B for details), we get 
A஑୧ஒ୨
∂ଶx୨
∂X஑ ∂Xஒ
= Fୣ୶୲ୣ୰୬ୟ୪ 
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A஑୧ஒ୨is usually called stiffness coefficient, which assumes simple form for isotropic 
material. Here it is calculated as  
A஑୧ஒ୨ = Aஒ୨஑୧ =
∂ଶW
∂F୧஑ ∂F୨ஒ
= ෍ ௡ܹ
߲ܫ௡
∂F୧஑ ∂F୨ஒ
ே
௡ୀଵ
+ ෍ ௠ܹ௡
߲ܫ௠
߲F୧஑
߲ܫ௡
߲F୨ஒ
ே
௠,௡ୀଵ
 
3.2.3 Details of elastic properties of the wound tissue and force balance 
equation in our model 
Incremental stress-strain curves of human skin shows that stress is almost immeasurable 
until a strain of about 20% is reached. Beyond this value, slopes of the elastic and viscous 
curves increase considerably. In this instance, the slope of the initial part of the elastic 
stress-strain curve for skin, corrected for its elastic tissue content (/0.02), is 0.4 MPa. The 
slope of the final part of the elastic stress-strain curve for skin, corrected for its collagen 
content(/0.1), is about 4GPa, a value closer to that for the elastic modulus of normal type 
I collagen.[86]  
Two different machanisms underlie the viscoelastic character and behavior of skin. It has 
been suggested that, at low strains, the viscoelasticity of skin is caused by stretching of 
the elastic fibers that normally surround its composite collagen fibers. Elastic fibers are 
easily stretched but offer little energy storage or dissipation. At high strains, the collagen 
fibers, which form a network independent of elastic fibers, bear loads and store energy 
that prevent premature mechanical failure of the skin. [86] 
The most popular form of strain energy function W is  
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ܹ =
ܿ
2
(ܫଵ − 3) +
݇ଵ
2݇ଶ
(݁௞ଶ∗(ூరିଵ)
మ
− 1) 
This strain energy function describes the elastic property of a material with constant 
elastic modulus which doesn’t change with strain. That is, when we eliminate the 
anisotropic part of W (eliminate the contribution of the embedded fibers), stiffness 
coefficients derived from the reduced W are constants. The form of strain energy function 
for human skin should be chosen to fulfill the following requirements: a) it should be able 
to generate a stress-strain curve similar to that from experimental measurement; b) it 
should reflect the change of tissue strength with the collagen density. To better resemble 
the stress-strain curve of human dermis, we modify the form of W, so that instead of 
linearly proportional to I1, W increases slowly when I1 is small, and increases more 
rapidly when I1 is large. We also make the anisotropic part of W to be modified by local 
collagen density.  
ܹ =
ܿ
2
(ܫଵ − 3)ଶ + [ܿ݋݈݈ܽ݃݁݊] ∗
݇ଵ
2݇ଶ
(݁௞ଶ∗(ூరିଵ)
మ
− 1) 
We are considering two types of forces exerted by fibroblasts, isomeric tension by static 
fibroblasts and traction forces by migrating cells. The isomeric tension is modeled as 
fibroblast density difference, while the traction forces are modeled as linearly 
proportional to the cell’s speed. These two mechanisms of fibroblast generated forces 
explain the tension distracting the wound and the forces pulling in the wound edges. In 
the scenarios of constantly existing tension, forces are added to both ends of the modeling 
space.  
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The force balance equation is solved using Deal.II library which provides Finite Element 
Method solvers for various partial differential equation and equation system.  
3.2.4 Fibroblasts 
Fibroblasts have an active role in wound contraction. First, fibroblasts modify the density 
and orientation of collagen matrix, thus modify the mechanical properties of the wound 
tissue. Secondly, the tension and traction produced by fibroblasts is one of the 
mechanisms of wound contraction. In our model, we don’t consider contraction caused 
by myofibroblasts, therefore tissue displacements are solely caused by fibroblast-
produced tension and traction. 
Initially, the wound site is devoid of fibroblasts and collagen. Fibroblasts distributed 
around the wound migrate inward following EGF gradient and layout collagen along their 
trails. As the collagen fibers are secreted and organized, they become a second directional 
guidance for fibroblast migration. We use f఩ሬ⃑  and v఩ሬሬሬ⃑   to denote the location vector and 
velocity vector of the j୲୦ fibroblast. The direction of each individual cell in successive 
step is described as proposed by J.A. Sheratt[82] as follows: 
ߠ௙(ݐ) =  ߩଵ ∗ min ቆ1,
݃ݎܽ݀ாீி
ܶℎ௚௥௔ௗ
ቇ ∗ ߠாீி ൫f఩ሬ⃑ , ݐ − 1൯ + ߩଶ ∗ [ܿ] ∗ ߠ௖(f఩ሬ⃑ , ݐ − 1)
+ (1 − ߩଵ − ߩଶ) ∗ ߠ௙(ݐ − 1) 
where ߩଵ, ߩଶ  are positive constants, and represent the influence of the EGF gradient and 
collagen matrix on the direction of the cell, respectively. ߠாீி(xሬ⃑ , ݐ) and ߠ௖(xሬ⃑ , ݐ) 
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represents the angle of local EGF gradient and collagen orientation. Fibroblasts cannot 
sense the gradient until it reaches certain threshold, above which the influence of gradient 
is proportional to its size. Similarly, the influence of collagen matrix depends on collagen 
density. The third term describes the bias of the cell to remain its direction in the last 
step. The speed of each fibroblast is determined as 
ݏ௙ = ൞
ݏ ∗
1 + 2 ∗ [݂݊]
3
                             (݂݅ [ܿ] < 0.7)
ݏ ∗
1 + 2 ∗ [݂݊]
3
∗ (1.7 − [ܿ])     (݂݅ [ܿ] ≥ 0.7)
 
v఩ሬሬሬ⃑ = [ݏ௙ cos ߠ௙ , ݏ௙ sin ߠ௙]  
This describes the fact that fibroblasts migrate more readily on fibronectin than on 
collagen. Therefore the speed function increases with the fibronectin density and 
decreases with the collagen density but is insensitive when collagen density is small. 
Tension produced by fibroblasts is calculated from fibroblast density, which is described 
as a smooth weight function over the location of fibroblast. The weight function will 
assume an elliptical shape centered at the location of fibroblast, with its long axis along 
with the migration direction.  
3.2.5 EGF 
The initial EGF concentration([e]) profile decrease from wound center to the wound 
boundary concentrically. It follows reaction-diffusion dynamics. The source of EGF is 
the neutrophils and macrophages fighting against bacteria at the wound center. When 
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fibroblasts start to migrate in, the inflammation phase is almost put to the end. So EGF 
concentration gradient is gradually diminished through diffusion, consumption by 
fibroblasts and natural decay. 
߲[݁]
߲ݐ
− Dୣ ∙ ∆[e] = −
d୤ୣ ∙ f ∙ [e]
Kୣ + [e]
− dୣ[e] 
3.2.6 Collagen matrix 
The collagen matrix is described by three different continuum – collagen density [c] and 
fibronectin density [fn] which describe the composition of ECM, and collagen direction 
θୡ.  
At the beginning of the proliferative phage, the wound is temporarily filled by blood clot 
formed by fibrins while devoid of collagen. During the proliferation phage, the 
composition of extracellular matrix is modified by fibroblasts as they remove the blood 
clot by degrading the fibrin and replacing it with a collagen network. The changes in 
collagen and fibrin density are described as proposed by J.A. Sheratt[87] as follows: 
[c]  +=  (pୡ − dୡ ∗ [c]) ∗ ෍ w୧(xሬ⃑ , t)
୒
୧ୀଵ
 
[fn]  −=  ݀௙௡ ∗ [fn] ∗ ෍ w୧(xሬ⃑ , t)
ே
௜ୀଵ
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3.2.7 Mechanism of collagen alignment: mechanical stress and tissue 
displacement effect 
The realignment of collagen should contain two mechanisms. First, the flux of fibroblasts 
will reorganize collagen fibers. Secondly, collagen will change direction in response to 
external stress and tissue displacement. Collagen will not be stretched at low strains. 
They will bear loads only at high stretch (>20%) and tend to align with the tension lines 
[86]. When there are not enough collagen fibers to resist tissue extension, the local tissue 
displacement will be very large so that collagen fibers which are not along the tension 
line start to bear loads. This will cause them to realign with the tension line. The 
realignment of collagen fibers is achieved mechanically and biologically. The detailed 
mechanism will be too complicated to incorporate into the model. Here we simplify it as 
a straightforward response, which is, collagen will realign with the tension line if the 
local tissue displacement is beyond some threshold.    
 The first mechanism is implemented as by J.A.Sherratt[87]. The overall effect of the cell 
population on the matrix is represented as weighted average of each cell’s influence.   
ߠ௙_௔௩௚(⃑ݔ, t) =
∑ w୧(xሬ⃑ , t)
୒
୧ୀଵ ߠ௙
௜ (ݐ − 1)
∑ w୧(xሬ⃑ , t)
୒
୧ୀଵ
 
w୧(xሬ⃑ , t) = aଵaଶ 
a୨ = max ቊ1 −
หf୨
୧(t) − x୨ห
L
, 0ቋ 
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θୡ += kappa ∗ ෍ w୧(xሬ⃑ , t)
୒
୧ୀଵ
∗ sin (ߠ௙_௔௩௚ − θୡ) 
where  ߠ௙_௔௩௚ is the angle of averaged fibroblast direction.  
The second mechanism is implemented as a separated step after the calculation of tissue 
displacement. If gradient of tissue displacement is larger than 20%, 
θୡ  += kappa ∗
grad_tissue_dis
Th୲ୢ
∗ sin (ߠ௧௘௡௦௜௢௡ − θୡ) 
 
In addition to realignment, collagen in the wound site is continuously secreted by 
fibroblasts. The newly-produced collagen with align according to the second mechanism. 
However, the newly produced collagen fibers are mechanically weak, and cannot be 
counted in the next calculation of tissue displacement. They will participate in building 
up material strength as they are matured. 
Something new in this algorithm is that collagen doesn’t assume a single direction at a 
certain point, instead it’s a mixture of collagen fibers with different direction. In 
calculating the tissue displacement, the effect of this mixture is represented by the 
weighted average of direction. 
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3.2.8 Initial and boundary conditions 
The computational domain consists of two disjoint parts: the wounded tissue and the 
undamaged tissue surrounding the wound. The model is initialized at the onset of the 
proliferative phase. At this stage, the wound site is devoid of fibroblasts and collagen. It’s 
filled with a temporary matrix made of fibronectin. Growth factors released during the 
inflammatory phase are highly concentrated within the wound site.  
3.2.9 Algorithm design 
First, finite difference methods are applied to solve large deformation soft tissue 
mechanics.  Mechanical property of wound tissue is determined by collagen density and 
alignment in the last step. Tissue displacements are updated according to force balance 
equation. Secondly, collagen alignment is updated according to tension and fibroblast 
migration direction. Thirdly, fibroblasts migrate and secrete collagen. These three steps 
are iterated until the wound comes to a full closure. A schematic description of the 
algorithm is as follows: 
force by cell(1)
୧୬୧୲୧ୟ୪ ୟ୪୧୥୬୫ୣ୬୲
ሱ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ሮ tissue displacement(1)→  collagen realignment(1) 
force by cell(2)
ୡ୭୪୪ୟ୥ୣ୬ ୰ୣୟ୪୧୥୬୫ୣ୬୲(ଵ)
ሱ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ሮ tissue diaplacement(2) →  collagen realignment(2) 
force by cell(3)
ୡ୭୪୪ୟ୥ୣ୬ ୰ୣୟ୪୧୥୬୫ୣ୬୲(ଶ)
ሱ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ሮ tissue diaplacement(3) →  collagen realignment(3) 
… 
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force by cell(n)
ୡ୭୪୪ୟ୥ୣ୬ ୰ୣୟ୪୧୥୬୫ୣ୬୲(୬ିଵ)
ሱ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ሮ tissue diaplacement(n) →  collagen realignment(n) 
Parameter Description Reference Value Unit 
Model 
ܮ௫  Width of the 2D modeling space. --- 1000 ߤ݉ 
ܮ௬  Length of the 2D modeling space. --- 1000 ߤ݉ 
ܮ௭  Depth of the wound assumed.  100 ߤ݉ 
݀ݔ, ݀ݕ Spatial step for calculating EGF 
concentration. 
--- 1 ߤ݉ 
--- Collagen direction grid. --- 100 × 100 --- 
ܶ Time duration of the whole simulated 
process. 
--- 50 ℎݎ 
݀ݐ Length of each time step for calculating 
the chemokine diffusion. 
--- 0.01 ℎݎ 
ݐ݈݁݊݃ݐℎ Length of each time step for updating 
location of fibroblasts and collagen 
orientation, etc. 
--- 0.15 ℎݎ 
Fibroblast 
ܨܰ݅݊݅ݐ Total number of fibroblasts in our 
modeling space. 
 
Jonathan et 
al.(1999)[87] 
Adams, 
J.J.(1997) 
Olsen et 
al.(1995)[80] 
1000 # 
 
ߩଵ The influence coefficient of chemokine 
gradient on the direction of fibroblasts.  
(Total influence isߩଵ ∗ min ൬1,
௚௥௔ௗಶಸಷ
்௛೒ೝೌ೏
൰) 
 --- 0.3 --- 
ߩଶ The influence coefficient of collagen 
orientation on the direction of fibroblasts. 
--- 0.3 --- 
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(Total influence is ߩଶ ∗ [ܿ݋݈݈ܽ݃݁݊]) 
1 − ߩଵ − ߩଶ Fibroblast polarization. --- --- --- 
ݏ Maximal speed of fibroblast migration.  Jonathan et 
al.(1999)[87] 
15 ߤ݉ ∙ ℎݎିଵ 
ܶℎ௚௥௔ௗ The upper threshold of the influence of 
chemotaxis on the direction of 
fibroblasts.  
Estimated 0.001 ܯ ∙ ߤ݉ିଵ 
Collagen 
ܮ Support of fibroblast weight function Jonathan et 
al.(1999)[87] 
10 ߤ݉ 
ߢଵ Rate at which the fibroblasts alter the 
collagen orientation.  
Jonathan et 
al.(1999) [87] 
20(5,10,20) --- 
݌௖ Rate of collagen production. Jonathan et 
al.(1999) [87] 
0.44-0.64 ℎݎିଵ 
݀௖ Rate of collagen degradation. Jonathan et 
al.(1999) [87] 
0.44 ℎݎିଵ 
݀௙௡ Rate of fibronectin degradation. Jonathan et 
al.(1999) [87] 
0.6 ℎݎିଵ 
 ߢଶ Rate at which collagen fibers realign with 
tension line. 
Estimated 5 ℎݎିଵ 
ܶℎ௧ௗ Threshold of local tissue displacement 
above which collagen will respond and 
align with the tension line. 
Collagen: 
structure and 
mechanics[86] 
20% --- 
Strain energy function 
ܿ  Estimated 
according to 
Hozapfel et 
al.(2001)[76] 
0.86 
 
݇ܲܽ 
 
݇1  Estimated 
according to 
Hozapfel et 
al.(2001)[76] 
12.0 
 
݇ܲܽ 
݇2  Estimated 
according to 
0.5,0.2 --- 
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Hozapfel et 
al.(2001)[76] 
݌௠௔௫ Maximal cellular active stress. Estimated 
according to 
Javierre et 
al.(2009)[76] 
10-4 
 
 
ܰ/݈݈ܿ݁
≈ 10ହPa 
 
Others 
[ܧܩܨ]଴ Initial EGF concentration at the wound 
site. 
Olsen et 
al.(1995)[80] 
10-8 ݃ ∙ ܿ݉ିଷ 
ܦாீி  Diffusion coefficient of EGF. Olsen et 
al.(1995)[80] 
5*10-2 ܿ݉ଶ/݀ܽݕ 
݀ாீி  The rate coefficient that fibroblasts 
consume EGF. 
(The actual rate is ݀ாீி ∙ [ܧܩܨ] ∙
[݂ܾ݅ݎ݋ܾ݈ܽݏݐ] ) 
Estimated 0.3 --- 
     
ܽ The long axis of the weight function 
describing influence of traction force 
generated by fibroblasts. 
Estimated 45 ߤ݉ 
b The short axis of the weight function 
describing influence of traction force 
generated by fibroblasts. 
Estimated 36 ߤ݉ 
 Area occupied by one fibroblast Estimated 1000 ߤ݉ଶ 
Table3.1 Parameter values. See Appendix A for discussion of the parameter values.  
3.3 Result 
3.3.1 The contraction process in time 
The pool of growth factors deposited at the wound during the inflammatory induces 
fibroblast infiltration into the wound sites. As the fibroblast migrate inward, they secret 
collagen and organize them into a matrix. The growth factors are removed from the 
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wound site by decay where the collagen matrix replaces the preliminary matrix formed 
by fibronectin, so that the chemokine gradient is reduced. Therefore after fibroblasts enter 
the wound site, they will assume a more random migration. Collagen fibers gradually 
accumulate and recover to the normal density. In parallel with collagen production, the 
migrating fibroblasts produce traction and induce wound contraction. The traction forces 
and contraction process are illustrated in Fig1. At the beginning of the healing, the wound 
granulation tissue is mechanically weak and will result in large deformation. Contraction 
is rapid at this stage.  Subsequently, collagen matrix is reconstructed from the boundary 
to center, and the mechanical strength of wound tissue is recovered from boundary to 
center, so that we can see the deformation is reduced at the wound boundary. At last, the 
wound tissue resumes the normal strength and tissue displacement is restored. 
3.3.2 The advantages of improved modeling strategies  
Modeling fibroblast tension as well as traction. In previous modeling efforts, cell 
traction is simply modeled as proportional to difference in cell density. This barely 
describes the tension produced by contracting static cells. However, according to 
experimental examination, the main forces that push the wound edge inward are the 
traction produced by migrating fibroblasts. What’s more, the effect of cell speed on the 
traction cannot be ignored. We here model both tension and traction. Tension is similarly 
modeled as density difference of fibroblasts as before, and traction is modeled as 
migration speed times fibroblast density times some traction coefficient. We compare the 
results from a model only describing tension vs. the results from our model in Fig2. It’s 
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clear that if traction is ignored, the wound will not contract for a long time. Instead, the 
wound will be distracted to be larger in area. The wound will not contract until a 
population of fibroblasts has migrated into the inner part of the wound and build a density 
gradient with the surrounding tissue.   
Modeling ECM as isotropic vs. anisotropic material. The treatment of wound tissue as 
fiber-reinforced anisotropic soft tissue clarifies the effect of collagen orientation on 
wound contraction pattern. The direction of large bundles of parallel collagen fibers has 
the most rigidity, thus resistant to large deformation. The direction perpendicular to the 
collagen alignment has the most flexibility, thus more pliable to large deformation 
(Appendix C). Therefore, the pattern of collagen alignment dictates the position of large 
deformation, which directly affects the contraction pattern.  
Modeling collagen alignment as fibroblast dependent vs. traction dependent. The 
alignment of collagen fibers with fibroblasts and the alignment of them with tension line 
are somehow intertwined. However, these two mechanisms should be distinguished, 
because alignment with fibroblasts is caused by production and degradation of collagen 
fibers by fibroblasts, while alignment with tension line is caused by mechano-sensing 
signaling. In a regular wound, the effects of these two mechanisms are overlapped (Fig 3) 
because the location of large deformation is almost in coincidence with the location of 
chemotaxis. The effect of mechanical alignment is revealed later in the scenarios in 
which wounds are under tension constantly existing in skin (Fig 11-12). In a wound free 
of tension, collagen doesn’t need to respond to external forces, thus will form a more 
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random matrix, which means a better healing with less scarring. However, in a wound 
under constant tension, if collagen doesn’t respond to external forces, the wound will be 
distracted and prohibited from closing. Therefore, the alignment of collagen fibers with 
tension line is a mechanism to maintain a stable mechanical micro-environment, but 
possibly at the cost of more severe scarring.  
3.3.3 Parameter variation 
There are two things to do with parameter values: one is find the biologically realistic 
parameter values or parameter value ranges; the other is to examine the effects of varying 
the parameter values in its biologically realistic ranges on the healing result. Only after 
the first aim is accomplished can we carry on to the second aim. 
First of all, we need to make sure the parameter set for strain energy function and force 
generation can best describe the mechanical properties of object we are modeling—
human dermis. In Appendix A, we do parameter fitting against an isotropic model, and 
find a default set of parameter values for the subsequent simulation.  
Of all the remaining parameters in this model, some are available from literature through 
experimental measurements, some can be estimated from the related measurements, 
while others are not easy to determine. The parameter values are given in Table1 and are 
discussed in Appendix A. In the following, we set the fixed parameters as default and 
examine the parameters that are variable. 
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Fibroblast proliferation. Fibroblasts proliferation can be incorporated to the model with 
a little more effort. We didn’t incorporate fibroblast proliferation just to keep the model 
more focused on other important mechanisms.  Actually fibroblasts carry out 
proliferation mostly previous to their infiltration to the wound site and layout of collagen 
fibers. Therefore the effects of fibroblast proliferation can be investigated by just altering 
the fibroblasts density at the wound boundary. In the default setting, we set fibroblasts 
density to be 1200/mm2, which is roughly the density after proliferation. In a comparison 
setting, we set fibroblasts density to half, representing a proliferation-repressed condition.  
As shown in Fig4 (b), the effects of fibroblast proliferation are multiple. Firstly, a wound 
with normal density of fibroblasts at the wound boundary heals faster than a wound with 
half the normal density of fibroblasts. That’s because collagen are laid out in a proper 
speed and then aligned to be more random in the remodeling process. Secondly, when 
more fibroblasts infiltrate the wound, they form a more densely packed rim pulling 
inward the dermal edges, thus the force field is more symmetric and the contraction 
pattern is more regular. These combined favor a better healing with less scarring.  
Collagen production rate. In fibrosis disease, fibroblasts can be overactive and produce 
excess amount of collagen. As shown in Fig4(c), over production of collagen fibers may 
prohibit the random migration of fibroblasts and thus prohibit the random layout and 
alignment of collagen, resulting in a collagen distribution with uneven density and large 
bundle of parallel fibers.  
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3.3.4 The contraction pattern of different shapes of wound and wounds under 
different treatment and mechanical condition 
Contraction pattern of wounds of different shapes. Wounds of different shapes heal 
with different dynamics. For a round wound, the forces generated and the contraction 
pattern is concentric, so the wound assumes a roughly round shape throughout the healing 
time (Fig5). However, wound contraction doesn’t always preserve the original shape of 
the wound. An elliptic wound becomes more elongated in the process of contraction since 
contraction is more pronounced at regions of boundary with low curvatures (Fig6).  It is 
explained as a result of the large myofibroblast activity in other models. However, our 
model reveals that even without myofibroblast activity, the elliptic wounds become 
elongated because of the fibroblasts migrating in form more pronounced paralleled array 
at the regions of boundary with low curvatures.  
A square or rectangular wound will contract to a stellate shape, with the four corners 
closer to the original location and the middle sections of the edges closer to the wound 
center (Fig7). This is in accordance with experimental results by Gross. A simple 
explanation to this phenomenon can be that the adjacent orthogonal edges are closer to 
each other than are opposing parallel sides and will become in contact sooner. However, 
when looking at the collagen alignment profile, more cells infiltrate along the diagonal 
than perpendicular to the edges. Therefore tissue displacement along the diagonal is 
small, while off the diagonal it is much larger, because collagen fibers on the diagonal are 
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realigned with fibroblasts and are almost parallel to diagonal, while off the diagonal they 
are much more random.  
The healing processes of another two types of wound are also given in Fig8 and Fig9, just 
to demonstrate the applicability of the model to more general scenarios. 
One outstanding phenomenon in our result is that, after maximal contraction is reached, 
the tissue displacement will be restored gradually. The time of maximal contraction 
coincides with the time when fibroblasts stop chemotaxis and starts moving more 
randomly. However, this is in contrast to real wound healing in which a permanent 
contraction is normally observed. The permanent tissue displacement is probably due to 
collagen and fibroblast dynamics and the ensuing contracting activity of myofibroblasts, 
which is not described in this model. Nevertheless, the model correctly predicts the 
contraction pattern of different shapes of wounds until a maximum contraction is 
reached. The importance and mechanism of permanent tissue displacement is further 
discussed in Section4. 
Contraction pattern of wounds under different mechanical conditions. Skin is under 
tension when human body assumes certain gestures requiring the contraction of certain 
group of muscles. Langer’s lines define the primary direction of tension within the human 
skin. Because collagen fibers tend to align with tension lines, Langer’s lines also define 
the direction along which the skin has the least flexibility. We examine the contraction 
dynamics of wounds under different tension scenarios (Fig10, 11, 12). Results indicates 
that elliptical wounds will be rounded up when their long axis is perpendicular to tension 
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lines, and will be further elongated if their long axis is along the tension lines(Fig10). 
Collagen alignment with tension lines is shown to be necessary for maintaining a stable 
mechanical environment when the wound is under constant tension. However, this risks a 
more severe scarring.(Fig11,12) Therefore the body is trying to strike a balance between 
a stable mechanical environment and less scarring.  
3.4 Discussion 
We have developed and studied a comprehensive wound contraction model which 
addresses the influence of collagen alignment pattern on the wound tissue mechanical 
properties, and the alignment of collagen in response to tissue displacement and tension. 
The model is inspired by the fact that tissue anisotropy has important influence in various 
events during wound healing. The dynamic interaction between collagen alignment and 
tissue deformation, bridged by the anisotropic nature of skin, results in interesting 
emergent patterns of wound contraction and delivers important information concerning 
the mechanisms of scar formation. It’s shown that collagen production rate, the tendency 
of the collagen fibers to align with the tension, and the wound shape have a significant 
impact on the overall contraction pattern and the resulting scarring.  
Simulation results of the model raise several problems about the mechanism of wound 
contraction. The function of myofibroblasts is deliberately excluded from this model, so 
dynamic traction and static tension of fibroblasts are considered as the only driving force 
of wound contraction. However, it is shown that fibroblasts activity is not able to 
maintain contraction after they stop polarized coordinated migration. The fact that small 
to intermediate-sized wounds in swine and rat dorsum can heal solely by contraction 
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indicate the importance of permanent tissue displacement. For larger wounds and wounds 
in tight-skin species, the contribution of contraction to wound closure varies from 30% to 
80%. Therefore it’s important to identify the mechanism for maintaining the contracted 
state. One possibility is that myofibroblast induced network-based contraction will 
reinforce the fibroblast-induced contraction pattern. However, experimental examination 
has shown that a wound repeatedly excised of granulation tissue will still come to a 
complete closure. Since myofibroblast only exerts its function inside the wound 
boundary, the excision of granulation tissue questions the function of myofibroblasts. As 
another possibility, attachment of the picture-frame cells to the overlying dermis and to 
the underlying deep fascia may be crucial for maintaining the tissue displacement. The 
attachment and release of the picture-frame cells from the deep fascia accomplishes 
coordinated inward movement of the wound edges, of which the mechanism is worth 
further examination. On the other hand, remodeling taking place in the wound edges may 
also contribute to reinforce the displacement.  
Scars, albeit outstanding from the surrounding tissue in appearance, are heterogeneous in 
nature. The minor scar collagen fibrils are more random than normal tissue, while the 
hypertrophic scar usually consists of highly aligned patch of unfunctional collagen. Here 
we only examine the latter case. Fig4c demonstrated scarring resulted from excessive 
amount of collagen produced by constantly active fibroblasts, while Fig10 and Fig11 
illustrate the scarring from over alignment of collagen with tension line. Collectively, our 
model results support the hypothesis that scar formation is the product of collagen fiber 
synthesis and alignment in the presence of the tensile stress field generated by a wound 
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contraction process. The scab and epithelium provides partial mechanical support against 
stretch and other disturbances. They cooperate to provide a stable micro mechanical 
environment for the wound to heal undisturbed.  However, the scab and new epithelia is 
still vulnerable. Treatments that provide additional mechanical support such as injecting 
the drug, BOTOX near the site of the wound, and by applying an appropriate scaffold 
should prevent the generation of oriented fibers.  
Our model provides a platform for further modifications to examine the effects of more 
conditions on wound contraction results. Here are a few aspects of modification within 
sight to raise the model to a higher level of biological relevance. First, in our model, we 
only consider fibroblasts entering the wound region from the surrounding unwounded 
area. However, fibroblasts from the underlying layer of tissue are also important. 
Secondly, collagen are biaxially oriented rather than aligned along a single axis in reality. 
In this model, we simply assume that collagen fibers have a primary direction on each 
point of the space. What’s more, our model didn’t incorporate the viscosity of soft tissue. 
It is desirable to consider the biaxial orientation of collagen fibers and tissue viscosity in 
the future work in order to make the model a better resemblance of biological reality. 
Finally, we show the wound contraction pattern by tissue displacement profile and the 
deformed wound boundary, but the collagen alignment and fibroblasts location are still 
expressed with respect to original undeformed mesh. It’s desirable to make the collagen 
alignment and fibroblasts representable on a deformed mesh, which will give a more 
realistic scenario that supports the modeling of ensuing activity. For example, a wound 
becoming smaller by contraction requires less amount of collagen to be laid out than a 
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wound remaining the original size. Further extension of the model may include the 
myofibroblast activity to examine the contraction in a long term of time. Myofibroblasts 
play a very important role in wound contraction. But they act in a very different way than 
fibroblasts. It’s highly desirable to incorporate the mechanisms of myofibroblasts-
induced contraction in the future model.  
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Figure 3.1 Contraction process of a rectangular wound. Upper lane: collagen alignment profile. White curves 
represent collagen fibers and yellow dots represent the location of fibroblasts. Lower lane: Tissue displacement profile 
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show as a vector plot. The direction and length of arrow correspond to the direction and the amount of tissue 
displacement. The amount of tissue displacement is emphasized by a color map.  
 
 ( 
(a) 
 
(b) 
Figure 3.2 Contraction of a round wound. White line marks the boundary of the wound, obtained from the tissue 
displacement profile. (a) Both static tension and traction produced by migrating fibroblasts are considered. (b) Tension 
is considered as the only source of forces for wound contraction.   
 (a)   
Figure 3.3 Collagen alignment pattern of an elliptical wound after 42 hrs of healing. Left: Collagen fibers only align 
with tension line. Middle: Collagen fibers align with both tension line and fibroblasts. Right: Collagen fibers only align 
with fibroblasts. 
 
     
88 
 
    
(a) 
     
      
(b) 
     
  
(c) 
Figure 3.4 The effects of parameters. (a)Default setting: initial fibroblast density is 1200 cells/mm2, pc = 0.44, one 
picture per 6hrs; (b) Initial fibroblast density is 1200 cells/mm2, pc = 0.44, one picture per 6hrs; (c) Initial fibroblast 
density is 1200 cells/mm2, pc=0.64, one picture per 6hrs. 
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Figure 3.5 Contraction and collagen alignment pattern of a round wound. One picture per 6hrs.  
 
 
Figure 3.6 Contraction and collagen alignment pattern of an ecliptic wound. One picture per 6hrs. 
 
 
Figure 3.7 Contraction and collagen alignment pattern for a rectangular wound. One picture per 6hrs. 
      
Figure 3.8 Healing process of an irregular shape of wound. 
      
Figure 3.9 Healing process of a circle cut. 
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    (a) 
    (b) 
    (c) 
Figure 3.10 Contraction of an elliptic wound (a) under no tension; (b) under tension in y direction; (c) under tension in 
x direction. One picture per 6hrs. 
     
    (a) 
      
    (b) 
Figure 3.11 Wound boundary and collagen alignment pattern for an elliptic wound under tension (in x direction). 
(a)Collagen fibers only align with fibroblasts; (b) Collagen fibers align with both fibroblasts and tension lines.  
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    (a) 
     
    (b) 
Figure 3.12 Wound boundary and collagen alignment pattern for an elliptic wound under tension (in y direction). 
(a)Collagen fibers only align with fibroblasts; (b) Collagen fibers align with both fibroblasts and tension lines. 
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4 A multi-scale model for wound healing proliferative phase 
4.1 Introduction 
4.1.1 Fibroblast activities during granulation tissue formation are coordinated by 
TGFbeta pathway  
There are many signaling events involved in regulating fibroblasts so that they carry out 
their duty in a timely order during granulation tissue formation. As stated in Section1.2.1, 
PI3K-Akt pathway and Integrin-FAK pathway modulates fibroblast migration, a 
spectrum of mitogenic growth factors stimulate fibroblast to proliferate, while TGFβ 
pathway mainly regulates collagen production. However, TGFβ is actually a central 
coordinator of granulation tissue formation. A diverse range of fibroblast activities can be 
induced by TGFβ. TGFβ has also been implicated as an initiating cytokine in numerous 
fibrotic disorders of the skin[88]. There is also a belief that TGFβ modulates fibroblast 
proliferation, migration, differentiation through its modulation of ECM composition and 
structure. 
Regulation of fibroblast proliferation by TGFβ. TGFβ is initially identified by its unique 
ability to stimulate anchorage-independent growth of normal fibroblasts[89, 90]. 
However, the presence of an EGF-related peptide is essential for TGFβ mitogenic 
activity. The role of TGFβ in regulating proliferation of various cell types is paradoxical 
since TGFβ has been shown to inhibit the growth of epithelial cells and vascular 
endothelial cells while it’s a potent mitogen for fibroblasts. 
Regulation of fibroblast migration by TGFβ. Fibroblasts infiltration of the wound from 
the surrounding tissue requires coordinated migration. TGFβ is involved in the fibroblast 
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phenotype switch from static to motile, and serve as one of the chemokines for fibroblast 
chemotaxis.   
In addition to chemotaxis, ECM provides another directional clue for fibroblast 
migration. On the one hand, fibroblasts will co-orient with local collagen direction. On 
the other hand, cells migrate up a gradient of cellular adhesion sites or substrate-bound 
chemoattractants (haptotaxis). These gradients are naturally present in ECM during 
wound healing. ECM mediates fibroblast migration through integrin-related signaling 
pathway. Integrin ligands, such as fibronectin, are not passive adhesive molecules but are 
active participants in the cell adhesive process that leads to signal transduction[91].  
Integrin-mediated cell adhesion causes increased tyrosine phosphorylation of focal 
adhesion kinase(FAK), leading to cytoskeletal organization and focal adhesion 
formation[92].       
Regulation of collagen production by TGFβ.  The main source of collagen is fibroblast. 
It can be degraded by collagenases and other factors, among which is matrix 
metalloproteinase (MMP). The function of MMP is inhibited by tissue inhibitor of 
metalloproteinase (TIMP)[93]. The balance between MMP and TIMP regulates the 
collagen deposition dynamics [94]. TGFβ regulate collagen production and metabolism. 
It stimulates the synthesis of collagen and fibronectin, as well as many other ECM 
components by fibroblasts. It also inhibits MMP production, while stimulate TIMP 
production[95]. There are principally two types of collagen: type I and type III. Type III 
collagen is abundant in granulation tissue, while type I mainly resides in normal tissue. In 
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the remodeling phase of wound healing, type III collagen is gradually replaced by the 
stronger type I collagen. The ratio of type I to type III collagen determines the diameter 
of collagen fibers, thus affecting the physical properties of collagen network. The role of 
TGFβ in ECM remodeling is  
Regulation of fibroblast differentiation by TGFβ. Several studies have indicated that 
TGFβ is a potent inducer of the myofibroblast phenotype. Experimental results argue 
strongly that fibroblast differentiation is the default path unless sufficient mitogenic 
growth factors are present to support cell proliferation in response to TGFβ[96].  
The coordinated regulation of fibroblast activity by TGFβ pathway. Fibroblast 
proliferation, migration, differentiation into myofibroblasts, and increased collagen 
synthesis are key events during wound healing. According to the above, TGFβ is a 
versatile growth factor that can elicit a spectrum of fibroblast activities including 
fibroblast proliferation, migration, differentiation into myofibroblasts and collagen 
production. Therefore, intuitively, TGFβ can be an important regulatory element during 
wound healing. Actually, TGFβ is a central coordinator of granulation tissue formation, 
and all fibroblast activities occur primarily in response to TGFβ pathway and are 
coordinated by other growth factor induced signaling. An important feature of these 
responses to TGFβ is that they are mutually exclusive, so that cells that are proliferating 
do not express alpha-SMA or elevated levels of collagen synthesis, while cells expressing 
alpha-SMA do not exhibit DNA synthesis but do coexpress higher levels of types I and 
III collagen mRNA. Fibroblast proliferation and differentiation are controlled by 
95 
 
combinatorial signaling pathways involving not only components of the TGFβ pathway, 
but also signaling events induced by EGF and IGF-2 activated receptors[96].  
The molecular mechanism whereby TGFβ induces these diverse and paradoxical( 
proliferation vs. differentiation) biological effects must occur postreceptor, as the same 
TGFβ receptors appear to be responsible for initiating the various signaling events. It has 
been determined that the growth stimulatory action of TGFbeta and the induction of 
collagen synthesis and accumulation occur via a post-TGFbeta receptor mechanism 
mediated by CTGF. 
For cells to proliferate in response to TGFβ, EGF or another suitable mitogenic factor 
must be present. For cells to differentiate into myofibroblasts and to increase collagen 
synthesis, IGF-2 is required. Experimental results argue strongly that differentiation is the 
default pathway unless sufficient mitogenic growth factors are present to support cell 
proliferation in response to TGFβ. Previous studies have reported that TGFβ can induce 
IGF synthesis, which is believed to explain the lack of an absolute requirement for IGF in 
TGFβ activated cells. 
TGFbeta signaling is tightly controlled by MAPK signaling cascade. Ras/MEK/ERK 
cascade phosphorylates and modifies Smad activity. In fibroblasts, addition of TGFb 
results in a transient activation of the ras/MEK/ERK cascade.  
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4.1.2 TGFβ signaling pathway  
TGFβ receptors. TGFβ initiates signaling by the assembly of receptor complexes. Three 
major classes of receptor proteins (TβR-I, TβR-II, and TβR-III) have been identified. 
TβR-I and TβR-II are protein kinases that contain an extracellular ligand-binding domain, 
a transmembrane domain, and a cytoplasmic serine-threonine kinase domain. Following 
binding of the TGFβ molecule to TβR-II, TβR-I is recruited to form a heterotetrameric 
complex. The constitutively active TβR-II then phosphorylates TβR-I on serine residues. 
TβR-III (glycan), the most abundant of the receptor types, is not directly involved in 
signaling but is thought to regulate TGFβ access to the signaling receptors TβR-I and 
TβR-II. 
Smad structure and function. Activation of TGFβ receptors results in the stimulation of 
an evolutionarily conserved, signal transduction pathway that is mediated by Smad 
proteins. Based on structural and functional considerations, Smads fall into 3 subfamilies, 
namely, the receptor-activated Smads (R-Smads; Smad1, Smad2, Smad3, Smad5, and 
Smad8), the common- mediator Smad (Co-Smad; Smad4), and the inhibitory Smads (I-
Smads; Smad6 and Smad7). Whereas Smad4 has a critical role in signaling by all the 
TGFβ superfamily members, R-Smads and I-Smads demonstrate pathway specificity and 
are selectively activated by different receptors. 
Smad2, Smad3, and Smad7 are activated primarily in response to TGFβ1, whereas 
Smad1, Smad5, and Smad8 are substrates of the BMP type I receptor and mediate BMP 
signaling. At their N- and C-termini, R-Smads and Co-Smads have highly similar amino-
acid sequences termed 'Mad homology domains', MH1 and MH2, respectively. The MH1 
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domain predominantly mediates DNA binding and assists in nuclear translocation, 
whereas the MH2 domain is responsible for receptor interaction, Smad oligomerization, 
and transcriptional activation. The MH1 and MH2 domains are separated by a variable 
proline-rich linker region which contains multiple consensus phosphorylation sites for 
mitogen-activated protein kinases (MAPKs) and, in the case of Smad4, a segment 
adjacent to the MH2 domain known as the Smad4 activation domain (SAD). SAD is 
essential for the mediation of signaling processes through its ability to confer 
transcriptional activity by binding to nuclear co-factors.  
In the resting state, Smad4 is rapidly and continuously shuttling between the cytoplasm 
and the nucleus. The distribution of Smad4 is dictated by the relative strengths of the 
nuclear localization and export signals (NLS and NES) within the MH1 domain of the 
Smad4 protein. Continuous nuclear-cytoplasmic shuttling is not considered to be a 
property of the R-Smads, because, in the absence of TGFβ, they are retained within the 
cytoplasm through interaction with other cytoplasmic proteins such as microtubules 
and/or Smad-anchor for receptor activation (SARA) molecules. Further, while R-Smads 
do not contain an NES, they do have an NLS which is capable of mediating ligand-
induced nuclear localization; in the absence of a signal, the NLS in Smad2 and Smad3 are 
masked. 
Dynamics of signal transduction through TGFβ pathway. Upon TGFβ-induced receptor 
activation, Smad2 and Smad3 are transiently recruited to the receptors via chaperone 
molecules such as membrane-associated SARA. Phosphorylation by TβR-I unmasks the 
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NLS of the R-Smads such that they are released back into the cytoplasm, where they 
form heterotrimeric complexes with Smad4. Although the exact mechanisms of nuclear 
import are not completely understood, it is postulated that Smad4 either cotranslocates 
with the R-Smads by utilizing the latter's nuclear import function or transports separately 
using its own nuclear import mechanism. Once inside the nucleus, R-Smads mask the 
NES of Smad4, and the complex is retained in the nucleus to facilitate transcriptional 
regulation. Within the nucleus, Smads function as transcriptional regulators and modulate 
the expression of target genes. The MH1 domains of Smad3 and Smad4, but not Smad2, 
bind directly to a specific DNA sequence called the Smad-binding element (SBE). SBEs 
have been found in multiple TGFβ-responsive promoter regions in a variety of genes. 
Since Smad protein affinity for this cognate sequence (CAGAC) is very low, additional 
DNA contacts with two classes of proteins—DNA binding cofactors and transcriptional 
co-activators and co-repressors—are necessary for specific, high-affinity binding of a 
Smad complex to a target gene. To date, more than 40 transcription factors, co-activators, 
and co-repressors are known to interact with Smad proteins.  
It is becoming apparent that Smad2 and Smad3 regulate different subsets of target genes. 
Smad3/Smad4 complexes activate immediate early genes by binding to SBE core repeats 
of target promoters, whereas Smad2 mediates the transmodulation of immediate-early 
and intermediate genes and may antagonize the effects of Smad3; interestingly, Smad3 
appears to regulate a different set of genes in keratinocytes and fibroblasts.  
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Regulation of receptor and Smad function. In the nucleus, Smad binding to DNA is 
transient, and deactivation of Smad function occurs through the actions of I-Smads and 
through R-Smad degradation and post-translational modification. I-Smad, Smad7, resides 
within the nucleus in the basal state, is induced in response to TGFβ, and functions via a 
negative feedback mechanism to control the intensity and duration of Smad signaling. 
The direct association of Smad7 with receptor complexes prevents further recruitment 
and phosphorylation of R-Smads, while its ability to recruit Smurf-1 and Smurf-2 leads to 
receptor degradation. 
Once receptor signaling is abrogated, Smad2 and Smad3 are rapidly de-phosphorylated, 
presumably by an as-yet unidentified R-Smad nuclear phosphatase. Evidence is 
accumulating to indicate that phosphorylated R-Smads are degraded via the ubiquitin 
proteosome system by the activity of E3 ubiquitin ligases, which function at both the 
cytoplasmic and nuclear levels. In contrast, Smad4 is not normally subject to regulation 
by phosphorylation or ubiquitination, most probably because it functions as a common 
mediator and is required to be present in significant levels at all times. Like the R-Smads, 
Smad7 also undergoes ligand-dependent ubiquitination and degradation. 
Modeling works of TGFβ pathway. Most of the parameters in TGF-beta pathway are not 
available in literature. However, modeling the TGF-beta has been promoted by different 
methods in parameter fitting. 
In 2006, Jose M.G. Vilar at el. use a ligand-receptor network model to explain the 
versatility of TGFβ signaling pathway. They show that coupling of siganling with 
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receptor trafficking results in a highly versatile signal-processing unit, able to sense by 
itself absolute levels of ligand, temporal changes in ligand concentrations, and ratios of 
multiple ligands. [97] 
 Another 2006 work by Pontus Melke at el., a rate equation model is proposed for TGF-
beta pathway. This model accounts for signaling from cell membrane to cytoplasm. 
Binding of TGFβ and two different receptors (ALK1 and ALK5) are separately 
considered. Total phosphorylated R-Smad (PSmad2 and PSmad3) are used as output to 
illustrate the overall dynamics. All the 33 parameters are generated from simulated 
tempering. A large number of parameter sets are generated that can accurately describe 
experimental time course, clustered according to, and filtered by further experiments. 
Feedback control from Smad7 is revealed as an important mechanism for time-
modulation of TGF-beta signallin. However, it didn’t deal with how the signal is 
transduct into nucleus[98].  
Also in 2006, almost the same time, David C.Clarke at el. proposed another rate equation 
model for TGF-beta pathway. This model accounts for signaling from activated receptor 
to nucleus, with detailed description of Smad shuttling(R-Smad, Co-Smad).  An 
imbalance in the rates of R-Smad phosphorylation and dephosphorylation is likely an 
important mechanism of Smad nuclear accumulation during TGFβ signalling. However, 
it didn’t consider any feedback mechanism from I-Smad[99]. 
Zhike Zhang built a constraint-based comprehensive model of TGFβ pathway which 
considers receptor internalization, Smad nucleocytoplasmic shuttling and complex 
101 
 
formation and negative feedback from I-Smad [100]. Further examination of the 
plasticity of TGFβ pathway dynamics shows that different types of TGFβ ligands can 
elicit sustained, transient, or oscillatory responses due to different kinetic 
parameters[101]. 
4.1.3 Multi-scale modeling of biological systems 
With growing computational power and increasing knowledge of biological systems from 
gene to organ level, it is increasingly practical to apply multi-scale modeling to reveal the 
biological complexity.Multi-scale modeling has been used in many biological system, 
such as tumor growth [102-104], cardiovascular system, musculoskeletal system and 
respiratory system[105]. Boolean network[102] or ODE system[103] [104] is used to 
encode subcellular signaling events, such as cell cycle control. Agent-based model 
(including cellular automata (CA) and lattice-free agent-based model) or a hybrid 
discrete-continuous model is used to encode the tissue level events. 
Multi-scale modeling has the advantage of capturing different levels of activity. 
However, it is restricted by its complexity and difficulty in analysis. Only when the 
robustness of a lower scale model has been validated can it be incorporated in a higher 
scale. Different model scales has different spatial and temporal resolution, which have to 
be meticulously set up to guarantee the biological relevance. Multi-scale model are 
generally computationally intensive, therefore parallel programming is required to 
accelerate the simulation. 
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4.1.4 A multi-scale model of wound healing proliferative phase 
We embedded a TGFβ pathway to each fibroblast. The subcellular level model is an ODE 
system. It is a mechanistic model which can capture TGFβ pathway in detail. The cellular 
level describes the determination of individual cell activities based on its internal 
signaling state. Fibroblast proliferation, migration and collagen production are considered 
in the cellular level model, but fibroblast differentiation into myofibroblasts is not 
considered. The tissue level model has three layers—diffusible layer, cell population 
layer, and ECM layer. In the diffusible layer, the dynamics of growth factor and 
inflammation are characterized by reaction-diffusion equations. In the cell population 
layer, fibroblasts are represented by discrete particles and carry out proliferation and 
migration in a lattice-free mode. In the ECM layer, a dynamically changing density and 
structure profile of collagen matrix are encoded.  These three layers in tissue level model 
are couple by fibroblast-collagen co-orientation, fibroblast chemotaxis and consumption 
of growth factors, as well as collagen mediation of inflammation. The three levels of 
models are further coupled by subcellular signaling events in response to environment 
and translating signaling states into cellular activities.  
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4.2 Methods 
Wound healing proliferation phase is a set of simultaneous events in which interplay of 
genetic, biochemical and cellular mechanisms and environmental factors are involved. 
We consider TGFβ pathway as the central signaling pathway mediating wound healing. 
TGFβ pathway is multifunctional during wound healing. Since there is ample evidence 
that TGFβ pathway directly stimulates the production of ECM by fibroblasts, we 
incorporate this effect directly into our model.  TGFβ pathway also regulates other 
fibroblast activities including proliferation, migration and differentiation. However, these 
effects are somehow indirect. It is believed that TGF-beta exerts its effects on cell 
proliferation, differentiation, and migration in part through its capacity to modulate the 
deposition of ECM components. 
4.2.1 Subcellular level 
In our model of subcellular signaling events, we consider the classical pathway module 
(TGFβ receptor-RSmad-CoSmad), as well as ECM induced Smad activation (crosstalk 
signaling).  
We extends an earlier model due to  Zhike and Edda [100] by incorporating the crosstalk 
with ECM induced signaling. The model by Zhike and Edda is a comprehensive model 
for TGFβ pathway which accounts for receptor internalization, RSmad phosphorylation 
and Smad complex formation, nuclear shuttling of Smad proteins and complex and 
negative feedback from ISmad.  In this earlier model, unknown parameters are estimated 
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by fitting to experimental data, resulting in many feasible sets of parameters. However, 
only one set of parameter is chosen to be baseline parameters in our model.  
ECM induced Smad activation is observed, which follows a similar chronological 
sequence and R-Smad specificity as induced by TGFβ. TGFβ participation is not required 
for crosstalk signaling. But the participation of TGFβ type II and type I receptor are 
required to propagate Smad2 activation induced by ECM. ECM induced signaling also 
requires a functional integrin β1 receptor, and involves focal adhesion kinase (FAK) and 
Src activity. The gene expression responses downstream of ECM induced signaling are 
distinct from that evoked by TGFβ. Inflammation-specific gene signature shows 
increased sensitivity to crosstalk signaling[106].  
It’s been shown that collagen matrix attenuate the collagen synthetic response of 
fibroblast to TGFβ in vitro and possibly in vivo. The mechanism of this attenuation effect 
is unknown, but it is not secondary to nonspecific binding of TGFβ to collagen matrix. 
The possibility that collagenous environment down-regulates TGFβ receptors is not 
supported by experimental evidence. The alternative hypothesis that collagen matrix may 
influence signal transduction needs further investigation. [107] 
Basic assumption of the TGFβ ECM crosstalk model according to experimental 
analysis[106] [107]: 
(i) Both Smad2 and Smad3 phosphorylation are induced by ECM. The extents of 
Smad2 vs. Smad3 phosphorylation are indistinguishable according to 
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experimental evidences to date. Therefore we use Smad3 to denote total 
amount of Smad2 and Smad3 for simplicity.  
(ii) ECM induced Smad3 phosphorylation competes with TGFβ induced Smad3 
phosphorylation in the usage of Smad3. 
(iii) The downstream effect of ECM induced Smad3 phosphorylation is 
inflammation inhibition. ECM induced Smad3 phosphorylation doesn’t cause 
ISmad production. 
(iv) The production rate of ECM is proportional to TGFβ induced phosphorylated 
Smad complex in nucleus.  
The detailed structure of TGFβ ECM crosstalk pathway is depicted in the Fig4.3. 
Appendix A gives model description, model equations, initial conditions and parameter 
values of the earlier model by Zhike and Edda[100], followed by a description of our 
modified crosstalk model.  
4.2.2 Individual cell activity:  the interface between sub-cellular level and tissue level 
Cell decision based on internal signaling events. Cell proliferation, migration and 
collagen production are determined by a cell’s internal protein concentrations. Here we 
don’t consider fibroblast differentiation into myofibroblast. Based on experimental 
results, we assume that one fibroblast cannot migrate and produce collagen while it’s 
dividing. However, migration and collagen production can occur at the same time. 
What’s more, fibroblasts residing in the surrounding tissue are quiescent before growth 
factors stimulate it to proliferate or migrate or produce collagen. Therefore, one fibroblast 
will switch between three states: quiescent state, dividing state or functional state 
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(migrating and collagen production).  We apply the following rules to dictate the switch 
between different cell-states. 
 Fibroblast is quiescent when [Smad3_4Nuc] is below threshold Th1. 
 Fibroblast becomes active when [Smad3_4 Nuc] is above Th1. If [Smad3_4 Nuc] is 
above Th2, and the age of fibroblast is above Tage fibroblast will be committed to 
division, otherwise it will be committed to migration and collagen production.  
 When a fibroblast is committed to division, it will process through a certain length of 
time Tdiv before it becomes two daughter cells. 
 When a fibroblast is committed to migration and collagen production, the migration 
speed is independent to signaling activity level, but dependent on ECM composition 
and TGFβ gradient; and the migration direction is dependent on TGFβ gradient and 
collagen orientation. The rate of collagen production is assumed to be proportional to 
[Smad3_4 Nuc].  
According to experimental evidence, fibroblasts proliferate in response to TGFβ only 
when EGF or another suitable mitogenic factor is present. However, in our model, 
fibroblast proliferation is set to be only dependent on TGFβ concentration. We choose 
this setting because the dynamics of EGF or other growth factor is not clear through 
literatures and don’t follow simple rules (there are many types of cells that can produce 
these growth factors), so that adding them into models only brings in uncontrollable 
factors. Mechanism for fibroblast proliferation in response to TGFβ is further discussed 
in Section 4.4.   
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 Feedback from cell activity to the tissue level. For each cell at spatial position (x, y), 
[TGFβ] and [collagen] are fed into the sub-cellular signaling model. 
Parameter Value Unit Reference 
Th1 20 nM This work. 
Th2 100 nM This work. 
Tdiv 1.25 hr This work. 
Tage 1.25 hr This work. 
Table4.1 Parameters for individual cell level model.  
4.2.3 Tissue level  
Cellular layer. Initially, the wound site is devoid of fibroblasts and collagen. Fibroblasts 
residing at the wound boundary migrate inward following TGFβ gradient and layout 
collagen along their trails. As the collagen fibers are secreted and organized, they become 
a second directional guidance for fibroblast migration. We use f఩ሬ⃑  and v఩ሬሬሬ⃑   to denote the 
location vector and velocity vector of the j୲୦ fibroblast. The direction of each individual 
cell in successive step is described as proposed by J.A. Sheratt[99] as follows: 
ߠ௙ೕ(ݐ) =  ߩଵ ∗ ݉݅݊ ቆ1,
݃ݎ்ܽ݀ீிఉ
ܶℎ௚௥௔ௗ
ቇ ∗ ߠ்ீிఉ൫ ఫ݂ሬሬ⃑ , ݐ − 1൯ + ߩଶ ∗ min (1, [ܿ]) ∗ ߠ௖( ఫ݂ሬሬ⃑ , ݐ − 1)
+ ቆ1 − ߩଵ ∗ ݉݅݊ ቆ1,
݃ݎ்ܽ݀ீிఉ
ܶℎ௚௥௔ௗ
ቇ − ߩଶ ∗ min (1, [ܿ])ቇ ∗ ߠ௙ೕ(ݐ − 1) 
where ߩଵ, ߩଶ  are positive constants, and represent the influence of the TGFβ gradient and 
collagen matrix on the direction of the cell, respectively. ߠாீி(⃑ݔ, ݐ) and ߠ௖(⃑ݔ, ݐ) 
represents the angular direction of local TGFβ gradient and collagen orientation. The 
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influence of collagen chemokine gradient linearly increases with the gradient level, with 
a saturation effect at certain threshold. Similarly, the influence of collagen matrix 
depends on collagen density. The third term describes the bias of the cell to remain its 
direction in the last step. The speed of each fibroblast is determined as 
ݏ௙ = ൞
ݏ ∗
1 + 2 ∗ [݂݊]
3
                             (݂݅ [ܿ] < 0.7)
ݏ ∗
1 + 2 ∗ [݂݊]
3
∗ (1.7 − [ܿ])     (݂݅ [ܿ] ≥ 0.7)
 
ݒఫሬሬሬ⃑ = [ݏ௙ ܿ݋ݏ ߠ௙ , ݏ௙ ݏ݅݊ ߠ௙]  
This describes the fact that fibroblasts migrate more readily on fibronectin than on 
collagen. Therefore the speed function increases with the fibronectin density and 
decreases with the collagen density but is insensitive when collagen density is small.  
Fibroblast population’s influence on collagen orientation, collagen and fibronectin 
density, TGFβ and inflammation is represented as weighted average of each cell’s 
influence. The weight function is given as follows: 
ݓ௜(⃑ݔ, ݐ) = ܽଵܽଶ 
௝ܽ = ݉ܽݔ ቊ1 −
ห ௝݂
௜(ݐ) − ݔ௝ห
ܮ
, 0ቋ 
Diffusible layer. Dynamics of TGFβ is subject to reaction-diffusion. Inflammatory cells 
acts as the source for TGFβ, while fibroblasts acts as sinks. We model inflammatory cells 
as another continuum component which is subject to reaction-diffusion dynamics, and 
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denote their density by [I]. We suppose that at the beginning of the simulation, bacteria 
and debris have been cleaned out of the wound site, so that inflammation is receding. 
Therefore there is no source for inflammatory cells. Inflammatory cells are subject to 
apoptosis. One of the downstream effects of ECM induced Smad signaling is 
inflammation inhibition, so that fibroblasts exposed to collagen serves as sinks of 
inflammation. Their behaviors are described by the following equations: 
݀[ܶܩܨߚ]
݀ݐ
= ܦ்ீிఉ ∗ ∆[ܶܩܨߚ] + ݌்ீிఉ_ூ ∗ [ܫ] − ෍ ݀௜
்ீிఉ_௙ݓ௜(⃑ݔ, ݐ)
ே
௜ୀଵ
− ்݀ீிఉ ∗ [ܶܩܨߚ] 
݀[ܫ]
݀ݐ
= ܦூ ∗ ∆[ܫ] − ݀ூ ∗ [ܫ] − [ܫ] ∗ ෍ ݀௜
ூ_௙ݓ௜(⃑ݔ, ݐ)
ே
௜ୀଵ
 
݀௜
ூ_௙ = ݀ூ_௖௢௟௟௔௚௘௡ ∗
[ܵ݉ܽ݀3_4݊_ܧܥܯ]
[ܵ݉ܽ݀3_4݊_ܧܥܯ]௡௢௥௠௔௟
 
ECM layer. The collagen matrix is described by three different continuum – collagen 
density [c] and fibronectin density [fn] which describe the composition of ECM, and 
collagen orientation profile θୡ. Fibroblasts modify the density and orientation of collagen 
matrix. 
Collagen alignment with fibroblasts is implemented as by J.A.Sherratt[21]. The overall 
effect of the cell population on the matrix reorientation is represented as weighted 
average of each cell’s influence.   
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ߠ௙_௔௩௚(⃑ݔ, ݐ) =
∑ ݓ௜(⃑ݔ, ݐ)
ே
௜ୀଵ ߠ௙
௜ (ݐ − 1)
∑ ݓ௜(⃑ݔ, ݐ)
ே
௜ୀଵ
 
ߠ௖  += ߢ ∗ ෍ ݓ௜(⃑ݔ, ݐ)
ே
௜ୀଵ
∗ ݏ݅݊ (ߠ௙_௔௩௚ − ߠ௖) 
where  ߠ௙_௔௩௚ is the angle of averaged fibroblast direction, and weight function ݓ௜(⃑ݔ, ݐ) 
as described before. 
At the beginning of the proliferative phase, the wound is temporarily filled by blood clot 
formed by fibrins while devoid of collagen. During the proliferation phase, the 
composition of extracellular matrix is modified by fibroblasts as they remove the blood 
clot by degrading the fibrin and replacing it with a collagen network. The changes in 
collagen and fibrin density are described as in J.A. Sheratt[108] except that the 
production rate of collagen from each fibroblast is now dependent on intercellular level 
of [Smad3_4n]. 
[ܿ]  += (݌௖ − ݀௖ ∗ [ܿ]) ෍
[ܵ݉ܽ݀3_4݊]௜ − ܶℎଵ
[ܵ݉ܽ݀3_4݊]௡௢௥௠௔௟ − ܶℎଵ
ݓ௜(⃑ݔ, ݐ)
ே
௜ୀଵ
 
[݂݊]  −=  ݀௙௡ ∗ [݂݊] ∗ ෍ ݓ௜(⃑ݔ, ݐ)
ே
௜ୀଵ
 
Parameter Description Value Unit Reference 
Model 
ܮ௫  Width of the 2D modeling space. 1000 ߤ݉ This work. 
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ܮ௬  Length of the 2D modeling space. 1000 ߤ݉ This work. 
ܮ௭  Depth of the wound assumed. 100 ߤ݉ This work. 
݀ݔ, ݀ݕ Spatial step for calculating 
diffusible components 
concentration. 
1 ߤ݉ This work. 
− Collagen direction grid. 100
× 100 
− This work. 
ܶ Time duration of the whole 
simulated process. 
50 ℎݎ This work. 
݀ݐ Length of each time step for 
calculating the chemokine 
diffusion. 
0.01 ℎݎ This work. 
ݐ݈݁݊݃ݐℎ Length of each time step for 
updating location of fibroblasts and 
collagen orientation, etc. 
0.25 ℎݎ This work. 
Diffusible layer. 
[ܶܩܨߚ]଴ Initial concentration of TGFβ in 
wound site. 
0.2 ݊ܯ Chandan et 
al.(2007) 
ܦ்ீிఉ Diffusion coefficient of TGFβ. 5∙10
-7 ܿ݉ଶ/ݏ  Chandan et 
al.(2007) 
݌ூ_்ீிఉ Rate of TGFβ production by 
inflammatory cells. 
0.016 ݊ܯ ∙ ℎݎିଵ Chandan et 
al.(2007) 
்݀ீிఉ Natural decay rate of TGFβ 0.144 ℎݎିଵ Chandan et 
al.(2007) 
[ܫ]଴ Initial density of inflammatory 
cells in wound site. 
1 Arbitrary 
unit. 
Chandan et 
al.(2007) 
ܦூ Diffusion coefficient of 
inflammation. 
5∙10-8 ܿ݉ଶ/ݏ   Chandan et 
al.(2007) 
݀ூ Natural decay rate of inflammation 
(through inflammatory cells 
apoptosis.) 
0.0072 ℎݎିଵ   Chandan et 
al.(2007) 
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݀ூ_஼௢௟௟௔௚௘௡ ECM induced inflammation 
inhibition coefficient. 
0.1 ℎݎିଵ Estimated. 
[ܵ݉ܽ݀3_4݊_ܧܥܯ]௡௢௥௠௔௟  Level of nucleus Smad complex 
induced by ECM which gives 
normal level of inflammation 
inhibition. 
100 ݊ܯ Estimated. 
Cellular layer. 
ܨܰ݅݊݅ݐ Total number of fibroblasts in our 
modeling space. 
100 # Jonathan et 
al.(1999)[108] 
Adams, 
J.J.(1997) 
Olsen et 
al.(1995)[108] 
ߩଵ The influence coefficient of TGFβ 
gradient on the direction of 
fibroblasts.  
(Total influence is 
ߩଵ ∙ min ൬1,
௚௥௔ௗ೅ಸಷ
்௛೒ೝೌ೏
൰) 
0.3 − Variable. 
ܶℎ௚௥௔ௗ   ݊ܯ
∙ ߤ݉ିଷ 
Estimated. 
ߩଶ The influence coefficient of 
collagen orientation on the 
direction of fibroblasts. 
(Total influence is  
ߩଶ ∙ min (1, [ܿ])) 
0.3 − Variable. 
(1 − ߩଵ − ߩଶ) Fibroblast polarization. 0.4 − Variable. 
ݏ Maximal speed of fibroblast 
migration. 
15 ߤ݉ ∙ ℎݎିଵ Jonathan et 
al.(1999)[108] 
ܮ Support of fibroblast weight 
function. 
10 ߤ݉ Jonathan et 
al.(1999)[108] 
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Table4.2 Parameters and initial conditions for tissue level model.  
ECM layer. 
ߢ Rate at which fibroblasts alter the 
collagen orientation. 
20 − Jonathan et 
al.(1999)[108] 
[ܿ]଴ Initial concentration of collagen in 
wound site. 
0 Arbitrary 
unit. 
Jonathan et 
al.(1999)[108] 
[݂]଴ Initial concentration of fibronectin 
in wound site. 
1 Arbitrary 
unit. 
Jonathan et 
al.(1999)[108] 
݌௖ Rate coefficient of collagen 
production. (Actual rate of 
production is  
pୡ ∗
max ቀ
[ௌ௠௔ௗଷ_ସ௡]ି்௛భ
[ௌ௠௔ௗଷ_ସ௡]೙೚ೝ೘ೌ೗ି்௛భ
, 0ቁ) 
 
0.64 ℎݎିଵ Jonathan et 
al.(1999) [108] 
[ܵ݉ܽ݀3_4݊]௡௢௥௠௔௟  Level of nucleus Smad complex 
which gives normal rate of 
collagen production. 
100 ݊ܯ Estimated. 
݀௖ Rate of collagen degradation. 0.44 ℎݎିଵ Jonathan et 
al.(1999) [108] 
݀௙௡ Rate of fibronectin degradation. 0.6 ℎݎିଵ Jonathan et 
al.(1999) [108] 
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4.3 Results 
4.3.1 Behavior of the subcellular level signaling model 
 Simulations were performed to observe the behavior of TGFβ ECM crosstalk model in 
response to different dose of TGFβ and collagen as well as the combination of the two. 
The parameter for ECM crosstalk is fitted against experimental data due to R.A.F. Clark 
et al.[107] 
Fig4.4a shows that when there is no collagen present, the response is saturated at 0.08nM 
TGFβ. Transient treatment of 0.08nM TGFβ is enough to elicit a sustained response, 
although this response will eventually die out approximately after 10 days (result not 
shown) when TGFβ is used up through constitutive degradation of the LRC in endosome 
and ligand-induced degradation of LRC in caveolar pit. These is a gradual change from 
transient to sustained response, when TGFβ dose changes from 0.004nM to higher, as is 
shown in Fig4.4b, and the duration of the sustained response is approximately linearly 
increasing with the TGFβ dose. In the presence of collagen, the amplitude of TGFβ 
signaling decreases, but the time duration of the sustained response is not altered 
(Fig4.4c, d). The long term behavior of the signaling model is especially of concern here 
since we are trying to model a physiological process across days. Fig4.5 shows the 
peaking and steady state levels (when there is sustained response) of responses under 
different combinatorial levels of TGFβ and collagen. 
In the real life settings, cells are exposed to constantly changing levels of TGFβ and 
collagen levels. Therefore we investigate the model behavior under these scenarios 
(Fig4.6, Fig4.7). Because of the saturation effect on the TGFβ dose, cells initially 
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exposed to high levels of TGFβ are reluctant to further replenishment of the growth 
factor.  
 
 
 
Fig4.4 Response of the model under different doses of TGFβ and collagen. TGFβ and collagen is added once at the 
initial time. (a) Response of the model under different dose of TGFβ when no collagen is present. (b) Long term 
response of the model under different dose of TGFβ when no collagen is present. (c) Response of the model under 
different dose of TGFβ when 0.2mM collagen is present; (d) Long term response of the model under different dose of 
TGFβ when 0.2mM collagen is present.  
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Fig4.5 (a) Peak levels of nuclear Smad complex under different combinatory levels of TGFbeta and ECM. (b)Steady 
state levels of nuclear Smad complex under different levels of ECM. There is only one curve because TGFβ lower than 
0.004nM cannot elicit sustained response, while the level of sustained response elicited by TGFβ higher than 0.006nM 
doesn’t depend on TGFβ dose.  
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Fig4.6 Response of the model under successively added dose of TGFβ. (a) 0.001nM TGFβ is added at the initial time. 
After 4hrs, TGFβ is replenished to 0.08nM. (b) 0.02nM TGFβ is added at the initial time. After 4hrs, TGFβ is 
replenished to 0.08nM. Dotted line gives the dynamics if no change is made at 4hrs (c) 0.08nM TGFβ is added at the 
initial time. After 4hrs, TGFβ is replenished to 0.08nM. 
  
Fig4.7 Response of the model under changed level of collagen. (a)0.08nM TGFβ is added at the initial time. No 
collagen at the initial time. After 4hrs, 0.2mM collagen is added. Dotted line gives the dynamics if no change is made 
at 4hrs. (b) 0.08nM TGFβ and 0.1mM collagen is added at the initial time. After 4hrs, collagen is supplemented to 
0.2mM. 
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4.3.2 General process of granulation tissue formation predicted by the multi-scale 
model 
A typical simulation result is shown in Fig4.9. The initial time for simulation is set to be 
at the end of inflammatory phase and at the beginning of proliferative phase. At the initial 
time, the wound site is devoid of fibroblasts and collagen, but filled with a temporary 
matrix made of fibronectin, as well as initial levels of inflammatory cells and TGFβ. 
Fibroblasts are evenly distributed in the surrounding uninjured tissue. However, to reduce 
the simulation time, only fibroblasts closed to the wound boundary (about 130 cells) are 
modeled. The exclusion of fibroblasts away from the wound boundary is justified by 
numerical experiments showing that contribution of these cells to the overall collagen 
density and pattern can be ignored compared to the cells close to the boundary. During 
the proliferative phase, fibroblasts are stimulated to proliferate by growth factors and 
migrate into the wound site following chemokine gradient, as well as layout collagen 
fibers and organize them into a structured matrix. The end time of simulation is set to be 
the time when average collagen level is restored. Under the default setting of parameters, 
it takes 70 hours for collagen level in a 1mm2 to be restored.  
The internal signaling states are recorded separately for each cell. We can trace a cell at 
tissue level by coloring them, and trace its signaling states by looking at the 
corresponding document recording its signaling states (Fig4.8). Fig4.9 (b)-(e) show 
detailed downstream signaling levels for four different cells. Most of the cells have noisy 
signaling states because they are moving through different levels of growth factor and 
collagen.  
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Fig4.8 Schematic representation of simulation result of multi-scale model. 
 
    
 
    
(a) 
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(b)      (c) 
 
(d)      (e) 
Fig4.9 (a)Healing process under default setting of parameters; 
 (b)Downstream signaling level for the 1st fibroblast (colored red in (a)); 
(c)Downstream signaling level for the 2nd fibroblast (colored blue in (a)); 
(d)Downstream signaling level for the 3rd fibroblast (colored green in (a)); 
(e)Downstream signaling level for the 4th fibroblast (colored pink in (a)); 
 
 
 
4.3.3 Sensitivity analysis of tissue and cellular level parameters 
In this section, we do numerical experiments to examine the effects of varying parameters 
for tissue level events and individual cell decision. Effects of altering ߩଵ, ߩଶ,  ݏ and ߢ on 
the structure pattern of collagen matrix,  as well as the effects of altering ݌௖, ݀௖ and 
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݀ ௙௡on the average collagen and fibronectin density, have been discussed in Jonathan et 
al.[108].Therefore we focus on investigating the effects of parameters newly introduced 
into our model. 
Table4.3 Sensitivity analysis of tissue and cellular level parameters.   
 
Initial concentration of  ࢀࡳࡲࢼ and rate of TGFࢼ production by inflammatory cells. 
When TGFβ level is altered in small range( [×0.25, ×4]), the intracellular signaling 
levels, collagen density and structure patterns, as well as the healing speed are similar to 
those under default setting due to the saturation effect of the TGFβ pathway shown in 
section 4.3.1.  The change in fibroblast numbers is more obvious when we alter TGFβ, 
since the peak value of signaling is more sensitive to the TGFβ dose than steady state 
Parameter Range of 
change 
Unit Sensitivity 
of 
fibroblast 
numbers 
Sensitivity 
of 
collagen 
level 
Sensitivity 
of 
collagen 
pattern 
Sensitivity 
of healing 
time 
[ܶܩܨߚ]଴ 0.2×[0.25, 
0.5, 2, 4] 
݊ܯ * --- --- --- 
݌ூ_்ீிఉ 0.016×[0.5,2] ݊ܯ ∙ ℎݎିଵ --- --- --- --- 
[ܫ]଴ 1×[0.5,2] Arbitrary 
unit. 
--- --- --- --- 
݀ூ_஼௢௟௟௔௚௘௡ 0.1×[0.5,2] ℎݎିଵ --- --- --- --- 
[ܵ݉ܽ݀3_4݊_ܧܥܯ]௡௢௥௠௔௟  100×[0.5,2] ݊ܯ --- --- --- --- 
[ܵ݉ܽ݀3_4݊]௡௢௥௠௔௟  100×[0.5,2] ݊ܯ --- ** * --- 
ܶℎଵ 20×[0.5,2] ݊ܯ --- * * --- 
ܶℎଶ 200×[0.5,2] ݊ܯ * * --- --- 
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signaling. Reducing ݌ூ_்ீிఉ doesn’t affect the model behavior until ݌ூ_்ீிఉ is close to 
zero, which results quick clearance of TGFβ, and fibroblasts stop producing collagen 
before collagen level is restored.  
Initial density of inflammatory cells and the coefficient of ECM induced inflammation 
inhibition. 
Effect of altering  [ࡿ࢓ࢇࢊ૜_૝࢔]࢔࢕࢘࢓ࢇ࢒ . We set the rate of collagen metabolism (both 
production and degradation) to be proportional to nuclear Smad complex level. Lowering 
the level of nuclear Smad complex which gives normal rate of collagen metabolism is 
equivalent to raising the rate of collagen metabolism, and it results in elevated collagen 
density close to the wound boundary and more structure pattern in the wound center 
(Fig4.10 (b)). The elevated collagen density close to the wound boundary can be 
explained as follows: At the area close to wound boundary, fibroblasts are moving inward 
quickly without much random migration, and when they arrive at the wound center, they 
will be sequestered by the high level of TGFβ there. Therefore, there is only one chance 
for fibroblasts to lay out collagen in this area; hence rate of collagen metabolism will 
determine the final level of collagen. On the other hand, final collagen level at the wound 
center is relatively insensitive to the rate of collagen production since fibroblasts will 
move around and replenish collagen fibers, and the final level of collagen is determined 
by the balance of production and degradation rate. Since cells move slower at high 
collagen density, quick collagen accumulation caused by higher metabolism rate will 
alter cell path, and the resulting structure pattern contains thicker bundles of collagen. 
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Effects of Th1 and Th2. Raising Th1 has the opposing effect to 
lowering[Smad3_4n]୬୭୰୫ୟ୪. Lower collagen density is found close to the wound 
boundary and less structural pattern is found in the wound center (Fig4.10(c)). Lowering 
Th2 leads to increased numbers of fibroblasts, thus elevated level of collagen close to the 
wound boundary, but the collagen level and structural pattern at the wound center is not 
altered(Fig4.10(d)). 
  
  
Fig4.10 Effects of altering [ܵ݉ܽ݀3_4݊]௡௢௥௠௔௟ , Th1 and Th2. (a) Default setting of parameters. (b) 
[ܵ݉ܽ݀3_4݊]௡௢௥௠௔௟=50nM. (c)Th1=40nM. (d)Th2=100nM. 
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4.3.4 Sensitivity analysis of sub-cellular level parameters 
Sensitivity analysis of kinetic parameters of TGFβ pathway has been done by Zhike 
Zhang et al. Here we choose the most sensitive parameters, and show their effects on the 
tissue level healing results. Numerical experiments show that these parameters have 
similar degree of sensitivity at the tissue level as at the signaling level. But the effects of 
altering these parameters cannot be completely explained by their effects in the sub-
cellular level model, since they affect collagen density as well as collagen matrix pattern, 
and the various pattern results from complicated interactions between the dynamics of 
collagen layout and that of realignment (Fig4.11).  
Parameter Sensitivity of 
subcellular 
level model 
Sensitivity of 
collagen 
level 
Sensitivity of 
collagen 
pattern 
v_TbRII ---    
v_TbRI **+ **+   
kiCave **- **-   
krCave ---    
kiEE ** *   
krEE ** **-   
kTbRIIDeg ---    
kTbRIDeg ---    
kLRC ---    
kcd *    
klid ---    
kSmad3Imp *    
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kSmad3Exp *    
kSmad4Imp *    
kSmad4Exp *    
kSmadComplex ** *  * 
kSmadComplexImp *    
kSmadComplexDiss ** *   
Table4.4 Sensitivity analysis of subcellular level parameters.   
 
   
   
Fig4.11 Effects of altering subcellular level parameters. (a) Default parameters; (b)pTbRI *2; (c)kiCave*2; (d)kiEE*2; 
(e)krEE*2; (f) kSmadComplex*2. 
4.4 Discussion 
We build a multi-scale model of granulation tissue formation. At the subcellular level, we 
consider a mechanistic TGFβ pathway model as the central coordinator of fibroblast 
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activities. Individual cells make their decision to proliferate or produce collagen based on 
internal signal level. At the tissue level, collagen metabolism and realignment are the 
main activities considered. We investigate the sensitivity of different set of parameters. 
Altering signaling pathway parameters change collagen density and structural pattern to 
different extents, which are hard to perceive from the pathway model in isolation.  
This multi-scale model allows us to perceive the reason for tissue level pathology through 
subcellular signaling events, and to test potential molecule-targeted treatment and see 
how they alter the tissue-level events. This model is a starting point for more complicated 
multi-scale model including angiogenesis and wound contraction.  
Mechanisms for functional versatility and specificity of signaling pathways have been the 
focus of many computational modeling studies. According to other intensely-investigated 
pathways (e.g.MAPK), response specificity is achieved by the control of duration and 
amplitude of downstream signal element, or by cross-talking with other signaling 
pathways. In granulation tissue formation, diverse cellular responses to TGFβ are 
achieved by the second mechanism according to experimental evidences which suggest 
that combinatorial signaling pathways determine fibroblast proliferation and 
myofibroblast differentiation. In our model, fibroblast response to TGFβ is set to be 
simply dose dependent, because there is not ample data to define the dynamics of EGF or 
IGF. This specious setting in our models should be subject to further investigation and 
modification. However, the effect of adding a mitogenic generic growth factor is 
intuitive: higher level of growth factor will cause cells to continuously proliferate. Cells 
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will keep dividing if the high growth factor level persists. However, fibroblasts mainly 
proliferate and migrate at the beginning of proliferative phase, while later they mainly lay 
down collagen matrix. This seems to indicate transient high level of mitogenic growth 
factor at the beginning of proliferative phase. The exact mechanism by which fibroblasts 
switch from proliferation to collagen production is subject to further investigation.  
The simulation results from our model give reasonable resemblance to biological reality. 
To raise the model to a higher level of clinical relevance, there are two things to do: First, 
the model needs to be calibrated against experimental data. However, time course data of 
granulation tissue growth, inflammation and growth factor levels are collected from 
wounds at the scale of centimeters, while the hypothetical wound in the model has an 
area of 1mm2. It’s a challenge to model a larger wound without compromising the spatial 
resolution.  Secondly, there are many more factors to be considered and incorporated into 
the model. The role of MMP and TIMP in regulating granulation tissue formation is 
prominent. Inflammatory cells produce MMP to degrade collagen, while one effect of 
TGFβ pathway is producing TIMP. The antagonism between MMP and TIMP will add a 
new layer of complexity to the model. On the subcellular signaling level, we only 
consider TGFβ pathway as a central coordinator. However, MAPK pathway, PI3K-Akt 
pathway and ECM induced signaling are also important in coordinating the fibroblast 
activities, thus affecting granulation tissue formation. They seem to operate downstream 
to TGFβ pathway, and the cross-talking between these pathways are to be clarified by 
experiments before computational modeling can help examine the dynamics of 
crosstalking signaling. What’s more, anti-fibrotic proteins TNFα and IFNγ suppress the 
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expression of matrix genes, also by modulating TGFβ signaling. As to the fibroblast 
activities, fibroblast differentiation into myofibroblast should be considered in future 
models.  
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 Figure 4.1 Multi-scale model overview (interaction diagram). 
 
 
Figure4.2 Flowchart of the simulation steps and iterations. 
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Figure4.3 Pathway and gene expression considered in our model. 
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5 Summary and future work 
5.1 Summary 
The overall goal of this thesis is to construct a comprehensive modeling framework for 
wound healing proliferative phase. Models for each critical event (including collagen 
metabolism and alignment, angiogenesis and wound contraction) during this phase, 
except epithelialization, are constructed using state-of-art mathematical modeling and 
simulation techniques. Each model is built on a basic model of fibroblast migration, 
collagen metabolism and alignment. The angiogenesis model in Chapter 2 demonstrates 
that various vasculature network structures will be generated under different settings of 
model parameters. This work also shows the scenario in which severe hypoxia can delay 
healing, and may result in chronic wound. The wound contraction model in Chapter 3 
employs a novel modeling strategy for describing the mechanical property of wound site 
ECM, and reproduces the experimental contraction pattern in early stage healing. The 
multi-scale model in Chapter 4 aim to couple tissue-level physiology with intracellular 
signaling events. It allows us to test the effects of altering subcellular level model 
parameters on the tissue level phenomena. 
5.2 Future directions of tissue-level models 
Each model can be further developed to raise their biological relevance to a higher level, 
or to be applied to special scenarios of clinical concerns.  
For the basic collagen metabolism and alignment model, interaction between fibroblast 
and collagen fibers can be characterized in more detail. Other factors affecting collagen 
organization and remodeling such as MMP, should be introduced to the model. Fibroblast 
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apoptosis is important for the termination of proliferative phase, preventing the healing 
from going overboard and leading to fibrotic diseases. It’s necessary to incorporate 
environment induced fibroblast apoptosis to distinguish a normal healing and a fibrotic 
scenario. 
For the angiogenesis model, the next step is to examine the efficiency of oxygen and 
nutrient delivery by different morphology of vasculature. This can be done by mapping 
the model generated vasculature network to a vascular graph characterized by the spatial 
coordinates of the nodes and the connections between them. Inflow and outflow nodes 
and their pressures will be assigned. The pressures at each node will be calculated by 
applying conservation of mass at each node. Efficiency of vascular network will be 
measured as the total flow under the same pressure drop. In addition to creation of new 
vessels, useless vessels should be removed by pruning. Vessels that are underperfused for 
a certain time will be removed from the vascular network. The scenarios of chronic 
wounds should be characterized in further detail by incorporating inflammation caused 
by non-healing wound.  
For the wound contraction model, mechanical property of wound site ECM can be 
characterized in more detail. We have assumed the local collagen fibers to have a single 
preferred direction, while in the reality, there is a mixture of collagen orientation at each 
spatial location. So the assumption of transversely isotropy can be replaced by 
assumption of anisotropy with two preferred directions. It’s highly desirable to 
incorporate myofibroblast induced contraction, since myofibroblasts is main mechanism 
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for late stage contraction after fibroblasts coordinated migration stops, and is also the 
main reason of scar contracture. The issue of permanent tissue deformation needs to be 
further examined with such a model, since fibroblasts induced contraction cannot sustain 
the tissue deformation in long time. The remodeling taking place at the displaced wound 
boundary may be important to anchor the displacement.  
It’s highly desirable to develop 3-D version of all models.  The additional dimension will 
have significant effect on the overall behavior of the models. It’s expected that when a 2-
D model is extended to 3-D, re-estimation of parameters and adjustment to the 
assumptions are necessary to maintain the validity of the models. For example, when 
angiogenesis model is extended to 3-D, the probability for two vessels to meet is 
significantly lower. Therefore anastomosis will not happen often, resulting in very 
densely packed vessel network. Long distance mechanical sensing should be incorporated 
to simulate contact inhibition. As to the wound contraction model, 3-D anisotropic elastic 
material will be more difficult to address, but we will be able to consider the collagen 
orientation perpendicular to the skin plane.   
5.3 Future directions of multi-scale model 
The present multi-scale model covers the energy balance of fibroblasts between 
proliferation and collagen production. TGFβ pathway is considered as the central 
coordinator of fibroblast activities. ECM crosstalk with TGFβ pathway is added. A multi-
scale model of wound-healing angiogenesis can be developed by considering the HIF 
induced angiogensis-related gene expression and VEGF release by hypoxic cells. Multi-
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scale aspects of wound contraction include growth factor induced fibroblast 
differentiation into myofibroblasts and ECM induced mechanical signaling. 
5.4 Modeling a larger wound 
At present, the spatial scale of all three models is 1mm∙1mm∙0.1mm, and the spatial 
resolution is 1μm. It’s highly desirable to up-grade the model to a higher spatial scale, 
considering that a clinically relevant wound has a spatial scale of centimeters, and the 
thickness of human dermis ranges from 0.5mm to 3mm.  
Modeling a larger wound can be done by simply defining a larger modeling area, without 
changing the spatial resolution and assumptions of the current models.  However, 
enlarging the modeling area by 4 times will increase the simulation time by 4 times; 
enlarging the modeling area from 1mm*1mm to 1cm*1cm will increase the simulation 
time to approximately100 times. We can accelerate simulation by reducing the spatial 
resolution, but we may risk losing some of the important patterns since the size of 
fibroblast and collagen fibers are at the scale of micrometers. The other strategy of 
accelerating simulation is through parallel programming. This is highly feasible in multi-
scale modeling, since the calculation of subcellular signaling model can be easily 
distributed to different processor. However, this is not the case with tissue level model, 
since fibroblasts are migrating and interacting with collagen fibers on the whole modeling 
area, which results in a high load of message passing between processors. The ability of 
parallel programming on reducing computational time is subject to future examination. 
  
135 
 
6 References 
1. Peter J.Franks, C.J.M., Quality of life issues in chronic wound management. 
British Journal of Community Nursing, 1999. 4(6): p. 283-289. 
2. Jorgensen Bo, F.G.J., Gottrup finn, Pain and quality of life for patients with 
venous leg ulcers. 
3. Yamada, B.F.A. and V.L.C.d.G. Santos, Quality of life of individuals with chronic 
venous ulcers. Wounds, 2005(7). 
4. Philips, T., et al., A study of the impact of leg ulcers on quality of life: financial, 
social, and psychologic implications. Journal of American academic dermatology, 
1994. 31(1): p. 49-53. 
5. Ronda G.Hughes, A.D.B., Ann O'Mara, Christine T.Kovner, Palliative Wound 
Care at the End of Life. Home Health Care Management & Practice, 2005. 17: p. 
196-202. 
6. Meerding, W.J., S. Mulder, and E.F.v. Beeck, Incidence and costs of injuries in 
the Netherlands. European Journal of Public Health, 2006. 16(3): p. 271-277. 
7. Hostetler, S.G., et al., Discharge patterns of injury-related hospitalizations with 
an acute wound in the United States. Wounds, 2007. 18(12). 
136 
 
8. Aarabi, S., M.T. Longaker, and G. C.Gurtner, Hypertrophic scar formation 
following burns and trauma: new approaches to treatment. PLoS Medicine, 2007. 
4(9): p. 1464-1470. 
9. Sherratt, J.A. and J.D. Murray, Models of Epidermal Wound Healing. Proceedings 
of the Royal Society, 1990. 241: p. 29-36. 
10. Velnar, T., T. Bailey, and V. Smrkolj, The Wound Healing Process: and 
Overview of the Cellular and Molecular Mechanisms. The Journal of 
International Medical Research, 2009. 37: p. 1528-1542. 
11. S.Midwood, K., L.V. Williams, and J.E. Schwarzbauer, Tissue repair and the 
dynamics of the extracellular matrix. the International Journal of Biochemistry 
and Cell Biology, 2004. 36: p. 1031-1037. 
12. Eming, S.A., T. Krieg, and J.M. Davidson, Inflammation in Wound Repair: 
Molecular and Cellular Mechanisms. Journal of Investigative Dermatology, 2007. 
127: p. 514-525. 
13. Lorenz, H.P. and M.T. Longaker, Wounds: Biology, Pathology, and Management, 
2003, Stanford University Medical Center. 
14. Hakkinen, L., et al., Human Granulation-tissue Fibroblasts show enhanced 
proteoglycan gene expression and altered response to TGFbeta1. Journal of 
Dental Research, 1996. 10: p. 1767-1778. 
137 
 
15. Hakkinen, L. and H.Larjava, Characterization of fibroblast clones from 
periodontal granulation tissue in vitro. Journal of Dental Research, 1992. 71: p. 
1901-1907. 
16. Anand-apte, B. and B. Zetter, Signaling mechanisms in growth factor-stimulated 
cell motility. Stem cells, 1997. 15: p. 259-267. 
17. Weiger, M.C., et al., Spontaneous PI3K signaling dynamics drive spreading and 
random migration of fibroblasts. Journal of Cell science, 2009. 122: p. 313-323. 
18. Haugh, J.M., et al., Spatial Sensing in Fibroblast Mediated by 3' 
Phosphoinositides. the Journal of Cell Biology, 2000. 151(6): p. 1269-1279. 
19. Holly, S.P., M.K. Larson, and L.V. Parise, Multiple Roles of Integrins in Cell 
Motility. Experimental Cell Research, 2000. 261: p. 69-74. 
20. Wang, H.B., et al., Focal adhesion kinase is involved in mechanosensing during 
fibroblast migration. PNAS, 2001. 98(20): p. 11295-11300. 
21. Woessner, J.F., Matrix metalloproteinases and their inhibitors in connective 
tissue remodeling. The FASEB Journal, 1991. 5: p. 2145-2154. 
22. Reynolds, J.J., Collagenases and tissue inhibitors of metalloproteinases: a 
functional balance in tissue degradation. Oral Dis, 1996. 2(1): p. 70-76. 
138 
 
23. S.Schultz, G. and A. Wysocki, Interactions between extracellular matrix and 
growth factors in wound healing. Wound Repair and Regeneration, 2009. 17: p. 
153-162. 
24. Lin, Y., Frederick, and Grinnell, Decreased level of PDGF stimulated receptor 
autophosphorylation by fibroblasts in mechanically relaxed collagen matrices. 
Journal of Cell Biology, 1993. 122(3): p. 663-372. 
25. Albino, F.P., P.F. Koltz, and J.A. Gusenoff, A comparative analysis and 
systematic review of the wound-healing milieu: implications for body contouring 
after massive weight loss. Plastic Reconstruction Surgery, 2009. 124(5): p. 1675-
1682. 
26. Rayment, E.A. and Z. Upton, Finding the culprit: a review of the influences of 
proteases on the chronic wound environment. The International Journal of Lower 
Extremity Wounds, 2009. 8(1): p. 19-27. 
27. Enoch, S. and P. Price. Cellular, molecular and biochemical differences in the 
pathophysiology of healing between acute wounds, chronic wounds and wounds 
in the elderly. 2004; Available from: 
http://www.worldwidewounds.com/2004/august/Enoch/Pathophysiology-Of-
Healing.html. 
139 
 
28. Agren, M.S. and M. Werthen, The Extracellular Matrix in Wound Healing: A 
Closer Look at Therapeutics for Chronic Wounds. The International Journal of 
Lower Extremity Wounds, 2007. 6: p. 82-97. 
29. Loots, M.A.M., et al., Cultured fibroblasts from chronic diabetic wounds on the 
lower extremity show disturbed proliferation. Archives of Dermatological 
Research, 1999. 291: p. 93-99. 
30. Agren, M.S., et al., Proliferation and Mitogenic Response to PDGF-BB of 
Fibroblasts Isalated from Chronic Venous Leg Ulcers is Ulcer-Age Dependent. 
the Journal of Investigative Dermatology, 1999. 112: p. 463-469. 
31. Lerman, O.Z., et al., Cellular Dysfunction in the Diabetic Fibroblast: Impairment 
in Migration, VEGF Production and Response to Hypoxia. American Journal of 
Pathology, 2003. 162(1): p. 303-312. 
32. Wolfram, D., et al., Hypertrophic scars and keloids-- a review of their 
pathophysiology, risk factors, and therapeutic management. Dermatoloty 
Surgery, 2009. 35(2): p. 171-181. 
33. Dietmar, U., et al., TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for 
skin fibrosis in patients following severe burn trauma. Plastic Reconstruction 
Surgery, 2003. 111(4): p. 1423-1431. 
140 
 
34. Luo, S., et al., Abnormal balance between proliferation and apoptotic cell death 
in fibroblasts derived from keloid lesions. Plastic Reconstruction Surgery, 2001. 
107(1): p. 87-96. 
35. Ferguson, M.W.J. and S. O'Kane, Scar-free healing: from embryonic mechanisms 
to adult therapeutic intervention. Philosophical Transactions of the Royal Society 
B, 2004. 359: p. 839-850. 
36. Diegelmann, R.F., et al., Hyaluronic acid modulates proliferation, collagen and 
protein synthesis of cultured fetal fibroblasts. Matrix, 1993. 13(6): p. 441-446. 
37. Frantz, F.W., et al., Biology of fetal wound healing: Collagen biosynthesis during 
dermal repair. Journal of Pediatric Surgery, 1992. 27(8): p. 945-949. 
 
 
38. Massague, J., Integration of Smad and MAPK pathways: a link and a linker 
revisited. Genes and Development, 2003. 17: p. 2993-2997. 
39. Guo, X. and X. Wang, signaling cross-talk between TGFbeta/BMP and other 
pathways. Cell Research, 2009. 19: p. 71-88. 
40. Blanchette, F., et al., Cross-talk between the p42/p44 MAP Kinase and Smad 
Pathways in Transforming Growth Factor beta1-induced Furin Gene 
141 
 
Transactivation. the Journal of Biological Chemistry, 2001. 276(36): p. 33986-
33994. 
41. Moustakas, A. and C.H. Heldin, Non-Smad TGFbeta signals. Journal of Cell 
Science, 2005. 118: p. 3573-3584. 
42. Chang, N., TGFbeta-induced matrix proteins inhibit p42/p44 MAPK and JNK 
activation and suppress TNF-mediated IkappaBalpha degradation and NFkappaB 
nuclear translocation in L929 fibroblasts. Biochemical and Biophysical Research 
Communications, 2000. 267: p. 194-200. 
43. Guo, X. and X. Wang, Signaling crosstalk between TGFbeta/BMP and other 
pathways. Cell Research, 2009. 19: p. 71-88. 
44. Davis, G.E. and D.R. Senger, Endothelial Extracellular Matrix: Biosynthesis, 
Remodeling, and Functions During Vascular Morphogenesis and Neovessel 
Stabilization. Circulation Research, 2005. 97: p. 1093-1107. 
45. Li, J., Y.-P. Zhang, and R.S. Kirsner, Angiogenesis in wound repair: angiogenic 
growth factors and the extracellular matrix. Microscopy Research and Technique, 
2003. 60(1): p. 107-114. 
46. Tonnesen, M.G., X. Feng, and R.A.F. Clark, Angiogenesis in wound healing. 
Journal of Investigative Dermatology. Symposium Proceedings, 2000. 5(1): p. 40-
46. 
142 
 
47. Byrne, H.M. and M.A.J. Chaplain, Mathematical models for tumour 
angiogenesis: Numerical simulations and nonlinear solutions. Bulletin of 
Mathematical Biology, 1995. 57: p. 461-486. 
48. Chaplain, M.A.J. and B.D. Sleeman, A mathematical model for the production 
and secretion of tumour angiogenesis factor in tumours. IMA Journal of 
Mathematics Applied in Medicine & Biology, 1990. 7: p. 93-108. 
49. Orme, M.E. and M.A.J. Chaplain, A Mathematical Model of the First Steps of 
Tumor-Related Angiogenesis:Capillary Sprout Formation and Secondary 
Branching. Journal of Mathematics Applied in Medicine & Biology, 1996. 13: p. 
73-98. 
50. Anderson, A.R.A. and M.A.J. Chaplain, Continuous and discrete mathematical 
models of tumor-induced angiogenesis. Bulletine of Mathematical Biology 1998. 
60: p. 857-899. 
51. Manoussaki, D., et al., A mechanical model for the formation of vascular 
networkds in vitro. Acta Biotheoretica, 1996. 44: p. 271-282. 
52. Holmes, M.J. and B.D. Sleeman, A mathematical model of tumour angiogenesis 
incorporating cellular traction and viscoelastic effects. Journal of Theoretical 
Biology, 2000. 202: p. 95-112. 
143 
 
53. C.Schugart, R., et al., Wound angiogenesis as a function of tissue oxygen tension: 
a mathematical model. PNAS, 2007. 105(7): p. 2628-2633. 
54. McDougall, S.R., Mathematical Modeling of Flow Through Vascular Networks: 
Implications for Tumor-induced Angiogenesis and Chemotherapy Strategies. 
Bulletine of Mathematical Biology, 2002. 64: p. 673-702. 
55. Stephanou, A., et al., Mathematical Modelling of Flow in 2D and 3D Vascular 
Networks: Applications to Anti-Angiogeneic and Chemotherapeutic Drug 
Strategies. Mathematical and Computer Modelling, 2005. 41: p. 1137-1156. 
56. Stokes, C.L. and D.A. Lauffenburger, Analysis of the roles of microvessel 
endothelial cell random motility and chemotaxis in angiogenesis. Journal of 
Theoretical Biology, 1991. 152(3): p. 377-403. 
57. Sun, S., et al., A deterministic model of growth factor-induced angiogenesis. 
Bulletine of Mathematical Biology, 2005. 67: p. 313-337. 
58. Milde, F., M. Bergdorf, and P. Koumoutsakos, A Hybrid Model for Three-
Dimensional Simulations of Sprouting Angiogenesis. Biophysical Journal, 2008. 
95: p. 3146-3160. 
59. Das, A., et al., A hybrid continuum-discrete modelling approach to predict and 
control angiogenesis: analysis of combinatorial growth factor and matrix effects 
on vessel-sprouting morphology. Philosophical Transactions of the Royal Society 
144 
 
A: Mathematical, physical & engineering sciences, 2010. 368(1921): p. 2937-
2960. 
60. Dallon, J.C., J.A. Sherratt, and P.K. Maini, Mathematical Modelling of 
Extracellular Matrix dynamics using Discrete Cells: Fiber Orientation and Tissue 
Regeneration. Journal of Theoretical Biology, 1999. 199: p. 449-471. 
61. Phillips, G.D., R.A. Whitehead, and D.R. Knighton, Initiation and Pattern of 
Angiogenesis in Wound Healing in the Rat. The American Journal of Anatomy, 
1991. 192: p. 257-262. 
62. Gerhardt, H., et al., VEGF guides angiogenic sprouting utilizing endothelial tip 
cell filopodia. Journal of Cell Biology, 2003. 161(6): p. 1163-1177. 
63. Dallon, J.C., J. A.Sherratt, and P. K.Maini, Mathematical Modeling of 
Extracellular Matrix Dynamics using Discrete Cells: Fiber Orientation and 
Tissue Regeneration. Journal of Theoretical Biology, 1999. 199: p. 449-471. 
64. Olsen, L., J.A. Sherratt, and P.K. Maini, A mechanochemical model for adult 
dermal wound contraction and the permanence of the contracted tissue 
displacement profile. Journal of Theoretical Biology, 1995. 177: p. 113-128. 
65. Silver, F.H. and W.J. Landis, Viscoelasticity, Energy Storage and Transmission 
and Dissipation by Extracellular Matrices in Vertebrates, in Collagen:structure 
and mechanics, P. Fratzl, Editor 2008, Springer. p. 133-145. 
145 
 
 
 
66. Ehrlich, H.P., Wound closure: evidence of cooperation between fibroblasts and 
collagen matrix. Eye, 1988. 2: p. 149-157. 
67. Watts, G.T., H.C. Grillo, and J. Gross, Studies in Wound Healing: II. The role of 
granulation tissue in contraction. Annals of Surgery, 1958. 148(2): p. 153-160. 
68. Gross, J., et al., On the mechanism of skin wound "contraction": A granulation 
tissue "Knockout" with a normal phenotype. Proceedings of National Academy of 
Science, 1995. 92: p. 5982-5986. 
69. Nedelec, B., et al., Control of wound contraction. Basic and clinical features. 
Hand Clinical, 2000. 16(2): p. 189-302. 
70. S.Kolodney, M. and R.B. Wysolmerski, Isometric contraction by fibroblasts and 
endothelial cells in tissue culture: a quantitative study. Journal of Cell Biology, 
1992. 117: p. 73-82. 
71. Wang, J.H. and J.S. Lin, Cell traction force and measurement methods. 
Biomechanical Model and Mechanobiology, 2007. 6(6): p. 361-371. 
72. C.Dollon, J. and H.P. Ehrilich, A review of fibroblast-populated collagen lattices. 
Wound Repair and Regeneration, 2008. 16: p. 472-479. 
146 
 
73. Ehrilch, H.P. and J.B. Rajaratnam, Cell locomotion forces versus cell contraction 
forces for collagen lattice contraction: an in vitro model of wound contraction. 
Tissue Cell, 1990. 22(4): p. 407-417. 
74. V.Yannas, I., The relation between wound contraction, scar formation and 
regeneration. 
75. Shin, D. and K. Minn, The effect of myofibroblast on contracture of hypertrophic 
scar. Plastic Reconstruction Surgery, 2004. 113(2): p. 633-640. 
76. Holzapfel, G.A., Biomechanics of Soft Tissue. Computational biomechanics, 
2000. 
77. Ogden, R.W., Anisotropy and Nonlinear Elasticity in Arterial Wall Mechanics, in 
Biomechanical Modelling at the Molecular, Cellular and Tissue Levels, G.A. 
Holzapfel and R.W. Ogden, Editors., SpringerWidenNewYork. p. 179-258. 
78. Murray, J.D. and G.F. Oster, Generation of Biological Pattern and Form. IMA 
Jounal of Mathematics Applied in Medicin & Biology, 1984. 1: p. 51-75. 
79. Tranquillo, R.T. and J.D. Murray, Continuum model of fibroblasts-driven wound 
contraction: inflammation-mediation. Journal of Theoretical Biology, 1992. 
158(2): p. 135-172. 
147 
 
80. Olsen, L., J.A. Sherratt, and P.K. Maini, A mechanochemical model for adult 
dermal wound contraction and the permanence of the contracted tissue 
displacement profile. Journal of Theoretical Biology, 1995. 177: p. 113-128. 
81. Ramtani, S., E. Fernandes-Morin, and D. Geiger, Remodeled-matrix contraction 
by fibroblasts: numerical investigations. Computers in Biology and Medicine, 
2002. 32: p. 283-296. 
82. Ramtani, S., Mechanical modelling of cell/ECM and cell/cell interactions during 
the contraction of a fibroblast-populated collagen microsphere: theory and model 
simulation. Journal of Biomechanics, 2004. 37: p. 1709-1718. 
83. Vermolen, F.J. and J.A. Adam, A finite element model for epidermal wound 
healing. Computational Sciences ICCS. Springer Berlin, 2007: p. 70-77. 
84. Javierre, E., et al., A mathematical analysis of physiological and morphological 
aspects of wound closure. Journal of Mathematical Biology, 2009. 59: p. 605-630. 
85. Javierre, E., et al., Numerical modeling of a mechano-chemical theory for wound 
contraction. International Journal of Solids and Structures, 2009. 46: p. 3597-
3606. 
86. Silver, F.H. and W.J. Landis, Viscoelasticity, Energy Storage and Transmission 
and Dissipation by Extracellular Matrices in Vertebrates, in Collagen:structure 
and mechanics, P. Fratzl, Editor 2008, Springer. p. 133-145. 
148 
 
87. Dallon, J.C., J. A.Sherratt, and P. K.Maini, Mathematical Modeling of 
Extracellular Matrix Dynamics using Discrete Cells: Fiber Orientation and 
Tissue Regeneration. Journal of Theoretical Biology, 1999. 199: p. 449-471. 
 
88. Leask, A. and D.J. Abraham, TGFbeta signaling and the fibrotic response. The 
FASEB Journal, 2004. 18: p. 816-827. 
89. Larco, J.E.d. and G.J. Todaro, Growth factors from murine sarcoma virus-
transformed cells. PNAS, 1978. 75(8): p. 4001-4005. 
90. Roberts, A.B., et al., Transforming growth factors: isolation of polypeptides from 
virally and chemically transformed cells by acid/ethanol extraction. PNAS, 1980. 
77(6): p. 3494-3498. 
91. Holly, S.P., M.K. Larson, and L.V. Parise, Multiple Roles of Integrins in Cell 
Motility. Experimental Cell Research, 2000. 261: p. 69-74. 
92. Wang, H.B., et al., Focal adhesion kinase is involved in mechanosensing during 
fibroblast migration. PNAS, 2001. 98(20): p. 11295-11300. 
93. Woessner, J.F., Matrix metalloproteinases and their inhibitors in connective 
tissue remodeling. The FASEB Journal, 1991. 5: p. 2145-2154. 
149 
 
94. Reynolds, J.J., Collagenases and tissue inhibitors of metalloproteinases: a 
functional balance in tissue degradation. Oral Dis, 1996. 2(1): p. 70-76. 
95. S.Schultz, G. and A. Wysocki, Interactions between extracellular matrix and 
growth factors in wound healing. Wound Repair and Regeneration, 2009. 17: p. 
153-162. 
96. Grotendorst, G.R., H. Rahmanie, and M.R. Duncan, Combinational signaling 
pathways determine fibroblast proliferation and myofibroblast differentiation. 
The FASEB Journal, 2004. 18: p. 469-479. 
97. Vilar, J.M.G., R. Jansen, and C. Sander, Signal processing in the TGFbeta 
superfamily ligand-receptor network. Plos Computational Biology, 2006. 2(1): p. 
0036-0045. 
98. Melke, P., et al., A Rate Equation Approach to Elucidate the Kinetics and 
Robustness of the TGF-b Pathway. Biophysical Journal, 2006. 91(December): p. 
4368-4380. 
99. Clarke, D.C., M.D. Betterton, and X. Liu, Systems theory of Smad signalling. IEE 
proceedings, 2006. 153(6): p. 412-424. 
100. Zi, Z. and E. Klipp, Constraint-based modeling and kinetic analysis of the smad 
dependent TGFbeta signaling pathway. Plos ONE, 2007. 2(9): p. e936. 
101. Celliere, G., G. Fengos, and D. Iber, The plasticity of TGFbeta signaling. 
150 
 
102. Ribba, B., T. Colin, and S. Schnell, A multiscale mathematical model of cancer, 
and its use in analyzing irradiation therapies. Theoretical Biology and Medical 
Modelling, 2006. 3(7). 
103. Alarcon, T., H.M. Byrne, and P.K. Maini, A multiple scale model for tumor 
growth. Multiscale modeling and simulation, 2005. 3(2): p. 440-475. 
104. Perfahl, H., et al., Multiscale modelling of vascular tumour growth in 3D: the 
roles of domain size and boundary conditions. Plos ONE, 2011. 6(4): p. e14790. 
105. Tawhai, M., et al., Multiscale modeling in computational biomechanics. IEEE 
Engineering in medicine and biology magazine 2010. 28(3): p. 41-49. 
106. Garamszegi, N., et al., Extracellular matrix-induced transforming growth factor 
beta receptor signaling dynamics. Oncogene, 2010: p. 1-13. 
107. Clark, R.A.F., et al., Collagen matrices attenuate the collagen-synthetic response 
of cultured fibroblasts to TGFbeta. Journal of Cell Science, 1995. 108: p. 1251-
1261. 
108. Dallon, J.C., J. A.Sherratt, and P. K.Maini, Mathematical Modeling of 
Extracellular Matrix Dynamics using Discrete Cells: Fiber Orientation and 
Tissue Regeneration. Journal of Theoretical Biology, 1999. 199: p. 449-471. 
151 
 
109. Olsen, L., J.A. Sherratt, and P.K. Maini, A mechanochemical model for adult 
dermal wound contraction and the permanence of the contracted tissue 
displacement profile. Journal of Theoretical Biology, 1995. 177: p. 113-128. 
  
152 
 
Appendix A. Discussion of parameter values for wound contraction 
model 
 Total number of fibroblasts in our modeling space (FN). According to Olsen et 
al.(1995), fibroblast density in undamaged dermis is 10000 cells/cm3, while 
fibroblast maximal capacity is 10^7 cells/cm3 , which is equal to 10^3cells in our 
modeling space (a thin layer with an area of 1mm2 and depth 0.1mm).The 
discrepancy between normal density and maximal density is caused by fibroblast 
proliferation and chemotaxis-induced accumulation at the wound site. We use 
maximal density to calculate FN in our model. 
 Collagen density and rate of collagen metabolism (pୡ, dୡ and d୤୬). We didn’t 
consider the real value of the collagen density in skin. Collagen density here has 
arbitrary unit, and is scaled to something between 0 and 1.7, with 1 representing 
collagen density in undamaged skin, and 0 means no collagen. The mechanical 
strength of the skin is assumed to be linearly proportional to collagen density—if 
x% of collagen density has been laid out, the mechanical strength of wound tissue 
is recovered to x% of strength of undamaged skin.  
 Elastic parameters c, kଵ and kଶ describing skin mechanical properties are not easy 
quantities to determine. These parameters vary with species, ages, and specific 
locations on body. Here we are considering some average parameter set for 
human skin (excluding special location like joints, etc).We can find similar 
parameters for undamaged skin and for vessel wall by looking through references. 
We are looking for best set of parameters that can give consistent mechanical 
properties when extrapolating to undamaged skin.  
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 Maximal cellular active stress  p୫ୟ୶  .10ିସN/cell =  10ିସN/1000μmଶ  =
 10ିସN/10ିଽmଶ  =  10ହPa 
E Undamaged skin Young’s modulus 
(consistent with initial slope of the stress-
strain curve) 
Khatyr et 
al.(2004) 
0.334 MPa 
 
v Undamaged skin Poisson’s ratio Khatyr et al. 
(2004) 
0.3 --- 
 Initial slope of stress-strain curve for 
dermis at strain rate 10% from 23yrs old 
male 
Viscoelastic 
properties of 
human 
dermis(2002) 
2.10 MPa 
 
 Final slope of stress-strain curve for 
dermis at strain rate 10% from 23yrs old 
male 
Viscoelastic 
properties of 
human 
dermis(2002) 
41.0 MPa 
 
 Elastic modulus of Types I and III 
collagen(skin) 
Collagen: 
Structure and 
mechanics 
6.3.2 
4.4 GPa 
 
 Elastic modulus of elastin(skin) Collagen: 
Structure and 
mechanics 
6.3.2 
0.040 GPa 
 
 Volumn fraction of elastic fibers in 
dermis 
Viscoelastic 
properties of 
human 
dermis(2002) 
0.02 --- 
 Volumn fraction of collagen in dermis Viscoelastic 
properties of 
human 
dermis(2002) 
0.1 [0.096, 
0.166] 
--- 
According to E and v, stiffness coefficients of the skin are: 
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቎
cଵଵଵଵ cଵଵଵଶ
cଵଶଵଵ cଵଶଵଶ
cଵଵଶଵ cଵଵଶଶ
cଵଶଶଵ cଵଶଶଶ
cଶଵଵଵ cଶଵଵଶ
cଶଶଵଵ cଶଶଵଶ
cଶଵଶଵ cଶଵଶଶ
cଶଶଶଵ cଶଶଶଶ
቏ =  
⎣
⎢
⎢
⎢
⎢
⎡
μଵ + μଶ 0
0
μଵ
2
0 μଶ
μଵ
2
0
0
μଵ
2
μଶ 0
μଵ
2
0
0 μଵ + μଶ⎦
⎥
⎥
⎥
⎥
⎤
= ቎
44.96 0
0 12.85
0 19.27
12.85 0
0 12.85
19.27 0
12.85 0
0 44.96
቏ (
N
cmଶ
=∗ 10kPa) 
According to estimated c, k1 and k2, stiffness coefficient of the skin are: 
C=1kPa, k1=1.2kPa, k2=0.2, transversely isotropic material with horizontally aligned 
fibers: 
቎
cଵଵଵଵ cଵଵଵଶ
cଵଶଵଵ cଵଶଵଶ
cଵଵଶଵ cଵଵଶଶ
cଵଶଶଵ cଵଶଶଶ
cଶଵଵଵ cଶଵଵଶ
cଶଶଵଵ cଶଶଵଶ
cଶଵଶଵ cଶଵଶଶ
cଶଶଶଵ cଶଶଶଶ
቏ = ቎
46.54 0
0 7.09
0 0
0 0
0 0
0 0
1 0
0 1
቏ (kPa) 
C=1kPa, k1=12kPa, k2=0.2, transversely isotropic material with horizontally aligned 
fibers: 
቎
cଵଵଵଵ cଵଵଵଶ
cଵଶଵଵ cଵଶଵଶ
cଵଵଶଵ cଵଵଶଶ
cଵଶଶଵ cଵଶଶଶ
cଶଵଵଵ cଶଵଵଶ
cଶଶଵଵ cଶଶଵଶ
cଶଵଶଵ cଶଵଶଶ
cଶଶଶଵ cଶଶଶଶ
቏ = ቎
456.4 0
0 61.91
0 0
0 0
0 0
0 0
1 0
0 1
቏ (kPa) 
A஑୧ஒ୨ = Aஒ୨஑୧ =
∂ଶW
∂F୧஑ ∂F୨ஒ
= ෍ W୬
∂I୬
∂F୧஑ ∂F୨ஒ
୒
୬ୀଵ
+ ෍ W୫୬
∂I୫
∂F୧஑
∂I୬
∂F୨ஒ
୒
୫,୬ୀଵ
 
 Innermost layer Middle layer Outermost layer 
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c1(kPa) 4.0 0.86 4.0 
c2 1.0 0.215 1.0 
k1(kPa)  260.0  
k2(dimensionless)  0.5  
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Appendix B. Force balance equation 
Definition of deformation gradient F and related terms 
For a deformed material, the position of a spatial point xϵΩ at time t is defined by the 
deformation map Φ(X,t). Then tissue displacement u has the following form: 
u(t) =  ϕ(X, t) −  X 
Deformation gradient F is defined as 
F ∶=  
∂ϕ
∂X
=  
∂u
∂x
+ 1 
It is assumed that both the matrix and fiber phases deform with the continuum 
deformation gradient F. Polar decompositions of  F give 
F = RU = VR 
R is a proper orthogonal tensor (unitary) that describe the rotation. U and V are positive 
definite and symmetric tensors, referred to as the right and left stretch tensors. 
Left and right Cauchy-Green deformation tensor B and C are constructed from F as 
B = FF୘ = Vଶ ,　C =  F୘F = Uଶ 
For fiber-reinforced anisotropic material, local direction of fiber is θ, structure tensor M 
is defined as  
M = P ∗ P = ቂ cos
ଶθ cosθsinθ
cosθsinθ sinଶθ
ቃ 
Deduction of the force balance equation  
Div ൬
∂W
∂F
൰ = Fexternal 
൬
∂
∂x
∂
∂y
൰
⎝
⎜
⎛
∂W
∂Fଵଵ
∂W
∂Fଶଵ
∂W
∂Fଵଶ
∂W
∂Fଶଶ⎠
⎟
⎞
= ൬
∂
∂x
∂W
∂Fଵଵ
 +
∂
∂y
∂W
∂Fଵଶ
,
∂
∂x
∂W
∂Fଶଵ
 +
∂
∂y
∂W
∂Fଶଶ
൰ = Fexternal 
∂
∂Xଵ
∂W
∂Fଵଵ
 +
∂
∂Xଶ
∂W
∂Fଵଶ
=
∂
∂X஑
∂W
∂Fଵ஑
 =
∂F୨ஒ
∂X஑
∂
∂F୨ஒ
∂W
∂Fଵ஑
=
∂ଶx୨
∂X஑ ∂Xஒ
∂
∂F୨ஒ
∂W
∂Fଵ஑
=  
∂ଶW
∂F୨ஒ ∂Fଵ஑
∂ଶx୨
∂X஑ ∂Xஒ
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∂
∂Xଵ
∂W
∂Fଶଵ
 +
∂
∂Xଶ
∂W
∂Fଶଶ
=
∂
∂X஑
∂W
∂Fଶ஑
 =
∂F୨ஒ
∂X஑
∂
∂F୨ஒ
∂W
∂Fଶ஑
=
∂ଶx୨
∂X஑ ∂Xஒ
∂
∂F୨ஒ
∂W
∂Fଶ஑
=  
∂ଶW
∂F୨ஒ ∂Fଶ஑
∂ଶx୨
∂X஑ ∂Xஒ
 
A஑୧ஒ୨
∂ଶx୨
∂X஑ ∂Xஒ
= Fexternal 
A஑୧ஒ୨ = Aஒ୨஑୧ =
∂ଶW
∂F୧஑ ∂F୨ஒ
= ෍ W୬
∂I୬
∂F୧஑ ∂F୨ஒ
୒
୬ୀଵ
+ ෍ W୫୬
∂I୫
∂F୧஑
∂I୬
∂F୨ஒ
୒
୫,୬ୀଵ
 
Then we expend the left hand side of the above equation to a form ready to implement in 
the computational model: 
෍ A஑ଵஒଵ
∂ଶxଵ
∂X஑ ∂Xஒ
+ A஑ଵஒଶ
∂ଶxଶ
∂X஑ ∂Xஒ
஑,ஒ
= Aଵଵଵଵ
∂ଶxଵ
∂Xଵ ∂Xଵ
+ Aଵଵଶଵ
∂ଶxଵ
∂Xଵ ∂Xଶ
 + Aଶଵଵଵ
∂ଶxଵ
∂Xଶ ∂Xଵ
  + Aଶଵଶଵ
∂ଶxଵ
∂Xଶ ∂Xଶ
 
+ Aଵଵଵଶ
∂ଶxଶ
∂Xଵ ∂Xଵ
+ Aଵଵଶଶ
∂ଶxଶ
∂Xଵ ∂Xଶ
 + Aଶଵଵଶ
∂ଶxଶ
∂Xଶ ∂Xଵ
  + Aଶଵଶଶ
∂ଶxଶ
∂Xଶ ∂Xଶ
 
෍ A஑ଶஒଵ
∂ଶxଵ
∂X஑ ∂Xஒ
+ A஑ଶஒଶ
∂ଶxଶ
∂X஑ ∂Xஒ
஑,ஒ
= 
= Aଵଶଵଵ
∂ଶxଵ
∂Xଵ ∂Xଵ
+ Aଵଶଶଵ
∂ଶxଵ
∂Xଵ ∂Xଶ
 + Aଶଶଵଵ
∂ଶxଵ
∂Xଶ ∂Xଵ
  + Aଶଶଶଵ
∂ଶxଵ
∂Xଶ ∂Xଶ
 
+ Aଵଶଵଶ
∂ଶxଶ
∂Xଵ ∂Xଵ
+ Aଵଶଶଶ
∂ଶxଶ
∂Xଵ ∂Xଶ
 + Aଶଶଵଶ
∂ଶxଶ
∂Xଶ ∂Xଵ
  + Aଶଶଶଶ
∂ଶxଶ
∂Xଶ ∂Xଶ
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Appendix C. Parameter variation. 
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FigC1 Vector plot for tissue displacement of transversely isotropic material.  
C=0.01, k1=0.012, k2=0.02, ddW_dIdI[1][1] = 0.1, 
 Collagen direction = 0, PI/18, PI*2/18, PI*3/18 … PI (bottom to top, left to right). 
 
FigC2 Vector plot for tissue displacement of transversely isotropic material.  
C=0.1, k1=0.12, k2=0.2, ddW_dIdI[1][1] = 0.1 
 Collagen direction = 0, PI/18, PI*2/18 
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FigC3 Vector plot for tissue displacement of transversely isotropic material.  
C=0.1, k1=0.12, k2=0.2, ddW_dIdI[1][1] = 0 
 Collagen direction = 0, PI/18, PI*2/18 
 
FigC4 Vector plot for tissue displacement of transversely isotropic material.  
C=0.1, k1=0.012, k2=0.2, ddW_dIdI[1][1] = 0 
 Collagen direction = 0, PI/18, PI*2/18 
 
FigC5 Vector plot for tissue displacement of transversely isotropic material.  
C=1, k1=0.12, k2=0.2, ddW_dIdI[1][1] = 0 
 Collagen direction = 0, PI/18, PI*2/18 
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FigC6 Collagen fibers have their largest capability to resist tissue displacement along their 
direction. 
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Appendix D. TGFβ pathway model  
The PlosONE model. PlosONE proposed a comprehensive model for Smad dependent 
TGFβ signaling pathway in mammalian cells, which includes three modules: receptor 
trafficking and signaling; Smad nucleo-cytoplasmic shuttling and signaling and I-Smad 
negative regulation. In the module of receptor trafficking, the model takes into account 
the following essential elements: (i) constitutive receptor synthesis and degradation; (ii) 
receptor and ligand-receptor complex trafficking by two distinct endocytic routes; (iii) 
the distribution of receptors and ligand-receptor complex in different pools, such as 
membrane surface, early endosome and caveolar lipid-raft; (iv) the formation of activated 
receptor complex induced by TGFβ. In the module of Smad nucleocytoplasmic shuttling, 
the signal events considered are (i) Smad nucleocytoplasmic shuttling; (ii) Smad complex 
formation; (iii)nuclear Smad complex dephosphorylation by nuclear phosphatase. In the 
module of ISmad negative regulation, the negative feedback contributing to the ligand-
induced degradation of the receptors by ISmad is simplified and modeled as a black box 
from the nuclear phosphorylated Smad. 
ୢ[୘ୋ୊ஒ]
ୢ୲
 =  0.001 ∗ (− k୐ୖେ ∗ [TGFβ] ∗ [TβRII] ∗ [TβRI] + krେୟ୴ୣ ∗ [LRCେୟ୴ୣ] + kr୉୉ ∗
[LRC୉୉])……………………………………………………………………………………… (1) 
ୢ[୘ஒୖ୍୍]
ୢ୲
= v୘ஒୖ୍୍ − kiେୟ୴ୣ ∗ [TβRII] + krେୟ୴ୣ ∗ [TβRIIେୟ୴ୣ] − ki୉୉ ∗ [TβRII] + kr୉୉ ∗
[TβRII୉୉] + krେୟ୴ୣ ∗ [LRCେୟ୴ୣ] − k୐ୖେ ∗ [TGFβ] ∗ [TβRII] ∗ [TβRI]………..……………..  (2) 
ୢ[୘ஒୖ୍୍ి౗౬౛]
ୢ୲
 = kiେୟ୴ୣ ∗ [TβRII] − krେୟ୴ୣ ∗ [TβRIIେୟ୴ୣ] ……………………..………….….... (3) 
ୢ[୘ஒୖ୍୍ుు]
ୢ୲
= ki୉୉ ∗ [TβRII] − kr୉୉ ∗ [TβRII୉୉] + kୈୣ୥
୘ஒୖ୍୍ ∗ [TβRII୉୉]……………..……..…. (4) 
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ୢ[୘ஒୖ୍]
ୢ୲
= v୘ஒୖ୍ − kiେୟ୴ୣ ∗ [TβRI] + krେୟ୴ୣ ∗ [TβRIେୟ୴ୣ] − ki୉୉ ∗ [TβRI] + kr୉୉ ∗ [TβRI୉୉] +
krେୟ୴ୣ ∗ [LRCେୟ୴ୣ] − k୐ୖେ ∗ [TGFβ] ∗ [TβRII] ∗ [TβRI]………………………..…………. (5) 
ୢ[୘ஒୖ୍ి౗౬౛]
ୢ୲
 = kiେୟ୴ୣ ∗ [TβRI] − krେୟ୴ୣ ∗ [TβRIେୟ୴ୣ] ……………………………………… (6) 
ୢ[୘ஒୖ୍ుు]
ୢ୲
= ki୉୉ ∗ [TβRI] − kr୉୉ ∗ [TβRI୉୉] + kୈୣ୥
୘ஒୖ୍ ∗ [TβRI୉୉]……………………….… (7) 
ୢ[୐ୖେ]
ୢ୲
=  k୐ୖେ ∗ [TGFβ] ∗ [TβRII] ∗ [TβRI] − kiେୟ୴ୣ ∗ [LRC] − ki୉୉ ∗ [LRC]…………….. (8) 
ୢ[୐ୖେి౗౬౛]
ୢ୲
=  kiେୟ୴ୣ ∗ [LRC] − krେୟ୴ୣ ∗ [LRCେୟ୴ୣ] − k୪୧ୢ ∗ [LRCେୟ୴ୣ] ∗ [Smad3_4n]….…. (9) 
ୢ[୐ୖେుు]
ୢ୲
=  ki୉୉ ∗ [LRC] − kr୉୉ ∗ [LRC୉୉] − kୡୢ ∗ [LRC୉୉]……………….…………….. (10) 
ௗൣௌ௠௔ௗଷ೎೤೟൧
ௗ௧
= −݇ூ௠௣
ௌ௠௔ௗଷ ∗ ൣܵ݉ܽ݀3௖௬௧൧ + ݇ா௫௣
ௌ௠௔ௗଷ ∗ [ܵ݉ܽ݀3௡௨௖] ∗
௏೙ೠ೎
௏೎೤೟
− ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗
ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗
[ܮܴܥாா]……………………………………………………………………..…………….... (11) 
ௗ[ௌ௠௔ௗଷ೙ೠ೎]
ௗ௧
= ݇ூ௠௣
ௌ௠௔ௗଷ ∗ ൣܵ݉ܽ݀3௖௬௧൧ ∗
௏೎೤೟
௏೙ೠ೎
− ݇ா௫௣
ௌ௠௔ௗଷ ∗ [ܵ݉ܽ݀3௡௨௖ ] + ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗
[ܵ݉ܽ݀3_4௡௨௖ ]………………………………………………………………………….….. (12) 
ௗൣௌ௠௔ௗସ೎೤೟൧
ௗ௧
= −݇ூ௠௣
ௌ௠௔ௗସ ∗ ൣܵ݉ܽ݀4௖௬௧൧ + ݇ா௫௣
ௌ௠௔ௗସ ∗ [ܵ݉ܽ݀4௡௨௖] ∗
௏೙ೠ೎
௏೎೤೟
− ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗
ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗
[ܮܴܥாா]……………………………………………………………………………….……. (13) 
ௗ[ௌ௠௔ௗସ೙ೠ೎]
ௗ௧
= ݇ூ௠௣
ௌ௠௔ௗସ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗
௏೎೤೟
௏೙ೠ೎
− ݇ா௫௣
ௌ௠௔ௗସ ∗ [ܵ݉ܽ݀4௡௨௖ ] + ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗
[ܵ݉ܽ݀3_4௡௨௖ ]……………………………………………………………………………... (14) 
ௗൣௌ௠௔ௗଷ_ସ೎೤೟൧
ௗ௧
=  ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗ ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗ [ܮܴܥாா ] − ݇ூ௠௣
ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗
[ܵ݉ܽ݀3_4௖௬௧]……………………………………………………………………………… (15) 
ௗ[ௌ௠௔ௗଷ_ସ೙ೠ೎]
ௗ௧
=  ݇ூ௠௣
ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗ ቂܵ݉ܽ݀3ସ௖௬௧ቃ − ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗
[ܵ݉ܽ݀3_4௡௨௖ ]……………… (16) 
Parameter Value  Unit  Reference 
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v_TbRII 0.02869 nM∙ min-1  
v_TbRI 0.0103 nM∙ min-1  
kiCave 0.33 min-1  
krCave 0.03742 min-1  
kiEE 0.33 min-1  
krEE 0.033 min-1  
kTbRIIDeg 0.025 min-1  
kTbRIDeg 0.005 min-1  
kLRC 2197 nM-2∙ min-1  
kcd 0.005 min-1  
klid 0.02609 min-1  
kSmad3Imp 0.16 min-1  
kSmad3Exp 1 min-1  
kSmad4Imp 0.08 min-1  
kSmad4Exp 0.5 min-1  
kSmadComplex 0.0000685 nM-1 ∙min-1  
kSmadComplexImp 0.16 min-1  
kSmadComplexDiss 0.1174 min-1  
Vcyt_Vnuc 3 ---  
Table A1. Parameters for the subcellular level model, common to the whole simulation, to all fibroblasts. 
 
Variable Value Unit 
TGFb 0.08 nM 
TbRII 0.202 nM 
TbRII_Cave 1.778 nM 
TbRII_EE 1.148 nM 
TbRI 0.237 nM 
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TbRI_Cave 2.092 nM 
TbRI_EE 2.06 nM 
LRC 0 nM 
LRC_Cave 0 nM 
LRC_EE 0 nM 
Smad3 492.61 nM 
Smad4 1149.4 nM 
Smad3_4 0 nM 
Smad3n 236.45 nM 
Smad4n 551.72 nM 
Smad3_4n 0 nM 
Table A2. Initial conditions for the subcellular level model. 
Our crosstalk model. We extend the above model by incorporating ECM crosstalk. The 
first 10 equations governing receptor internalization and ligand-receptor complex 
formation are specific for TGFbeta signaling and therefore not altered. ECM induced 
Smad3 activation follows the same dynamics as the TGFbeta induced Smad3 activation. 
Therefore the following 8 equations (11a)-(16a), (17), (18) are used in replace of 
equation (11)-(16) in the earlier model.  
ௗൣௌ௠௔ௗଷ೎೤೟൧
ௗ௧
= −݇ூ௠௣
ௌ௠௔ௗଷ ∗ ൣܵ݉ܽ݀3௖௬௧൧ + ݇ா௫௣
ௌ௠௔ௗଷ ∗ [ܵ݉ܽ݀3௡௨௖] ∗
௏೙ೠ೎
௏೎೤೟
− ݇ௌ௠௔ௗ಴೚೘೛೗೐ೣ ∗
ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗ [ܮܴܥாா ] − ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗ ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗ [ܧܥܯ] 
………………………………………………………………………………...….. (11a) 
ௗ[ௌ௠௔ௗଷ೙ೠ೎]
ௗ௧
= ݇ூ௠௣
ௌ௠௔ௗଷ ∗ ൣܵ݉ܽ݀3௖௬௧൧ ∗
௏೎೤೟
௏೙ೠ೎
− ݇ா௫௣
ௌ௠௔ௗଷ ∗ [ܵ݉ܽ݀3௡௨௖ ] + ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗
[ܵ݉ܽ݀3_4௡௨௖ ] + ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗ [ܵ݉ܽ݀3_4௡௨௖ா஼ெ]………………………………….. (12a) 
ௗൣௌ௠௔ௗସ೎೤೟൧
ௗ௧
= −݇ூ௠௣
ௌ௠௔ௗସ ∗ ൣܵ݉ܽ݀4௖௬௧൧ + ݇ா௫௣
ௌ௠௔ௗସ ∗ [ܵ݉ܽ݀4௡௨௖] ∗
௏೙ೠ೎
௏೎೤೟
− ݇ௌ௠௔ௗ಴೚೘೛೗೐ೣ ∗
ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗ [ܮܴܥாா ] − ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗ ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗ [ܧܥܯ] 
………………………………………………………………………………...….. (13a) 
ௗ[ௌ௠௔ௗସ೙ೠ೎]
ௗ௧
= ݇ூ௠௣
ௌ௠௔ௗସ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗
௏೎೤೟
௏೙ೠ೎
− ݇ா௫௣
ௌ௠௔ௗସ ∗ [ܵ݉ܽ݀4௡௨௖ ] + ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗
[ܵ݉ܽ݀3_4௡௨௖ ] + ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗ [ܵ݉ܽ݀3_4௡௨௖ா஼ெ] …………………………………. (14a) 
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ௗൣௌ௠௔ௗଷ_ସ೎೤೟൧
ௗ௧
=  ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗ ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗ [ܮܴܥாா ] − ݇ூ௠௣
ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗
[ܵ݉ܽ݀3_4௖௬௧] …………………………………………………………………………… (15a) 
ௗ[ௌ௠௔ௗଷ_ସ೙ೠ೎]
ௗ௧
=  ݇ூ௠௣
ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗ ൣܵ݉ܽ݀3_4௖௬௧൧ ∗
௏೎೤೟
௏೙ೠ೎
− ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗ [ܵ݉ܽ݀3_4௡௨௖]  
(16a) 
ௗൣௌ௠௔ௗଷ_ସ೎೤೟
ಶ಴ಾ൧
ௗ௧
=  ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗ ൣܵ݉ܽ݀3௖௬௧൧ ∗ ൣܵ݉ܽ݀4௖௬௧൧ ∗ [ܧܥܯ] − ݇ூ௠௣
ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗
[ܵ݉ܽ݀3_4௖௬௧
ா஼ெ]……………………………………………………………………………  (17) 
 
ௗൣௌ௠௔ௗଷ_ସ೙ೠ೎
ಶ಴ಾ൧
ௗ௧
=  ݇ூ௠௣
ௌ௠௔ௗ_஼௢௠௣௟௘௫ ∗ ൣܵ݉ܽ݀3_4௖௬௧
ா஼ெ൧ ∗
௏೎೤೟
௏೙ೠ೎
− ݇ௌ௠௔ௗ_஼௢௠௣௟௘௫஽௜௦௦ ∗
[ܵ݉ܽ݀3_4௡௨௖ா஼ெ]…………………………………………………………………………… (18) 
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